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Abstract 
My thesis hypothesises that cells isolated from human bone marrow could be 
stimulated to differentiate into osteoblasts and that, these cells when cultured on a 
scaffold could be used in the tissue engineering of bone, as the constructs could 
potentially be implanted into patients' bone defects resulting in increased healing. 
The multipotency of the bone marrow-isolated cells was assessed by the use of 
histological stains to show that they could be stimulated to differentiate into 
osteoblasts, chondrocytes and adipocytes. The cells were further characterised by Stro- 
1 and, as a result, were defined as mesenchymal stem cells (MSCs). More specifically, 
it was shown that when the cells were cultured with osteogenic stimulants, the 
production of osteoblastic proteins, such as alkaline phosphatase, osteopontin and 
osteocalcin increased (P<0.05), indicating that they were differentiating into 
osteoblasts. The cells were shown to retain their multipotent potential, and could be 
manipulated by surfaces and culture supplements in vitro. 
The ability of MSCs to differentiate in this way is fundamental for their use in tissue 
engineering of bone. This concept was investigated by growing marrow-isolated 
human MSCs on 3-dimensional porous hydroxyapatite (HA) scaffolds. In this 
environment, MSCs were shown to differentiate into osteoblasts, producing 
extracellular bone matrix proteins, even without the use of osteogenic stimulants. 
In order to simulate living bone conditions, where osteoblasts are perfused with tissue 
fluid, a novel bioreactor was developed for the culture of the MSC-HA constructs. Use 
of the bioreactor, to perfuse MSCs with oxygenated medium, promoted 3-dimensional 
growth of cells and stimulated differentiation into active osteoblasts resulting in 
increased production of extracellular matrix. Furthermore, the flow of medium through 
the scaffold encouraged the movement of cells and increased penetration into the HA 
(P<0.05). 
Cryopreservation was shown to be an effective method of storage, as it did not alter the 
cell function, measured by proliferation and the ability to differentiate into osteoblasts. 
Thus, it can be used as a practical method for storage of MSCs between harvest and 
2 
implantation. These results indicate that, as marrow-isolated MSCs can be cultured 
successfully on a scaffold, they could be used for the tissue engineering of bone and 
implanted into patients to repair bone defects. 
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1.1 Background to thesis 
The aim of this thesis is to investigate the use of cells isolated from human bone 
marrow for the healing of bone defects. It has been suggested that bone marrow 
contains cells that have the potential to differentiate into osteoblasts. Current treatment 
of bone defects that are too large to heal by primary intention require bridging by a 
structural support, which involves the use of metal prostheses and often additional 
bone graft to encourage bone union, neither of which are ideal. 
Tissue engineering is the study of generating tissue from cells cultured in the 
laboratory to repair damaged tissues that would not heal without intervention. 
Engineering of tissue grafts requires the use of appropriate scaffolds on which to grow 
3-dimensional (3-d) cellular structures and which aid the transfer of this tissue to the 
site of defect. Therefore, the hypothesis investigated in my thesis was that cells 
isolated from human bone marrow could be stimulated to differentiate into 
osteoblasts and that these cells, when cultured on a scaffold could be used in the 
tissue engineering of bone, as the constructs could potentially be implanted into 
patients' bone defects resulting in increased healing. 
1.2 Clinical conditions requiring bony reconstruction 
There are many causes of tissue loss, through for example, trauma, infection, neoplasm 
and metabolic disorders, as well as genetic and congenital conditions, and there are as 
many different tissue types from which loss can occur. As this is such a widespread 
problem that is difficult to treat, the cost to society is vast. Since disability can result 
from tissue loss, the goal is healing with the restoration of function. 
Examples of orthopaedic situations that result in bone loss, which will not heal, 
include bone defects associated with fractures, bone tumour excision, revision 
arthroplasties and spinal fusion surgery, for which interventional treatment is therefore 
required to prevent loss of function. Treatment options depend on the tissue type, size 
and site of defect, and include autologous grafting, allograft implantation, synthetic 
substitutes or the use of metal prostheses. However, each of these treatments has 
limitations (see 1.3 Current bone defect treatments). 
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1.2.1 Fractures 
Fractures usually heal by primary union. However fracture non-union, defined as a 
fracture that has failed to unite 6 months after injury, do occur. A fracture will not 
repair if there is a gap between the fracture ends that is too large, either due to bone 
loss, separation by tissue or distraction, all of which are more common following open 
fractures. In these situations, where primary healing has not occurred, other methods of 
repair are needed. 
The concept of a critical bone defect is the smallest sized bony gap that will not unite 
spontaneously (Schmitz & Hollinger 1986). It has been suggested that a distance 
greater than the diameter of the bone is the critical defect size. This critical defect 
concept has been used experimentally in animals to test healing of segmental bone 
defects. 
1.2.2 Bone tumours 
Bone tumours are another source of bone tissue defects. Primary bone tumours are 
rare, especially when compared to metastatic deposits. However, metastases in bone 
are usually multiple and therefore treatment involves the maintenance of structural 
skeletal function by prevention or treatment of pathological fractures, rather than 
curative procedures. Breast, prostate, renal, thyroid and lung carcinomas are the most 
frequently found metastases in the bone. 
Primary bone tumours can be classified into benign and malignant tumours. Osteoid 
osteoma are the most common benign tumours, others include osteoblastomas, 
osteomas and osteochondromas. The need for excision of these tumours varies with 
each case depending on certainty of diagnosis, possibility of malignant transformation, 
site and size of lesion. 
Osteosarcoma is a malignant bone tumour, where proliferating spindle cells produce 
neoplastic stroma. They tend to occur in adolescents and affect males more than 
females. Fifty percent of osteosarcomas occur in the proximal tibia or the distal femur, 
in the metaphysis of the bone. Osteosarcomas can be divided further into different 
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types of osteosarcoma with varying degrees of malignancy. These tumours invade the 
bone locally, but also metastasise. Historically treatment involved amputation. 
Recent use of adjuvant chemotherapy with methotrexate, doxorubicin, cisplatin and 
adrimycin has been shown to improve survival of osteosarcomas from about 15% to 
nearer 50% (Bacci et al. 1991). Advances in imaging such as MRI and CT over the last 
three decades, have allowed the margin of tumours to be more accurately defined. 
These two improvements have made it easier to excise malignant bone tumours rather 
than amputating. Subsequently, studies have shown that limb salvage does not shorten 
the disease free interval or reduce the long-term survival compared with amputation 
(Simon et al. 1986; Springfield et al. 1988), hence modem treatment aims towards 
limb salvage. 
The result of tumour excision and limb salvage is a bony defect that needs to be 
bridged to maintain skeletal function. At the present time this is achieved using 
autologous and allogenic bone graft, autologous vascularised fibula graft or massive 
prosthetic implants. 
1.2.3 Joint fusions 
Spinal fusion is a surgical procedure whereby sequential vertebrae are fused together. 
This can be performed to relieve pain at the joint, by preventing movement between 
the vertebral bodies. Over 20,000 lumbar spinal fusions are performed in the US every 
year. Indications for lumbar spinal fusion include traumatic spinal injury, weakness 
due to infection or tumour, deformities such as scoliosis or spondylolisthesis, after 
discectomy for degenerative disease, and in association with decompression for spinal 
stenosis (Esses & Huler 1992). 
Bone graft is used between the vertebrae to fuse them together and it is the graft that 
once united, provides structural strength rather than the metal fixation, which is used 
initially to hold the position of the spine. Currently, although autologous bone graft is 
taken from the patient's posterior iliac crest at the time of surgery, this is often 
insufficient and is therefore mixed with allograft, to increase the volume. Furthermore, 
there is a significant incidence of donor site morbidity associated with autologous bone 
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graft harvest (Laurie et al. 1984) and allograft also has limitations (see 1.3 Current 
bone defect treatments). 
1.2.4 Revision arthroplasty 
Total hip arthroplasty is one of the most successful treatments for osteoarthritis of the 
hip as it eliminates pain, thereby improving quality of life. In the UK 50,000 total hip 
replacements are performed each year, of which 9% are revision procedures. The 
Swedish hip register quotes that 71% of revision arthroplasties were due to aseptic 
loosening, the most common reason for revision surgery. Furthermore, a long-term 
study has shown that the probability of aseptic loosening after 20 years was 73% for a 
Charnley hip replacement (Jacobsson et al. 1996). Osteolysis induced by wear particles 
has been implicated as a cause of aseptic loosening, as it results in bony defects around 
the prosthesis both in the femur and acetabulum (Horowitz et al. 1993; Jiranek et al. 
1993). As patients live longer and hip replacements are performed on younger patients, 
the number of revision operations will increase. 
Bone defects that result from aseptic loosening need to be filled at the time of revision 
surgery, to ensure fixation of the new prosthesis. Currently, these defects are usually 
filled using a mixture of autologous bone graft, allograft and cement. However, the 
success of bone grafting has been shown to vary in the treatment of such bone defects 
(Gerber & Harris 1986) and custom-made prostheses are often required as graft 
materials are not sufficient to fill the defects. 
1.2.5 Other causes 
There are also other causes of bone lesions, which may manifest themselves as 
segmental bone defects. Osteomyelitis, especially when an infected sequestration is 
present, leads to the formation of bone defects and other conditions, such as 
hyperparathyroidism and gout, can present with lytic lesions in bone. 
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1.3 Current bone defect treatments 
1.3.1 Bone grafts 
Osteogenesis, in relation to bone grafts, refers to the presence of cellular elements 
within a graft which once implanted synthesise new bone. Osteoinduction infers that 
the graft has properties that recruit and stimulate mesenchymal stem cells (MSCs) 
within the host tissue to differentiate into osteoblasts. The term osteoconduction refers 
to a scaffold structure that facilitates the ingrowth of bone. 
1.3.2 Autologous tissue graft 
Autologous grafting is where tissue is taken from another site in the body and 
transplanted into a defect. In the case of bone, graft can be taken from the patients' 
iliac crest. The advantages of autologous grafting are that there is no risk of immune 
rejection and that the graft contains the patient's own osteoprogenitor cells and 
osteoinductive factors, which stimulate the formation of bone following implantation. 
Furthermore, as this type of graft is taken at the time of surgery, under sterile theatre 
conditions, the risk of pathogenic contamination and transmission of infection on the 
graft is reduced. 
However, harvesting of bone graft can result in donor site morbidity, which manifests 
itself as pain and scarring. Additional risks at the donor site include infection and 
haematoma formation. The incidence of donor site morbidity, following bone graft 
harvesting from the iliac crest, was 72 out of 104 harvests (Laurie et al. 1984). The 
amount of graft available for grafting is limited to 10 -15m1 from the anterior iliac 
crest (Wheeless 1996) and this is often insufficient. 
1.3.3 Allogenic bone graft 
Allogenic graft is tissue that is taken from one person and transplanted into another. In 
the case of bone allograft, the main supply comes from femoral heads donated by 
patients, following total hip arthroplasty. Use of freshly obtained allograft induces an 
immune reaction, resulting in likely graft rejection. The graft therefore, either has to be 
blood group and HLA matched, or processed to reduce the immune reaction. In 
comparison to organ transplantation, where it is not possible to remove all the 
antigens, bone graft can be processed to reduce this immune reaction. The aim of this 
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processing is to reduce the immune response with minimal effect on the biomechanical 
strength and osteogenic properties of the graft. 
In the UK, allograft is commonly washed to remove any marrow and blood, the fat is 
removed with alcohol and the graft is cleaned by ethylene oxide. Alone this is 
insufficient to produce an acceptable level of host immune response and hence, most 
grafts are also freeze-dried, which significantly reduces the immune response, but also 
kills osteogenic cells, with the result of reducing primary osteogenesis. The process 
also decreases the biomechanical strength of the graft (Wheeless 1996). Therefore, 
cancellous allograft only acts as an osteoconductive porous scaffold for the ingrowth 
of host bone. 
Additionally, the use of allograft carries the risk of transmission of infection, both 
bacterial and viral. Bacterial contamination of femoral heads donated for use as 
allograft was found to be 22% in one study (Sommerville et al. 2000) and the risk of 
deep bacterial post-operative infection has been approximated to between 10 -15% 
(Dick & Strauch 1994; Lord et al. 1988). 
The risk of transmission of viral infections such as hepatitis B, C and HIV by allograft 
is greatly reduced if the graft is washed and freeze-dried, as this processing removes 
most of the marrow and blood, although it does not constitute sterilization. The donors 
are therefore screened at the time of donation and six months later for viruses that are 
transmitted via blood. The estimated risk of transplanting graft from an HIV positive 
patient has been calculated as less than 1 in 1.6 million (Buck et al. 1989) and there 
have been no reported cases in the US of viral transmission by allograft since 1995. 
Although autoclaving bone graft sterilises it, reducing the risk of transmission of 
infection, heating also denatures proteins including Bone Morphogenic Proteins 
(BMPs). However, cleaning allograft with ethylene oxide and freeze-drying does not 
destroy all BMPs, thus some osteoinductive properties remain in the graft (Goldberg & 
Stevenson 1987). 
Unfortunately, the availability of allograft is limited due to the lack of donors, each of 
whom has a fixed supply. Furthermore, the bone needs to be processed and stored in 
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tissue banks, which are expensive to run. Thus, the demand for allograft for use at 
revision hip surgery has been predicted to exceed supply in the next 5 years (Galea et 
al. 1998). 
When comparing autologous bone graft with allograft, the most noticeable difference 
is that the incorporation of allograft into bone is slower, resulting in longer healing 
times (Glancy et al. 1991). This has been attributed to the immune response induced by 
allograft (Goldberg & Stevenson 1987). 
1.3.4 Synthetic substitutes 
Due to the limitations of autologous and allogenic bone grafts outlined above, 
especially the predicted shortfall in supply, much research has been carried out into 
potential synthetic materials. The ideal bone graft substitute would be biocompatible, 
absorbable, osteoconductive, osteoinductive and structurally similar to bone. Various 
synthetic bone graft substitutes are now available. 
Current grafts, commercially available, can be categorised depending on the material 
used: demineralised bone matrix (DBM), DBM mixed with a second substance, 
calcium phosphate based materials and calcium sulphate based materials. 
DBM is formed from bone graft that has been decalcified by treatment in hydrochloric 
acid, leaving the bone-protein matrix. There is evidence to suggest that segmental bone 
defects grafted with plasma coated DBM heal with a similar torsional strength as 
autologous bone grafting (Bolander & Balian 1986). However, DBM is subject to 
similar risks and limitations as allograft and lacks the structural strength of allografl. 
DBM has also been mixed with substances, such as glycerol, to make a pliable 
material that can be injected as a gel, i. e. Grafton® (Feighan et al. 1995) and with 
calcium sulphate to form putty that can be used to fill irregular defects, i. e. 
Allomatrix®. Although these mixtures may have improved structural properties, they 
still require an allograft substrate. 
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Calcium phosphate, as one of the main components of bone mineral, has been used in 
various forms as bone graft substitutes. Hydroxyapatite (HA) has been derived from 
coral to make grafts that are porous in structure resembling trabecular bone - the 
resulting grafts can be packed into a bone defect. In an animal study, 48 months after 
implantation, autologous graft contained 73% bone, whereas the HA contained 51 % 
bone (Holmes et al. 1987). Thus, although HA is poorly absorbed, it is 
osteoconductive, but additionally, it is fragile to handle. 
Mouldable hydroxyapatites have been developed to improve the handling properties of 
the HA. An example of this is Orthofix®, which is made from tetracalcium phosphate 
and dicalcium dihydrate and is in a form similar to cement. However, the disadvantage 
of this viscous substance is that it can be difficult to squeeze into small bone defects. 
Lastly, calcium sulphate has been used, as it is a biologically inert material that can act 
as a scaffold for the ingrowth of bone. It is available in the form of pellets, known as 
Osteoset®, which dissolve rapidly, within a couple of months of implantation. 
Although a disadvantage of HA is that it has been suggested to be absorbed too slowly, 
in comparison calcium sulphate based materials may fail before the bone has healed. 
Therefore none of these synthetic bone graft substitutes are ideal. 
1.4 Tissue engineering 
The definition of tissue is a group of cells united to perform the same specific function 
Tissue engineering uses scientific methods of biology, chemistry and engineering to 
grow and maintain living tissue for regeneration (Langer & Vacanti 1993; Oreffo & 
Triffitt 1999). These techniques have been applied to repair damaged liver, pancreatic 
tissue in the case of diabetes mellitus and for the creation of blood vessels (Martin et 
al. 1997). However, for the purpose of my thesis, the use of tissue engineering of bone 
will be discussed. 
For the tissue engineering of bone, the aim is to generate tissue from cells on a 
structural scaffold in vitro for implantation in vivo to repair defects. One of the 
significant benefits of tissue-engineered material over the use of allograft is that 
autologous cells can be used. In comparison to autologous tissue grafting, tissue 
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engineering requires a smaller donor site, as harvested cells can be expanded in 
culture, reducing donor site morbidity. 
1.4.1 Basic Components of Skeletal tissue engineering 
CELLS X SCAFFOLD 
Osteoprogenitor I Osteoconductive 
BIOACTIVE 
FACTORS 
BMP 
It is suggested that three factors are necessary for skeletal tissue engineering: cells, 
scaffold and bioactive factors. 
1.4.1.1 Cells 
Progenitor cells would be useful for tissue engineering due to their capacity for 
proliferation. However, they need to be stimulated to differentiate down the specific 
lineage and synthesise extracellular proteins, forming a matrix. Bone marrow is a 
source of osteoblast progenitor cells (see 1.7 Mesenchymal stem cells), thus isolation 
of these cells will be investigated for tissue engineering in this thesis. 
1.4.1.2 Scaffold 
For tissue engineering the scaffold used needs to meet certain criteria. Firstly, the 
scaffold is required to support the growth of cells, therefore the surface material must 
be biocompatible allowing cell attachment. The scaffold should also be porous, to 
encourage the diffusion of nutrients and colonisation of cells into its centre in a 
uniform distribution. Once implanted, a porous scaffold will also allow rapid 
vascularisation and the material should be absorbed as cellular regeneration occurs. 
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1.4.1.3 Bioactive factors 
Osteoinductive agents used in tissue engineering are chemotactic for osteoprogenitor 
cells. These agents include growth factors such as fibroblastic growth factor, insulin 
growth factor, platelet-derived growth factor and in the case of bone, BMPs. This last 
factor has been used with a combination of HA scaffolds and been shown to improve 
repair of bone defects in rats compared with HA alone (Takagi & Urist 1982). 
However, the dose of BMP necessary to induce bone regeneration is many times 
greater than those detected in normal bone tissue (Boyne et al. 1997; Howell et al. 
2002; Noshi et al. 2000). Large doses of bovine BMP would cause concern in human 
clinical trials and recombinant BMP is expensive. It may be possible to use gene 
therapy to enhance cellular production of these factors, as it has been shown that MSCs 
transfected to encode for BMP-2 increase healing of large bone defects (Lieberman et 
al. 1998). 
1.5 What is a stem cell 
Stem cells have been the subject of much research over recent years due to their 
potential for medical treatments. The definition of a stem cell however, has remained 
contentious. Stem cells have been described as "cells with the capacity for unlimited or 
prolonged self-renewal that can produce at least one type of highly differentiated 
descendant" (Watt & Hogan 2000). A further definition of stem cells is "a cell type by 
which in the organism can maintain its own numbers, in spite of physiological or 
artificial removal of cells from the population" (Lajtha 1982). 
A key factor is that all the different cell types present within a foetus are derived 
originally from a single cell. Thereby, cells present early within the embryo must be 
able to differentiate into any cell type and are thus known as totipotent stem cells. As 
these totipotent cells are usually derived from embryos of aborted foetus or in vitro 
fertilised eggs, ethical considerations have restricted embryonic stem cell research 
(Annas et al. 1996). 
It has been shown that such cells, with the capacity to differentiate into different cell 
types, can be derived from various adult mammalian tissues and these cells have been 
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shown to possess some of the qualities of stem cells. However, in addition to the 
controversy on the definition of stem cells, no specific marker has been found to 
identify all stem cells, making the labelling of stem cells within a tissue difficult. 
Another key factor is that, in contrast to embryological development, the role of cell 
division in the adult is to maintain a constant number of each cell type within tissue. 
Human tissue can be classified into three types denoted by the rate of cell turnover: 
static cell populations, conditional renewal populations and permanently renewing 
populations (Leblond 1963). Each tissue type has been found to contain cells that meet 
the criteria for stem cells, thus it is suggested that these cells are the source of new 
cells. 
The first type of tissue is composed a static population of cells, which do not 
regenerate in the adult and most of the development is antenatal, for example nerves. 
However, within the central nervous tissue of rats and mice, there are cells with the 
capacity for self-renewal and differentiation, hence they fulfil the current definition for 
stem cells (Doetsch et al. 1999; Johansson et al. 1999). This suggests that other factors 
as well as the presence of these cells are necessary for regeneration. 
Liver is an example of the second tissue type identified, as cell division is in response 
to stimuli, allowing renewal of the tissue. Hepatic stem cells have been found to persist 
in liver as a source of progenitor cells that can differentiate to replace mature 
hepatocytes (Sell 1990). 
Lastly, there are tissues comprising of mature cells with short half-lives that are 
constantly replaced by proliferating progenitor cells, for examples blood and skin. 
Within the haematopoietic lineage, a common precursor cell has been identified by the 
CD34 antigen (Dexter & Spooncer 1987). This and other antigens have aided 
characterisation of the lineage, showing that a multipotent stem cell (cells that can 
differentiate down several cell lineages within a tissue) is present, which differentiates 
into different types of blood cell (Baumheter et al. 1993; Huss et al. 2000). 
Furthermore, embryonic stem cells can be stimulated to differentiate into cells from 
different types of tissues, suggesting potency between different lineages. There is 
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evidence that some stem cells from adult tissue may possess this property, as marrow 
stem cells can be stimulated to differentiate into hepatic cells (Petersen et at. 1999) and 
neural stem cells differentiate into haematopoietic cells (Bjornson et al. 1999). 
In summary, the main properties of stem cells are their ability to maintain a stem cell 
pool and to produce various differentiated cells. 
1.5.1 Self-renewal 
Stem cells are thought to divide to produce a progenitor cell, which maybe committed 
to a specific cell type, and a daughter stem cell. These progenitor cells multiply rapidly 
before dividing into differentiated cells, thereby increasing the number of 
differentiated cells produced from a single stem cell. Therefore, although stem cells are 
present at a low density within the tissue and divide infrequently, the number of 
differentiated cells can be maintained by the pool of progenitor cells that is created 
from the division of a single stem cell (Morrison & Weissman 1994; Watt & Hogan 
2000). 
1.5.2 Methods of Division - asymmetric & symmetric 
The division of stem cells to produce a differentiated cell and a stem cell can be 
achieved by two methods of division. Asymmetric division, where a stem cell divides 
into a stem daughter cell and a differentiated daughter cell, and symmetric division, 
where a stem cell divides into either two stem or two differentiated cells. On average, 
both methods achieve equal numbers of stem and differentiated cells per population, 
hence the method of division is indistinguishable from examination of tissue. 
Asymmetric division is observed in unicellular organisms and invertebrates such as the 
Drosophilia ovary and symmetric division is more frequently seen in mammalian cells 
(Morrison et al. 1997). 
1.5.3 Control of division 
Stem cell proliferation can be a normal response to tissue damage, whereby cells 
divide and produce differentiated cells to replace cells (Forge et al. 1993). In this case, 
cell division could be stimulated by mitogens released by cell death or the removal of a 
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protein normally produced by healthy cells that acts in a negative feedback 
mechanism. 
In addition to this, the division of stem cells into a differentiated cell and a replacement 
stem cell is controlled by intrinsic and extrinsic factors. The intrinsic mechanisms for 
asymmetric divisions involve nuclear factors controlling gene expression and 
chromosomal modifications. 
Extrinsic, environmental factors have been identified in the control of mammalian 
stem cell division. The idea of a niche model was developed, suggesting that stem cells 
reside within a specific microenvironment that keeps them in their stem cell state (Hall 
& Watt 1989). Therefore, when a stem cell divides there is only limited space within 
this area for the presence of one stem cell, for self-renewal. The other daughter cell 
leaves the niche, subsequently differentiating. Thus, as the local environment affects 
the phenotype of the daughter cells produced by symmetric division, this can limit the 
proportion of stem to differentiated cells (Kimble et al. 1992; Potten & Loeffler 1990). 
The surfaces of keratinocyte stem cells express ß1 integrin, the adhesion of which to 
the extracellular matrix, preventing its loss has been found to suppress differentiation 
(Jones & Watt 1993). Thus, while this integrin is expressed, cells are held within the 
stem cell niche thereby preventing differentiation. Following loss of this protein, cells 
leave the niche, where extracellular matrix proteins can then act as extrinsic factors to 
stimulate differentiation. 
Further external control of stem cell division within the niche is achieved through cell- 
cell contact via the Notch receptor. The Notch family are transmembrane receptors that 
are involved in signalling pathways between cells directing them to adopt different cell 
fates. Notch activity is required for the differentiation of sensory precursor cells in the 
Drosophilia eye (Artavanis-Tsakonas et al. 1999). 
1.5.4 Control of differentiation 
In addition to the environmental factors discussed above, differentiation occurs as a 
result of cells exiting the stem cell state and entering a specific lineage. There is 
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evidence that entry into a differentiated cell lineage is controlled by gene expression. 
PIE-1 is a germ cell specific nuclear protein that has been identified as an inhibitor of 
the expression of genes involved in the commitment of cells to a differentiated state. 
Therefore, the presence of this protein prevents differentiation of the cell. PIE-1 is 
inherited by only one daughter stem cell during asymmetric stem cell division due to 
blastomere distribution (Mello et al. 1996). Thereby the presence of PIE-1 in one of 
the cells maintains its stem cell state, but its lack in the other cell allows 
differentiation. 
Further investigation into the choice of differentiation lineage by multipotent stem 
cells suggests that growth factors and cell-cell interaction influence the outcome (Shah 
et al. 1996). However, further research is needed into the methods that control stem 
cell division and differentiation, as few controlling factors have been identified so far. 
1.6 Stroma 
Bone marrow connective tissue network is called stroma, the word derived from Greek 
for a bed, as the function of stroma is to support bone marrow by providing a structural 
environment for haematopoiesis. Stroma involves many types of cells and forms a 
complex extracellular matrix, which supports the haematopoietic process. 
Haematopoietic precursors express CD34 (Clark & Keating 1995), thus the presence of 
this protein on cell membranes has been used to differentiate between haematopoietic 
precursors and fibroblastic stromal cells (Huss et al. 2000). 
1.7 Mesenchymal stem cells 
In the trilaminar embryo, the mesodermal (middle) layer forms between the ectodermal 
and endodermal cell layer. This mesodermal cell layer contains mesenchymal stem 
cells (MSCs), which develop into connective tissue (mesenchyme). MSCs are a 
population of multipotent mesenchymal progenitor or stem cells that persist after birth. 
1.7.1 History and nomenclature of MSCs 
Alexander Friedenstein was a Polish scientist working in Moscow, when he pioneered 
research into bone marrow and stromal precursor cells. He discovered evidence for 
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fibroblastic progenitor cells in bone marrow by showing that colonies, measuring 
about 0.5cm in diameter and containing thousands of fibroblastic cells, formed when 
bone marrow was plated in vitro for 10 days. He suggested that these colonies resulted 
from multiple divisions of a single cell and that this was characteristic of stem cells. 
Therefore, Friedenstein named these cells Colony Forming Units-Fibroblastic (CFU-F) 
(Friedenstein et al. 1966; Friedenstein et al. 1970). 
Maureen Owen, working with Friedenstein and Beresford, adopted the term marrow 
stromal cell in the 1980's to describe cells that are isolated from bone marrow with the 
potential for skeletal differentiation (Beresford 1989; Owen & Friedenstein 1988). 
However, Triffitt raised concerns with the use of this term, as stromal cells also 
include reticular cells, epithelial cells and macrophages that are haematopoietic in 
origin and do not differentiate down skeletal cell lines (Seshi et al. 2000; Triffitt 1996). 
Caplan has consistently referred to these isolated marrow cells as mesenchymal stem 
cells (Caplan 1991), although the use of this term has been criticised as the stem cell 
nature has still to be fully proved. 
1.8 Characteristics of MSCs 
1.8.1 Self-renewal capacity 
As discussed above, stem cells have the capacity for self-renewal, maintaining a 
population of stem cells within the tissue, despite differentiating into other cell types. 
It has been shown that in culture 20% of MSCs are in the quiescent Go phase of the 
cell cycle. Cells that are in this phase replicate infrequently and have been shown to 
possess the stem cell characteristic of self-renewal, hence this is consistent with the 
presence of a low density of MSCs in tissue (Conget & Minguell 1999). 
When regeneration of tissue is needed following cell death, the stem cells have the 
ability to rapidly produce a large number of progenitor cells. This high proliferation 
capacity was first noted by Friedenstein (Friedenstein 1976) and has been confirmed 
more recently, where proliferated MSCs have been shown to retain their differentiation 
ability (Bruder et al. 1997b). 
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1.8.2 Bone marrow cells' differentiation 
The ability of marrow to form bone was first suggested by Goujon as early as 1869. 
Little more was discovered about the potential of cells present in marrow until the last 
three decades, when it has been shown that they have the ability to differentiate down 
the different mesenchymal cell lines, including chondroblastic, adipocytic and 
osteoblastic. In 1970, Friedenstein first provided evidence that CFU-F were 
multipotent stromal cells capable of supporting haematopoiesis, as when mouse 
marrow CFU-F cells were transplanted under the renal capsule several cell lines - 
bone, adipose and marrow reticular tissue were found to produced (Friedenstein et al. 
1970). Later, evidence of host cellular haematopoiesis within this heterotopic bone was 
found (Friedenstein 1980). 
Bone marrow was initially shown to have osteogenic potential. When rat marrow was 
implanted in vivo in a diffusion chamber, about 40% of CFU-F formed osteogenic 
tissue within the chambers (Friedenstein 1976). More recently, these results have been 
confirmed, as when human marrow was loaded into a diffusion chamber and implanted 
intraperitoneally into athymic mice, mineralised tissue formed after 4 to 8 weeks (Bab 
et al. 1988b). 
However, cartilage has also been noted to form in the centre of the chamber (Bab et al. 
1984), suggesting that marrow contained both osteoblastic and chondrocytic 
precursors. The formation of cartilage in the centre of the chamber is consistent with 
chondrogenesis occurring preferentially in an avascular environment. 
In an additional experiment, when HA ceramics have been loaded with bone marrow 
and implanted subcutaneously or intraperitoneally into rats, it has been shown that 
bone forms in the pores of the ceramic 3-4 weeks after implantation (Ohgushi et al. 
1989a). This has been a reproducible finding that confirmed the presence of an 
osteoblast precursor cell in bone marrow. 
1.8.3 MSC differentiation 
MSCs that have been isolated from whole bone marrow have been proposed as skeletal 
precursors, as discussed. Evidence for MSCs possessing the ability to differentiate into 
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osteoblasts was demonstrated in studies where MSCs were separated from rat marrow, 
grown in vitro, then implanted subcutaneously on HA scaffolds. Two weeks after 
implantation bone was noted to have formed, confirming that isolated MSCs from 
marrow differentiate into osteoblasts (Dennis et al. 1992; Goshima et al. 1991b). This 
finding has been confirmed by various groups, showing that human MSCs loaded onto 
HA and implanted subcutaneously in an animal model form bone, thus this method has 
also been used as an assay for the presence of MSCs (Haynesworth et al. 1992b; 
Lazarus et al. 1997). 
In vitro work has further characterised the differentiation potential of MSCs, by 
showing that marrow-isolated cells, with homogenous morphology, do not 
differentiate in standard culture conditions (Beresford 1989), but can be stimulated to 
differentiate into osteoblasts, chondrocytes and adipocytes under appropriate 
conditions. Various research groups have shown that MSCs isolated from rat marrow 
can be differentiated into osteoblastic expressing cells when cultured in vitro using 
glycerophosphate, ascorbic acid and dexamethasone (Maniatopoulos et al. 1988; 
Ohgushi et al. 1996a). When cultured under the same conditions, human MSCs also 
differentiate into osteoblastic cells, identified by the increased production of bone 
markers (Jaiswal et al. 1997). Therefore, marrow-derived MSCs possess osteoblastic 
potential, although this may be via an intermediate osteoblastic progenitor cell. 
In addition to MSCs possessing osteogenic differentiation potential, the multipotency 
of these marrow cells has been suggested, as MSCs have been differentiated into 
chondrocytes. Conditions that stimulate chondrocytic differentiation of rat MSCs in 
culture include dexamethasone, TGF-ß 1 and 3-dimensional cell aggregates (Johnstone 
et al. 1998). These culture conditions have also been shown to have the same effect on 
MSCs isolated from human marrow (Mackay et al. 1998). 
Human MSCs can also be differentiated into adipocytes, following culture with larger 
doses of dexamethasone (Cui et al. 1997). The results of these experiments show that 
MSCs isolated from human bone marrow can be differentiated down the osteoblastic, 
chondrocytic and adipocytic cell lineages, which confirms their multipotency and is 
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further evidence of their mesenchymal stem cell origin (Pittenger et al. 1999). These 
MSCs are the source of cells responsible for connective tissue healing. 
Of the lineages, the osteoblastic and adipocytic cell lines seem to be more closely 
related, as there is evidence that a single transduction pathway controls the 
differentiation between these two lineages. The levels of MAP kinase increase when 
the cells are stimulated to differentiate into osteoblasts. Conversely, the blockage of 
this pathway causes the cells to differentiate into adipocytes (Jaiswal et al. 2000). This 
suggests that MSCs differentiated into osteoblasts or adipocytes depending on the 
MAP kinase levels. It is of interest to note that MSCs sub-cultured many times retain 
the potential to differentiate into osteoblasts, but fail to differentiate into adipocytes 
after the third passage (Conget & Minguell 1999). 
There is histological evidence from studying the embryonic development of chick 
limbs that, during endochondral ossification, the cartilaginous framework is replaced 
by bone, but chondrocytes do not differentiate into osteoblasts (Pechak et al. 1986). 
Caplan and Bruder have attempted to outline the osteoblastic differentiation lineage 
using embryological development as a model (Bruder et al. 1994b). 
1.8.4 Homogeneous or Heterogeneous Population 
There has been much debate as to whether MSCs isolated from bone marrow are a 
homogeneous or heterogeneous population of cells. Certainly, marrow-derived 
adherent fibroblastic cells have been referred to as MSCs by several groups of 
investigators, thus assuming the status of homogeneous population. For example, after 
isolation of adherent cells and negative immunoselection for antigens known to be 
specific for haematological and epithelial cells, the cells were referred to as a 
homogeneous population of MSCs (Rickard et al. 1996). Furthermore, MSCs express a 
homogeneous set of antigens suggesting a single cell type, although the individual 
antigens are not unique to MSCs being shared with epithelial cells (Conget & Minguell 
1999). 
Cell culture work has raised concerns about the homogeneity of MSCs. Owen's 
experiments proposed that cells within colonies were heterogeneous, as the cellular 
expression of alkaline phosphatase (ALP) varied between cells throughout a colony 
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(Beresford & Owen 1998). These findings could also be explained by an initial stem 
cell dividing into a daughter stem cells and a progenitor cell, which in turn 
differentiates into an ALP-producing osteoblast. Thus, an isolated population of 
homogenous MSCs would produce a heterogeneous population of cells, although these 
observations would be indistinguishable from an initially heterogeneous population of 
cells. 
Further, as isolated MSCs are low in density and proliferate rapidly, it is difficult to 
study the initially isolated population. However, comparison between marrow cells 
from different donors and collection at different times has revealed large variations in 
growth rate and osteoblastic differentiation potential (Phinney et al. 1999). 
It has also been shown that only 58% of MSCs when assayed in vivo have the capacity 
to form bone (Kuznetsov et al. 1997). This may be the result of stem cell renewal to 
maintain a pool or progenitors committed to other cell lineages. This suggests that 
mesenchymal cells isolated from marrow form a heterogeneous population of cells, but 
until there are specific markers for stem cells and each precursor cell, it is likely that 
this question will remain unanswered. 
1.9 Markers of MSCs 
In the haematopoietic cell lineage, the multipotential stem cell, committed progenitor 
cells and mature cells were identified initially by their morphology (Dexter & 
Spooncer 1987). Furthermore, markers for specific colony-stimulating factors that 
stimulate the differentiation of cells at each step along the lineage have been identified, 
making it possible to characterise cells at each step (Orlic & Bodine 1994). However, 
the characterization of a MSC and its derivatives has proved more difficult due to the 
lack of identification of similar factors. The nature of stem cells to differentiate into 
multiple cell lines means that the phenotype varies and specific markers for cells at 
different stages have yet to be identified. 
Despite these difficulties, various groups have investigated ways to identify markers 
for MSCs. Simmons identified a monoclonal antibody Stro-1 that recognizes marrow 
stromal progenitor cells in bone marrow (Simmons & Torok-Storb 1991). Stro-1 
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antibody binds to 10% of mononuclear cells in bone marrow, but was not found to 
react with haematopoietic precursors in the marrow (Simmons & Torok-Storb 1991). 
Stro-1 separated marrow cells were shown to differentiate into osteoblasts, 
chondrocytes and adipocytes when cultured with the correct stimuli (Ahdjoudj et al. 
2001). Furthermore, MSCs have been shown to express high copy numbers of Stro-1 
and therefore, Stro-1 has been suggested as a useful marker of MSCs. 
Hybridomas can also be used to raise monoclonal antibodies against specific cellular 
antigens. Caplan and colleagues have generated hybridoma lines that secrete antibodies 
that recognise antigens on the cell surface of differentiating isolated marrow cells, but 
do not label mature osteoblasts. Despite the identification of these monoclonal 
antibodies no exclusively specific marker for MSCs has been developed. 
1.10 Markers of osteoblastic lineage cells 
Characterisation and identification of cell markers for osteoblastic cells at each stage 
of differentiation has been researched, partly to aid characterisation of MSCs, as well 
as defining the osteoblastic cell lineage. 
Attempts have been made to raise monoclonal antibodies against cells along the 
osteoblastic lineage and monoclonal antibodies SH-1 (Bruder & Caplan 1990), 2,3 & 
4 (Haynesworth et al. 1992a) have been raised, with varying combinations of 
expression being evident by cells at different stages of mesenchymal differentiation. 
The monoclonal antibody SB-10 recognises a further cell surface antigen expressed on 
isolated human marrow cells, but does not react with cells that express ALP, hence it is 
a marker of early osteoblast precursors rather than osteoblasts themselves (Bruder et al. 
1997a). The expression of these antigens has been used by the authors as evidence for 
an osteoblastic differentiation pathway (Bruder et al. 1994a; Caplan 1991). 
There are currently no other methods to confirm these stages of cell differentiation. 
Additionally, there has been limited success in confirmation of such stages, as these 
antibodies have reacted diversely to the cell surface, cytoplasm and extracellular 
matrix proteins, and very few antibodies have detected cells other than the most mature 
in the osteoblast cell lineage (Aubin & Turksen 1996). 
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Therefore, in addition to cellular markers, a further method of identification of cells at 
different stages of maturity is by the changing biochemical features of the cells. 
Extensive investigation of osteoblast progenitor cells by Aubin et al has suggested that 
the gene expression indeed changes as the cells mature from osteoblast progenitors to 
pre-osteoblasts to osteoblasts, and correspond with decreasing proliferation and 
increasing differentiation. Therefore protein or mRNA expression can be used as 
temporal differentiation markers. Using relative gene expression over time the three 
phases of osteoblastic differentiation postulated (Lian & Stein 1992), are: 
1. Proliferation 
2. Extra-cellular matrix maturation 
3. Mineralisation 
Markers of proliferation include the gene expression of histones, proto-oncogenes 
(such as c-fos and c-myc) (McCabe et al. 1995). From the study of these it has been 
suggested that osteoblast progenitor cells divide eight times before they differentiate 
and start to produce osteoblastic extracellular matrix. 
Using methods to detect mRNA (poly-A-PCR and in situ hybridization) and 
immunocytochemistry to label individual cells, specific proteins were found to be 
modulated during the process of differentiation (Aubin 1998). 
Initially active cells, during the proliferation stage, express collagen type 1, 
osteopontin and fibronectin. As the proliferation rate decreases, this is coupled with an 
increase in matrix production, with production of ALP and a second peak in 
osteopontin. This is followed by an increase in bone sialoprotein (BSP), a glycoprotein 
essentially found in mineralising connective tissue, and osteocalcin with the onset of 
mineralisation (Owen et al. 1991). 
There are thought to be restriction points in the gene expression at the end of the first 
and second stage of osteoblastic differentiation. The extra-cellular matrix deposition 
contributes to both the reduction in proliferation rate and the development of the 
osteogenic phenotype. These interactions control whether cells proliferate further or 
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differentiate and are especially important in tissue remodelling and new bone 
formation (Stein et al. 1990). 
However, there are variations in the stage of osteoblastic differentiation at which 
maximal levels of individual gene expression have been detected. For example, instead 
of peaking during proliferation, collagen type I mRNA was found to peak during 
matrix mineralisation (Malaval et al. 1994). This may reflect the method used to 
measure mRNA. However, there is evidence that the effect of growth factors, in 
stimulation of gene expression by the osteoblastic target cell, is affected by the 
individual cell's stage of differentiation. Therefore, this variation noted in gene 
expression, may result from different cell conditioning and may further be explained 
be the heterogeneity of MSCs at different stages of differentiation in culture (Liu et al. 
1997), which, as markers of differentiation makes the use of gene expression by cells 
limited. 
Osteoblast progenitor cells isolated from bone marrow can be separated on the basis of 
their expression of ALP. The cells that were found to be ALP positive formed bone 
nodules in culture without dexamethasone, however cells that did not express ALP 
needed the stimulation of dexamethasone to mature forming bone nodules (Turksen & 
Aubin 1991). It was therefore suggested these represent osteoblast progenitor cells in 
different stages of differentiation. However, it could also represent committed and 
uncommitted osteoblast progenitor cells, with the latter requiring further stimulation to 
trigger osteoblastic differentiation. 
The characterisation of the postulated MSC cell line has therefore developed, initially 
from the identification and variation in different mature and precursor cell types. 
1.11 Osteoblastic cell markers 
1.11.1 Extracellular matrix proteins 
Extracellular matrix proteins form the basis for bone synthesis, thus production of 
these proteins is characteristic of the osteoblastic phenotype and can be used as 
markers for osteoblastic cells in vitro. The following are a list of such proteins, the 
presence of which is used to confirm production of extracellular matrix: 
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Collagen type I is the single most abundant protein in the body and the major organic 
component of bone. It is produced during the proliferation phase of osteoblastic 
development, making it an early recognisable marker of osteoblastic function (Risteli 
& Risteli 1993). As seen under transmission electron microscopy, the collagen fibrils 
are arranged staggered end to end in an ordered cross-banding pattern. 
Osteocalcin is an important non-collagenous protein of bone that is vitamin K 
dependent and has a low molecular weight (Brozovic 1976). It is synthesised 
exclusively by osteoblasts and ondoblasts (Price 1985), being produced during the 
mineralisation stage of osteoblastic differentiation. Osteocalcin is known to bind 
calcium mineral in bone, although its precise function is not fully understood. It may 
also act as a cytokine for the chemo-attraction of osteoblasts and osteoclasts (Malone 
et al. 1982). Consequently, osteocalcin levels in serum and synovial fluid have been 
shown to correlate with new bone formation and conditions of increased bone 
turnover, for example Paget's disease (Eyre 1997). 
Osteopontin protein is located at the cell-matrix interface in mineralised tissue 
deposited by osteoblasts. Osteopontin binds to calcium within the extracellular bone 
matrix, anchoring osteocalcin in the mineral. The expression of osteopontin by 
osteoblasts is increased as a result of the over expression of Cbfa-1 (Tsuji et al. 1998). 
Additionally, mechanical forces have also been shown to influence osteopontin 
expression, as intermittent hydrostatic compression of osteoblasts in culture increases 
osteopontin and ALP protein and mRNA levels (Klein-Nulend et al. 1997; Kubota et 
al. 1993). It has been suggested that these forces act on cell attachment, modifying the 
gene expression via a signalling pathway. 
Osteopontin is therefore a useful marker of osteoblastic activity, although it is a non- 
specific marker, as it is widely expressed in body fluids particularly at sites of 
inflammation. Evidence of this is seen in the elevated levels of osteopontin found in 
humans during metastatic cancer and sepsis. The expression of osteopontin in these 
conditions may result from the high number of proliferating cells. 
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Osteonectin is another protein present in the extracellular matrix of bone. Its action 
involves modifying the interaction between cells and the extracellular matrix (Termine 
et al. 1981). It has also been shown to increase the production of other proteins, 
including collagen, by fibroblasts and endothelial cells, therefore it a non-specific 
marker of osteoblasts. Furthermore, osteonectin mRNA expression was not found to 
change significantly during osteoblast development (Malaval et al. 1994), suggesting 
that it is less useful as a marker of osteoblastic cells. 
Bone sialoprotein (BSP) is an attachment protein that is found exclusively in bone 
(Oldberg et al. 1988a). It acts as an integrin binding protein with an affinity for the 
vitronectin cell receptor and collagen, which suggests that it mediates the attachment 
between cells and collagen (Oldberg et al. 1988b). BSP has been identified, by 
immuno-histochemistry, preceding mineralisation of the extracellular matrix, 
suggesting that BSP is a necessary trigger for mineralisation (Roach 1994). 
1.11.2 Isoenzymes 
Alkaline phosphatase (ALP) is an enzyme that catalyses the hydrolysis of phosphate 
esters at an alkaline pH. Bone, liver and kidney isoenzymes of ALP have been 
identified and the skeletal isoform of ALP is a glycoprotein on the cell and nuclear 
membranes and in the cytoplasm of osteoblasts. 
Gene expression for ALP begins, following the cessation of osteoblastic proliferation 
stage, increases during matrix maturation and declines with mineralisation. This 
implies that ALP is important during the initiation of mineralisation (Stein et al. 1990). 
Total ALP expression has been recognized as a reliable indictor of osteoblastic activity 
in the Saos-2 osteosarcoma cell line (Rodan et al. 1987) and ALP serum levels are 
frequently used clinically to assess both physiological and pathological bone turnover. 
Therefore, ALP is a widely used marker of osteoblast phenotype (Risteli & Risteli 
1993). 
1.11.3 Transcription factors 
Signals initiate DNA transcription of the corresponding gene prior to synthesis of the 
extracellular proteins. Hence these signals, known as transcription factors, are present 
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within the cells before the protein and are indicators of early cell differentiation. Cbfa- 
1 is a transcription factor within osteoblastic cells that is part of the runt-domain gene 
family and is essential for bone formation. It was found that Cbfa-1 knockout mice 
were unable to mineralise extracellular matrix to form bone, although osteoblastic cells 
expressed ALP. As a result the mice died just after birth due to suffocation (Komori et 
al. 1997). 
Cbfa-1 expression has been detected in osteoblasts and T-cells, and weakly in 
chondrocytes and dermal fibroblasts, but it seems to be specific to connective tissue, as 
it is not found in fibroblasts elsewhere. 
In the embryological development of mice, cells within mesenchymal condensations at 
12.5 days post-conception expressed Cbfa-1 and by day 16 mesodermal cells destined 
to become skeletal tissue, in both intramembraneous and endochondral bone 
ossification centres also expressed Cbfa-1 (Ducy et al. 1997). This provides further 
evidence that Cbfa-1 is a marker of early skeletal development. 
In rats, the DNA binding site for Cbfa-1 has been identified in the promoter region of 
the gene for osteocalcin (Merriman et al. 1995), suggesting that Cbfa-1 signals 
osteocalcin transcription. In addition to osteocalcin, in mouse mesenchymal cells 
osteopontin and BSP genes also have Cbfa-1 binding sites (Duey et al. 1997). 
Therefore, the expression of these genes is also induced by the transient expression of 
Cbfa-1 transcription factor. As osteocalcin production in closely related to the 
mineralisation of bone, it has been suggested that Cbfa-1 is an essential factor for 
osteoblastic maturation, as suggested above. Therefore, it has been used as a marker 
for differentiating osteoblasts in vitro (Gori et al. 1999). 
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1.12 Potential clinical uses for MSCs 
As discussed in section "1.2 Clinical conditions requiring bony reconstruction" there 
are many clinical conditions that are currently treated with various types of bone 
grafting. As these treatments are less than ideal, methods using bone marrow and 
MSCs could potentially improve treatment. 
1.12.1 Evidence for the use of bone marrow to heal segmental bone defects 
Red bone marrow has been known to form bone since the late 1800's, therefore it has 
been suggested that marrow could be used to augment bone healing. Marrow and 
marrow cells separated by centrifugation have been injected percutaneously into radial 
fracture defects, with the effect of increasing osteogenesis (Connolly et al. 1989b). 
The Connolly group has since investigated the use of marrow in healing of 20 un- 
united tibial fractures with good results, suggested to be equivalent to autologous bone 
grafting. Nineteen of the 20 fractures, originally Gustilo-Anderson type III had failed 
to unite following multiple attempts however, after marrow injection 18 of the 
fractures united (Connolly et al. 1991b). This suggests that from within the marrow 
osteoprogenitor cells proliferated and differentiated to form bone. 
The use of bone marrow to increase healing of a segmental bone defect has also been 
shown in rats, when porous calcium phosphate ceramics were loaded with marrow and 
implanted into the defect, bone union occurred after 2 months in 8 out of 12 defects 
(Ohgushi et al. 1989b). 
1.12.2 Use of MSCs to heal segmental bone defects 
As the ability of marrow to regenerate bone is attributed to MSCs and progenitor cells 
present within it, the use of MSCs to heal a segmental bone defect has been 
investigated. When culture expanded autologous MSCs were re-implanted on a 
ceramic into a canine bone defect, the healing rates improved after 16 weeks (Bruder et 
al. 1998a). Other groups have also improved healing of a critical bone defect in a sheep 
model, by implanting culture expanded MSCs on HA (Kon et al. 2000). However, the 
injection of isolated and culture expanded rat MSCs into a distraction model was not 
found to improve bone regeneration and healing, as new bone formed independently of 
whether cells were injected or not (Richards et al. 1999). 
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A myocutaneous flap can be used to transpose muscle and skin to reconstruct a tissue 
defect. As bone has been shown to form when human MSCs have been implanted on a 
HA scaffold on a latissimus dorsi flap in nude mice (Casabona et al., 1998), a 
myocutaneous flap could be converted to an osteo-myocutaneous flap. This procedure 
could be performed with autologous marrow and would avoid bone graft harvest and 
its complications. 
1.12.3 Potential treatment of osteoporosis with MSCs 
As osteoporosis causes at least 1.5 million fractures in the US per year, it is a key 
cause of morbidity and mortality in the elderly population. It is the result of an 
imbalance between bone re-absorption and production, due in part to reduced levels of 
protective oestrogen hormone, consequently reducing skeletal bone mass. 
It has been suggested from in vitro research, that in animals the number of MSCs per 
volume of marrow decreases with age (Bergman et al. 1996; Huibregtse et al. 2000). It 
has also been suggested that the proliferation rate (Egrise et al. 1992) and 
differentiation rate of MSCs into osteoblasts is lower in osteoporosis (Rodriguez et al. 
1999). 
As noted above, the differentiation of MSCs down the osteoblastic and adipocytic cell 
lines is closely related (Jaiswal et al. 2000), (see 1.8.3 MSC differentiation section). In 
osteoporotic patients the decrease in bone volume correlates with an increase in 
adipose tissue (Gimble et al. 1996). Therefore, in osteoporotic bone the MSCs may be 
stimulated to differentiate into adipocytes instead of osteoblasts. 
The potential for use of MSCs in the treatment of osteoporosis has already been 
investigated. Following intravenous injection of culture expanded MSCs into humans, 
engraiment into marrow maybe as low as 1- 2% (Caplan & Bruder 2001). Thus, for 
the treatment of generalised bone diseases, the cells need to be delivered on a carrier to 
the intended site or labelled with specific attachment proteins for tissue targeting. 
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1.12.4 Uses of MSCs in genetic bone disorders 
Osteogenesis imperfecta (01) is a genetic disorder (autosomal dominant), where 
osteoblasts produce defective type I collagen, which results in elastic connective tissue 
and weak bones that become deformed and fracture easily (Primorac et al. 2001). 
Bone marrow has been used with success to treat 3 children with this condition 
(Gerson 1999). Allogenic, HLA matched marrow was infused intravenously into the 
patients. Three months after engraftment, bone biopsies showed that 1.5% - 2% of 
osteoblasts were of donor origin, resulting from infused mesenchymal progenitors 
migrating into the bone and giving rise to normal osteoblasts. However, even with this 
low cellular engraftment rate, the total mineral content of bone increased and the 
fracture rate was reduced (Horwitz et al. 1999). 
An explanation for these observations is that in 01 the severity of the disease is 
dependant on the proportion of normal to abnormal collagen produced. So the 
engrafted osteoblasts, although a small percentage of the total osteoblasts, may 
produce enough normal collagen to shift the balance resulting in clinical improvement. 
Although, further research is needed to determine the number of MSCs needed to give 
long lasting clinical improvement. 
1.12.5 Possible use of MSCs in gene therapy 
As MSCs are also known to disseminate through connective tissues when injected 
intravenously (Pereira et al. 1995), MSCs could have specific genes introduced into 
their genome by viral vectors. These cells could be engrafted into patients with 
connective tissue gene dysfunction resulting in the production of normal proteins, for 
example for the treatment of OI. This could also be potentially useful for delivery of 
genes to correct other diseases, such as the clotting disorders haemophilia (factor XIII 
deficiency) and Christmas disease (factor IX deficiency). 
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1.13 Aims and Hypothesis 
In summary, current treatment of the common clinical problem of bone defects has 
limitations. As there is evidence that MSCs could be used to tissue engineer bone, my 
thesis will investigate the methodology and viability of this, to provide better treatment 
of such defects. 
In order to establish a methodology for the tissue engineering of bone, various factors 
need to be first established. For instance it is necessary to show that MSCs can be 
isolated from bone marrow aspirates harvested from patients. Further, as MSCs 
are known to occur at low density in bone marrow, the isolated cells would then need 
to be expanded in culture to produce the larger numbers required for tissue 
engineering. It is also proposed that bone marrow-isolated MSCs from every 
patient can be stimulated to differentiate into osteoblasts. 
For clinical use in bone defects, cells would require stability, afforded it is proposed by 
using a scaffold on which to grow a 3-d structure. As a major constituent of bone 
extracellular matrix, HA has been shown as osteoconductive and therefore a suitable 
material for the scaffold. HA has also been shown to encourage the osseointegration of 
bone when coated on metal prostheses (Furlong & Osborn 1991). A key hypothesis of 
my thesis is therefore that MSCs will grow on HA and differentiate into 
osteoblasts without other stimulation in culture. 
The biological structure of engineered tissue used to replace lost tissue must be similar 
to the original. It is hypothesised that when grown within a novel perfusion 
bioreactor, which simulates the environment of osteoblasts in bone, this will 
stimulate the osteoblastic differentiation of MSCs and the production extra 
cellular matrix. As, to construct 3-d tissue a uniform distribution of cells is needed 
through the scaffold, it is also hypothesised that the penetration of cells through a 
porous scaffold will be increased by culture in my bioreactor. 
Lastly, for these methods to be used clinically, it is necessary to devise a means of 
storing MSCs derived from marrow, without altering the osteoblastic potential of the 
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cells. It is hypothesised that cryopreservation will allow the storage of freshly 
isolated MSCs without changing their cell function and potential. 
In conclusion, the general hypothesis of the thesis is that a population of 
multipotent cells can be isolated from bone marrow and that the differentiation 
these MSCs into osteoblasts, chondrocytes and adipocytes can be controlled and 
maintained and that osteoblastic differentiation will be affected by surfaces on 
which they are cultured. Further it is hypothesised that growth and differentiation 
will increase in a 3-d bioreactor culture system and will not be affected by 
cryopreservation storage. Therefore, my thesis will investigate the suitability of 
MSCs for the tissue engineering of bone, with the aim that this tissue could be 
implanted into patients' bone defects resulting in increased healing. 
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CHAPTER 2 
Human Bone Marrow as a Source of Mesenchymal Stem Cells 
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2.1 INTRODUCTION 
2.1.1 Background to chapter 
The overall aim of this thesis was to investigate whether cells isolated from human 
bone marrow could be used in the tissue engineering of bone. Hypothetically, this 
engineered tissue could be used clinically as graft substitutes in the reconstruction of 
bone defects. 
In this first chapter, several main factors need to be established. Firstly, that 
mesenchymal stem cells (MSCs) can be isolated from human bone marrow aspirates. 
Secondly, that such cells could be stimulated to differentiate into osteoblastic, 
adipocytic and chondrocytic cells in culture, thereby confirming the multipotency of 
the marrow-isolated mesenchymal cells. Furthermore, that the isolated cells can be 
expanded in culture to produce the large numbers of cells required for tissue 
engineering. 
As the focus of this thesis is the tissue engineering of bone, in this chapter it was the 
potential of the isolated cells to differentiate into osteoblasts that was most closely 
studied. 
2.1.2 Origins of the identification of Mesenchymal Stem Cells 
As detailed in Chapter 1, in the late 1960s Friedenstein found that, when rat bone 
marrow was plated in culture colonies of fibroblast-like cells formed, which he called 
Fibroblastic-Colony Forming Units (CFU) (Friedenstein et al. 1970). The stem cell 
nature of these cells was suggested as, in vitro, large colonies of cells seemed to form 
rapidly from the initial division of a single cell. Several research groups have 
demonstrated the pluripotent nature of this cell type in vitro (Conget & Minguell 1999; 
Maniatopoulos et al. 1988; Pittenger et al. 1999), (see Chapter 1: MSC differentiation). 
However, as previously discussed, a wide nomenclature has been applied to these cells 
in scientific literature (see Chapter 1: History and nomenclature of MSCs section). 
This variety is likely to have resulted not only from the heterogeneous nature of the 
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isolated cells, but also from the variation in cell phenotype expressed in different 
environments which may have resulted in the same cells being identified differently. 
Furthermore, lack of stem cell markers has limited the identification and labelling of 
marrow-isolated cells, also potentially resulting in different names being given to 
similar cells. In this chapter, the bone marrow-derived cells will be referred to as 
MSCs. 
2.1.3 Distribution of MSCs in Bone Marrow 
Studies outlined in Chapter 1 provide evidence that MSCs are present in bone marrow 
and have the potential for differentiation into cells of mesenchymal tissue. In adults, 
haematopoietically active marrow retracts to the medullary cavity of the axial skeleton, 
as can be seen by the colour of the marrow, which remains red in these bones 
compared with the yellow fatty marrow in the distal skeleton. Thereby, to obtain 
marrow that is rich in haematopoietic stem cells marrow is aspirated from the axial 
skeleton, for example the iliac crest or sternum. It is likely that MSCs will also be 
present in a higher frequency in this red marrow and bone marrow can easily be 
harvested from this site. 
2.1.4 Source of MSCs 
In addition to marrow, peripheral blood has also been investigated as a source from 
which MSCs are potentially recruited to sites of skeletal injury. Evidence for this has 
been documented by Huss et al, who found that peripheral blood contained fibroblastic 
cells with characteristics of MSCs, including the expression of CD34 and osteocalcin. 
Although in culture these cells initially expressed CD34, suggesting that they were 
haematological precursors (Huss et al. 2000), they lost the CD34 antigen during 
culture, which may be associated with the cells differentiating into MSCs. However, it 
should be noted that other researchers have not been able to isolate MSCs from 
peripheral blood (Lazarus et al. 1997). Although this does not exclude their presence, it 
would suggest that MSCs occur in too low a density in blood to be detected. Hence, for 
my study, bone marrow alone was investigated as a source of MSCs. 
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2.1.5 Isolation of MSCs from bone marrow aspirates 
Bone marrow can be taken by aspiration from the medullary cavity of the posterior 
iliac crest of humans; this is routinely performed for the diagnosis of haematological 
conditions. The majority of low density MSCs have been found to be present in the 
initial part of the aspirate (Muschler et al. 1997). This has been suggested is due to the 
limited amount of marrow in the trabeculae local to the bevel of the needle, with 
further aspiration subsequent to this yielding venous blood only (Batinic et al. 1990). 
In my thesis, 2m1 samples of human bone marrow were obtained by aspiration from 
the iliac crest of patients following local ethical committee approval and informed 
consent. 
Various methods have been investigated for the isolation of MSCs from bone marrow, 
as it also contains blood cells at all stages of differentiation, as well as reticular cells. 
As the majority of blood cells are erythrocytes (red blood cells), which do not adhere 
in tissue culture, partial isolation of MSCs can be easily achieved as these cells do 
attach. As the other less adherent cells present will also be removed with medium 
changes, plating fresh marrow in tissue culture will in itself isolate the MSCs to a 
certain extent (Lazarus et al. 1997). These factors can be used as a simple method of 
separation of MSCs from marrow - after several passages any remaining 
haematopoietic cells, antigen positive for CD 45,34 & 14, and macrophages disappear, 
leaving mesenchymal cells. Thus, as originally observed by Friedenstein, when whole 
bone marrow is cultured, characteristic spindle shaped MSCs adhere to the plastic 
forming colonies. 
Haynesworth has investigated extensively the characteristics of MSCs in vitro, 
including the separation of MSCs from bone marrow, finding that a Percoll® gradient 
separates the marrow into three fractions based on density. On culturing the cells from 
each of these fractions, it was found that the low-density fraction, otherwise known as 
the `huffy layer', contained MSCs (Haynesworth et al. 1992b). 
Methods for separating the MSCs from bone marrow aspirates have been compared. 
Simple centrifugation of the marrow produced the buffy layer, but when this was 
compared with other methods it was found to produce the lowest yield of nucleated 
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cells (Connolly et al. 1989a). Ficoll®, a dense liquid not dissimilar to Percoll®, can be 
used to separate the cell types in marrow, using differential density centrifugation, 
whereby erythrocytes fall though the Ficoll® layer while mononuclear cells which are 
less dense remain on top. The yield of MSCs improved when the marrow was 
centrifuged at 400g for 30 minutes over a Ficoll® gradient, but was found to be 
greatest when the cells were allowed to separate by gravity during a4 hour period over 
the gradient (Connolly et al. 1989a). However, in my study, due to practical 
implications of time and the risk of contamination, the MSCs were centrifuged over a 
Ficoll® gradient for 30 minutes, and it was determined that any other cells that 
remained in the culture would be removed due to their reduced ability to adhere to 
tissue culture plastic. 
2.1.6 Yield of MSCs 
By applying the stem cell colony theory first used by Friedenstein (that a colony of 
cells results from the division of a single cell), the number of MSCs present in a 
marrow sample can be determined by the number of colonies counted in the primary 
cultured marrow. The number of cell colonies has been found to be proportional to the 
number of nucleated cells originally isolated from the bone marrow (Majors et al. 
1997), which suggests that a constant proportion of nucleated cells are MSCs. This has 
been quantified as 1 MSC per 1x105 to 1x106 mononucleated cells in marrow (Hicok et 
al. 1998). As tissue engineering requires a large number of cells to be delivered back 
into the patient, the small number of aspirated MSCs needs to be expanded and so 
proliferation of isolated MSCs will also been investigated in my study. 
The number of MSCs in the marrow was found to correlate negatively with the age of 
the patient (Majors et al. 1997). However, no correlation was found between the 
growth rates of MSCs and the age of the donor when studied at a population level, 
with great variation in both these factors being observed between patients (Phinney et 
al. 1999). An explanation for this is that the density of MSCs within bone marrow 
decreases with age, but the growth rate of the individual MSCs does not. In view of 
this, throughout my thesis MSCs from each patient were used in both the control and 
test populations and the age of the patients from which aspirates were taken was 
limited to between 16 and 40 years. 
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2.1.7 Behaviour of MSCs in culture 
The ability of bone marrow-isolated MSCs in vitro to form colonies does not persist 
after the first passage and it has been observed that the population cell growth follows 
lag, log and plateau phases (Goshima et al. 1991b). In the primary culture, both the lag 
and log phases last for longer periods of time, resulting in confluence after 12 days. 
MSCs continue to proliferate in culture and maintain the potential to differentiate into 
osteoblastic cells for up to 38 population doublings (approximately passage 18) 
(Bruder et al. 1997b). Furthermore, there is evidence that, after passage 25, an 
increasing proportion of MSCs display apoptotic features, as noted by the loss of 
specific cell markers and integrins, which results in a reduction in the production of 
extracellular matrix proteins by these cells (Conget & Minguell 1999). As a result of 
these observations, in my studies, MSCs were only used up to passage 7. 
2.1.8 Investigation of MSCs 
Two experimental approaches have previously been used to research the potential of 
MSCs. In the first method, bone marrow has been investigated in vivo in animal 
models (Bab et al. 1988b). However, the experimental results of this research cannot 
be attributed to any specific cell type within the marrow and, furthermore, the effect of 
growth factors present within the animal cannot be quantified. Therefore, the second 
method of completing research in vitro has the advantage that the conditions can be 
easily controlled, although it is an artificial environment. 
2.1.9 Markers of MSCs 
Although it has proved difficult to identify a consistent marker for multipotent MSCs, 
as discussed in Chapter 1: Markers of MSCs section, Stro-1 has been suggested as a 
reliable marker (Gronthos et al. 1994). Therefore, Stro-1 was used in my study to aid 
confirmation of the isolation of MSCs from the bone marrow aspirates. The Stro-1 
IgM mouse antibody labels MSCs, following which a fluorescent-labelled secondary 
antibody is attached to Stro-1 allowing the cells to be identified. Stro-1 has also been 
used to isolate MSCs by indirect fluorescence-activated cell sorting and these 
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separated cells have been shown to possess the potential to differentiate into 
osteoblastic cells (Stewart et al. 1999). 
In this chapter, in addition to Stro-1 identification, the morphology and behaviour of 
the isolated cells will also be used as primary evidence of existence of MSCs. 
2.1.10 Osteoblastic cell markers 
One of the important characteristics of MSCs, which provides potential for the tissue 
engineering of bone, is the ability of these cells to differentiate into osteoblasts. This 
differentiation occurs in osteogenic culture conditions and can be measured by the 
presence of osteoblastic cell markers. The presence of osteoblasts in the differentiated 
culture indicates that the original isolated marrow cells contain committed osteoblast 
progenitor cells or MSCs that have been stimulated to differentiate via an osteoblast 
progenitor into osteoblasts, as there is evidence for such a pathway (Aubin et al. 1995). 
In this chapter, osteoblastic differentiation of bone marrow-isolated cells was 
investigated as evidence for their potential use in the tissue engineering of bone, as 
well as retrospective evidence for the isolation of osteoblast progenitor cells/MSCs. 
Markers used to identify osteoblasts were discussed in Chapter 1: Osteoblastic cell 
markers section. In brief, the markers used in this chapter include: ALP, which is 
produced during early osteoblastic development and is widely used as a reliable 
marker of the osteoblast phenotype and cellular activity (Rodan et al. 1987), 
Osteopontin, which is an extra-cellular matrix protein that binds calcium to bone 
matrix, making it a sequentially later marker of osteoblastic maturation than ALP, and 
lastly Osteocalcin, which has been shown to be synthesised exclusively by mature 
odontoblasts and osteoblasts during mineralisation phase (Price 1985). 
Initially, the specific messenger RNA (mRNA) for each of the markers was detected 
by a process of reverse transcriptase - polymerise chain reaction (RT-PCR). In brief, 
within cells mRNA is produced as a result of promoter signalling by a transcription 
factor, causing a gene sequence of DNA to be transcribed into mRNA, which is then 
translated into an amino acid sequence that is then folded into a protein. This results in 
the presence of mRNA before the protein can be detected. Detection of a specific 
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mRNA sequence within a cell involves extraction of RNA from cells, its conversion 
back to cDNA by the process of reverse transcriptase, followed by the addition of a 
specific gene primer and amplification of this sequence by polymerise chain reaction. 
Following this, the gene specific DNA can be separated and viewed on an 
electrophoresis gel identified by its size. This allows the protein specific mRNA 
sequences to be probed for and its presence within the cells was used as an indicator of 
cell phenotype. Biochemical assays were then also used in my study to detect the 
specific proteins produced by osteoblastic cells, thereby further characterising their 
phenotype. 
As also detailed in Chapter 1, not only has Cbfa-1 been identified as a transcription 
factor that acts as a promoter for the transcription of osteocalcin (Ducy et al. 1997; 
Merriman et al. 1995), but there is also evidence that Cbfa-1 expression is essential for 
the mineralisation of bone (Komori et al. 1997). Therefore, it can be postulated that 
Cbfa-1 is expressed early in osteoblastic differentiation and maturation, before the 
osteocalcin gene is expressed. The presence of Cbfa-1 gene expression may also be 
essential for osteoblastic differentiation of cells and so the expression of Cbfa-1 was 
also investigated in this chapter. 
2.1.11 In this chapter 
In summary, for MSCs to be used for the tissue engineering of bone, which is the 
overall aim of my thesis, firstly it is necessary to show that MSCs can be isolated from 
human bone marrow aspirates. Therefore, aspirates were taken from the iliac crest of 
patients, an accessible source of red marrow, and a Ficoll® gradient was used to 
separate the MSCs. The behaviour of the cells was observed in culture and Stro-1 was 
used as a marker to identify the presence of MSCs. As their name suggested, MSCs are 
multipotent cells with the ability to differentiate down the mesenchymal cell lines. 
Hence, as further evidence of their multipotent potential marrow-derived cells were 
stimulated to differentiate into osteoblasts, chondrocytes and adipocytes. 
For MSCs to be useful in the tissue engineering of bone, it was specifically necessary 
to demonstrate their ability to differentiate into osteoblasts. This was investigated more 
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closely by culturing half the MSCs from each aspirate in osteogenic supplements, 
using markers of osteoblasts to compare the two populations. 
As discussed above, due to the low density of MSCs in marrow, the use of these cells 
for clinical treatments requires their proliferation in culture and so expansion of these 
cells in culture was also investigated. A further aim of this chapter was to detail the 
methods used throughout this thesis, for the isolation and culture of MSCs from bone 
marrow and the identification of osteoblastic cells. 
2.1.12 Hypothesis 
Therefore, the hypotheses of this chapter were: 
1. MSCs can be isolated from human bone marrow aspirates; 
2. When cultured in monolayer and in the presence of appropriate supplements, 
the marrow-isolated cells differentiate into osteoblasts, adipocytes and 
chondrocytes, confirming the presence of MSCs. 
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2.2 MATERIALS and METHODS 
2.2.1 Materials 
General 
Bone marrow aspirate needles (Rocket Medical 131000) 
Ficoll (Amersham Pharmsin Biotech 75285) 
Cell culture 
Dulbecco's modified phenol red free medium (Sigma D5921) 
Trypsin Hepes 0.25% (Sigma T8003) 
Dulbecco's phosphate buffered saline (PBS) (Sigma D8662) 
Trypan blue solution (Sigma T8154) 
Haematocytometer (Sigma Z35952-9) 
Standard medium 
Dulbecco's modified eagles medium (Sigma D6429) 500ml 
Foetal calf serum (Sigma F7524) 500m1 
Penicillin 50U/ml (Sigma P0906) 
Streptomycin 50µg/ml (Sigma P0906) 
Additional supplements added to standard medium: 
Osteogenic supplements (OS) 
Dexamethasone 10"7M (Sigma D1756) 
Ascorbic acid 50µM (Sigma A4544) 
ß-glycerol phosphate 10mM (Sigma G6376) 
Adipoc is supplements 
Dexamethasone 10-6M (Sigma D1756) 
Insulin lOg/ml (Sigma 10516) 
Indomethacin 100mM (Sigma 17378) 
Chondrocytic supplements 
Transforming growth factor-(3 (TGF-ß) lOng/ml (Sigma T7039) 
Dexamethasone 10"7M (Sigma D1756) 
Ascorbic acid 50ng (Sigma A4544) 
Sodium pyruvate 1nM (Sigma P5280) 
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Histological stains 
Formaldehyde (BDH Chemicals) 
Haematoxylin (BDH Chemicals 340374T) 
ALP: Napthol AS-B 1 sodium phosphate 
New Fuchsin 4% in HCL (Sigma) 
Sodium nitrate (Sigma S2252) 
Napthol AS-B1 phosphate (Sigma N2250) 
Methyl-green counter stain (HD Supplies 465) 
Calcification: Von Kossa 
Silver nitrate 2% (Sigma S2252) 
Sodium thio-sulphate 2.5% (BDH Chemicals 10268) 
Neutral red 1% (Sigma N6634) 
Lipid: Oil Red 0 
Oil Red 0 (RA Lamb S2672) 
Absolute isopropyl alcohol (BDH Chemicals 296946H) 
Dextrin (Sigma D2256) 
Mayer's Haemalum Solution (dissolved in 1 litre distilled water): 
Haematoxylin (BDH Chemicals 340374) 10ml 
Sodium Iodate (Sigma S4007) 0.2g 
Alumininium potassium sulphate (BDH 27085 SR) 50g 
Chloral hydrate (BDH 276684R) lg 
Citric acid (BDH Chemicals 100813M) lg 
Collagen: Alcian Blue/Sirius Red 
Alcian blue (HD Supplies) 
Molybdophosphate acid (BDH Chemicals) 
Sirius red (HD Supplies) 
Stro-1 antibody 
Stro-1 supernatant mouse IgM (Developmental Studies Hybridoma Bank, University 
of Iowa, US) 
FICA anti-mouse IgM (Sigma F9259) 
SEM (Scanning Electronic Microscopy) 
Sodium cacodylate (BDH Chemicals 30118) 
Glutaraldehyde (Agar scientific R1011) 
Osmium tetroxide 2% (Agar Scientific R1022) 
Ethyl alcohol (James Burrough) 
Hemamethyldisaiazane (Agar Scientific) 
Aluminium stubs 32mm diameter (Agar Scienitific 9318) 
Tannic acid (Sigma T0125) 
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RNA 
RNAeasy mini kit (Qiagen 74104) 
dNTP's (Promega U1240) 
Oligo dT Primers (Promega C1101) 
RNAsin (Promega M21 11) 
RNA polymerase (P 1085) 
MMLV-RT (Gibco Life technologies 28025-013) 
Amphi Taq (Applied Biosystems N808 0158) 
Primers (Severn Biotech) 
Ethidium bromide (Sigma E1510) 
TAE buffer (Sigma T9650) 
Assays 
Alkaline phosphatase assay (Randox EC 3131) 
Human Osteopontin enzyme immunometric assay (Metachem Diagnostics 90027) 
Osteocalcin OSCA test (B. R. A. H. M. S. 57.1) 
DNA assay Hoeschst 33258 (Sigma B2883) 
2.2.2 MSC Isolation methods 
2.2.2.1 Bone marrow aspiration 
Local ethical committee approval was gained for the procedure of bone marrow 
aspirations from patients undergoing orthopaedic operations under general anaesthetic 
at the Royal National Orthopaedic Hospital. Following informed consent, bone 
marrow aspirations were obtained from the posterior iliac crest of patients. The age of 
the patients ranged from 16-40 years. 
The procedure was performed while the patients were under general anaesthetic for 
elective orthopaedic procedures, just before the start of the operation. The patients 
were placed in the left lateral position and the skin over posterior iliac crest was 
cleaned with chlorhexidine and draped. Under sterile conditions, using a bone marrow 
aspiration needle, 2m1 of bone marrow was aspirated from the intramedullary cavity of 
the ilium. This volume of marrow has been shown to harvest 85% of the stem cells 
from the area aspirated (Muschler et al. 1997). As the volume of the bone marrow 
aspirated increases, the percentage of stem cells decrease as venous blood starts to be 
aspirated in addition to marrow. To maximise the harvest of marrow, the plunger on 
the syringe is pulled back sharply, multiple times, as this technique draws the marrow 
out of the surrounding trabeculae. 
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The aspirate was taken from the posterior iliac crest 5cm lateral to the sacro-iliac joint. 
The marrow was aspirated into a syringe, which contained lml of 5000 units of 
heparin to prevent clot formation. The mixture of marrow and heparin was then placed 
into a sterile universal container and mixed. 
2.2.2.2 Processing of bone marrow sample 
The MSCs were separated from the other cells present in bone marrow by density 
centrifugation using a Ficoll® gradient. The aspirate was slowly added to 3ml of Ficoll 
where the aspirate formed a separate layer on top of the Ficoll®, which was 
centrifuged at 400g (1510 rpm) for 30 minutes. The sample separated into 4 distinct 
layers with haematopoietic cells at the bottom, a clear Ficoll® above this and serum 
upper most. A fourth layer, known as the buffy layer, containing mononuclear cells 
including MSCs, formed at the interface between the Ficoll® and serum, and this layer 
was carefully harvested using a pipette. 
The mononuclear cells were washed with standard medium and centrifuged at 1000g 
(2000 rpm) for 10 minutes, resulting in the formation of a cell pellet, which was 
collected and resuspended in medium and centrifuged again at 1000g for 5 minutes, 
resulting in a cell pellet that contained the MSCs. This pellet was resuspended in 2m1 
of medium through a 23-gauge needle and plated in two 75 cm2 flasks, which were 
placed in an incubator at 37°C and 5% CO2 to culture the cells. These incubator 
conditions were used throughout the studies in this thesis. A total of twelve patients' 
bone marrow aspirations were used in the experiments within this chapter. 
2.2.2.3 Cell culture 
The MSCs adhered to the tissue culture plastic and the culture medium was changed 
every 3 days to remove any remaining non-adherent, haematopoietic cells. The cells 
were cultured until confluence, at which point the cells were trypsinised and divided 
into 3 culture flasks (passage 1). 
To trypsinise the cells, the medium was removed and the cells were washed with 5m1 
of phosphate buffered saline (PBS). A volume of 8m1 of 10% trypsin (with 1% hepes 
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buffer) was added to the cells and agitated for 5 minutes. Any remaining adherent cells 
were removed following brief use of a cell scraper. The trypsin containing cells in 
suspension was removed and the flask was washed twice with standard medium. These 
fluids were placed in a universal container and centrifuged at 2000 rpm for 5 minutes. 
As a result of this, a cell pellet formed which was resuspended and re-plated into 3 new 
culture flasks. This method of trypsinisation was used to divide confluent flasks of 
cells throughout my thesis. 
In order to count the number of cells used in each experiment throughout my thesis, 
trypan blue was used to stain the cells, distinguishing dead cells as these membranes 
allowed reagent through, staining the whole cell blue. A haemocytometer was used to 
count cells ensuring that the same number of MSCs was used in each sample. 
2.2.3 Characterisation of MSCs 
2.2.3.1 Observation of cells in culture 
The morphology and behaviour of all the isolated bone marrow cells in monolayer was 
regularly observed under light microscopy. 
2.2.3.2 Stro-1 antibody marker 
The monoclonal IgM murine antibody, Stro-1 was used to identify adult MSCs. For 
each of four patients' marrow-isolated cells, eight glass autoclaved cover slips were 
cultured with 25,000 cells on each for 48 hours. The first two cover slips were cultured 
with isolated marrow cells in standard medium and, on the second two cover slips, 
cells were cultured in with osteogenic supplements (OS), which was made up of 
standard medium with the addition of dexamethasone (10-7M), ascorbic acid (50µM) 
and ß-glycerol phosphate (10mM) - the same concentrations were used throughout my 
thesis for OS. Two different osteosarcoma cell lines were cultured as controls on the 
remaining four cover slips. One of the osteosarcoma cell lines, MG 63 cells, was a 
positive control, as this cell line is known to express Stro-l and Saos-2 cells were used 
as a negative control, as these are known not to express Stro-l (Stewart et al. 1999). 
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After 48 hours in culture the medium was removed and the cells were washed four 
times with PBS. Following this lml of 1: 6 diluted Stro-1 monoclonal antibody was 
added to the cells and the cells were then incubated at 37°C for 1.5 hours. The primary 
antibody was removed and replaced with the goat anti-mouse IgM fluorescent-labelled 
antibody (FICA) and the cells were incubated for a further hour. Following six further 
washings with PBS, the presence of cell labelling was observed under the fluorescent 
microscope, the relative intensity of fluorescence between cell types was compared 
and photographed. 
2.2.4 Mesenchymal lineage differentiation - Histological stains 
2.24.1 Osteoblastic differentiation 
2.2.4.1.1 ALP stain: Naphtol-AS-B1 sodium phosphate 
Two autoclaved glass cover slips were seeded with 20,000 marrow-isolated cells and 
cultured for 7 days in standard medium. The same numbers of cells were also cultured 
on two cover slips with the addition of OS, for 7 and 14 days. This was repeated with 
cells isolated from the marrow of five patients. 
At the end of the culture period, the medium was removed and the cells were fixed 
with 2% formaldehyde and stained for ALP with Naphtol-AS-B 1 phosphate. Equal 
volumes of 4% New Fuchsin in 2M HCl and 4% sodium nitrate, followed by buffer 
(0.2M Tris with 0.1M HCl) and Napthol AS B1 phosphoric acid were added to stain 
the cells. These were then counter stained with fast red violet and the mounted cells 
were observed and photographed under the light microscope. After the same culture 
period, 2 repeats of the Saos-2 osteosarcoma cells, cultured in standard medium as a 
positive control, were stained for ALP expression using the same method. 
2.2.4.1.2 Calcification stain: Von Kossa 
Von Kossa stain was used to identify extra-cellular calcium produced by osteoblasts 
during the mineralisation phase. 
Four glass cover slips were each seeded with 250,000 cells and two were cultured for 
21 days and two for 28 days, for each time period, one in the presence and one in the 
absence of OS. This was repeated for bone marrow-derived cells of four patients. Saos- 
66 
Chapter 2 Methods 
2 osteosarcoma cells were again used as a positive control and two repeats were used 
for each condition. After the culture period, the medium was removed and the cells 
were placed in 2% silver nitrate and exposed to bright light until the control blackened. 
After two washes with distilled water, the cells were treated with 2.5% sodium thio- 
sulphate and then counter stained with I% neutral red. Following mounting on slides, 
the cells and mineralisation stained black were observed under light microscopy and 
photographed. 
2.2.4.2 Adipocytic differentiation 
2.2.4.2.1 Lipid stain: Oil Red 0 
Marrow-isolated cells were grown on 8 autoclaved glass cover slips at a seeding 
density of 50,000 cells per cover slip. Cells on half of the cover slips were cultured in 
standard medium and the remaining half were cultured in adipocytic medium. 
Adipocytic medium consisted of standard medium with the addition of insulin 
(1Og/ml), dexamethasone (10-6M) and indomethacin (100mM). Two cover slips from 
each condition were then cultured for 7 days and the other two for 14 days. This was 
repeated for each of 4 patients' marrow samples. 
Following these culture periods, the cells were stained for intracellular lipid using oil 
red 0 stain. Firstly, the medium was removed and the cells were rinsed with PBS and 
fixed in 10% formaldehyde for 5 minutes. This was rinsed off with distilled water and 
the cover slips were placed in glass boats filled with oil red 0 stain for 20 minutes. The 
cover slips were washed briefly under running water to remove excess stain and 
counterstained with Mayer's haemalum for 3 minutes, following which any excess 
stain was rinsed off. The cover slips were air-dried, mounted on slides and cells were 
visualized under light microscopy. As a result of this staining process, lipid droplets 
within the cells were stained red and the nuclei blue. 
2.2.4.3 Chondrocytic differentiation 
2.2.4.3.1 Collagen: Alcian Blue/Sirius Red 
Similarly to the methods described above, 50,000 marrow-isolated cells were cultured 
on six cover slips for 14 days; pairs of cover slips were cultured in standard, 
osteogenic and chondrocytic medium, and a further two cover slips were cultured with 
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bovine chondrocytes in standard medium as a positive control. This was repeated for 
the isolated marrow cells from four patients. The chondrocytic supplements that were 
added to standard medium were TGF-ß (IOng/ml), dexamethasone (10-7M), ascorbic 
acid (50ng) and sodium pyruvate (lnM). 
After the culture period, the cells were stained on cover slips for collagen using alcian 
blue/sirius red. The cells were rinsed in PBS and placed in a glass boat, into which the 
stain solutions were added, with distilled water rinses in between each solution. The 
first solution used was Weigert's haematoxylin and the second was alcian blue. The 
cells were stained for 10 minutes in each of these. Following this, the boat was filled 
with molybdophosphatic acid for 20 minutes. This was removed and the cells were 
stained with sirius red for 60 minutes, after which the cells were washed for a final 
time in distilled water, air dried and mounted on slides. In order to visualize the 
collagen lattice, the slides were observed under polarized light and photographs were 
recorded. 
2.2.5 Further investigation of osteoblastic differentiation 
The effect of OS on MSCs was investigated by culturing marrow-derived cells in 
standard medium, to act as a control, compared with culture in osteogenic medium. 
The following factors were used to characterise the osteoblastic phenotype: 
1. Morphology observed under light microscopy 
2. Morphology under SEM 
3. Histological staining (as above) 
4. Messenger RNA expression 
5. Protein production 
2.2.5.1 Osteoblastic differentiation - Morphology 
2.2.5.1.1 Light microscopy 
Bone marrow-derived cells in culture were observed regularly under light microscopy, 
to assess their growth and morphology. Photographs were taken of both control cells 
cultured in standard medium and of cells cultured with OS. 
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2.2.5.1.2 Scanning electron microscopy (SEM) 
Therminox discs were seeded with 25,000 cells and cultured in 24-well plates. Three 
discs were cultured in OS and three in control medium, to compare the effect of 
osteogenic factors on marrow-isolated cells. After 1 and 7 days in culture the discs 
were processed for scanning electron microscopy (SEM). This was repeated for cells 
derived from the bone marrow of five patients. 
The processing for SEM firstly involved removing the therminox discs from the 
incubator and cooling them at 4°C, before replacing the medium with 1.5% 
glutaraldehyde in 0.2M sodium cacodylate buffer. The processing then consisted of a 
series of incubations in various solutions to stain the cells and dehydrate the sample. 
Firstly, the glutaraldehyde was removed and any remaining was washed off by 
covering the samples with 0.2M sodium cacodylate buffer for 60 minutes. Following 
this, the samples were placed in 1% osmium tetroxide in 0.1M sodium cacodylate 
buffer for 60 minutes, to stain the cellular material. This is a strong oxidising agent so 
particular care was used with this substance, handling only while wearing gloves in the 
fume hood. 
The osmium was removed and the samples were washed three times with 0.1M sodium 
cacodylate buffer. Each wash was left for 5 minutes to allow equilibration. The 
samples were then placed in 1% tannic acid in 0.05M buffer for a further 60 minutes, 
after which this solution was similarly removed with three buffer washes. The samples 
were dehydrated by placing them in increasing concentrations of alcohol. From 20% 
ethyl alcohol, the concentration of alcohol was serially increased in 10% increments to 
100% ethyl alcohol, allowing equilibration with each concentration of alcohol. The 
samples were dried in hexamethyldisiazane, air dried, mounted on aluminium stubs 
and coated with gold/palladium in argon for 2 minutes. 
The cells on the therminox discs were observed under the scanning electron 
microscope (Joel Winsem JSM-35C 6300) and the morphology of the cells was 
compared between those that had been cultured in osteogenic and control conditions, 
after days 1 and 7 in culture. 
69 
Chapter 2 Methods 
2.2.5.2. Messenger RNA (mRNA) analysis of cells 
The expression of various genes normally expressed by pre-osteoblasts and osteoblasts 
was compared between marrow-isolated cells from three patients cultured in standard 
medium and OS after 0,1,3,5 and 7 days. Saos-2 osteosarcoma cells were again used 
as a positive control. 
The expression of 2 genes osteopontin and osteocalcin, which are expressed by 
osteoblastic cells during the stages of maturation, was investigated. Cbfa-1 expression 
was studied as a marker of osteoblast progenitor cells and GAPDH (a house keeping 
gene) was used as a positive control for each experiment. 
The primer sequences used to assess the gene expression by these cells were: 
Cbfa-1 5' TCT TCA CAA ATC CTC CCC 3' 230 bp 
5' TG ATT AAA AGG ACT TGG TG 3' 
(Christiansen et al. 2000) 
Osteopontin 5' CCA AGT AAG TCC AAC GAA AG 3' 347 bp 
3' GGT GAT GTC CTC GTC TGT A 5' 
(Rickard et al. 1996) 
Osteocalcin 5' CAT GAG AGC CCT CAC A 3' 310 bp 
3' AGA GCG ACA CCC TAG AC 5' 
(Rickard et al. 1996) 
GAPDH 5' ACC ACA GTC CAT GCC ATC AC 3' 452 bp 
5' TG ATT AAA AGG ACT TGG TG 3' 
(Christiansen et al. 2000) 
ALP 5' ACG TGG CTA AGA ATG TCA TC 3' 475 bp 
3' CTG GTAG GCG ATG TCC TTA 5' 
(Phinney et al. 1999) 
2.2.5.2.1 RNA extraction 
Confluent flasks of marrow-derived cells were trypsinised and the number of cells in 
each was counted using a haematocytometer. One million cells were resuspended and 
centrifuged at 2000 rpm to form a cell pellet, from which RNA was extracted using a 
Qiagen RNA easy kit. The amount of RNA extracted was then measured and the yield 
of xRNA was found to vary between 200 - 4004g/ml in 50µml volume. 
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2.2.5.2.2 Reverse Transcriptase reaction 
Reverse Transcriptase reaction synthesized cDNA from 21ig of mRNA in a 50µ1 
volume, with dNTP's 200µM, Oligo dT 0.25µg, MMLV-RT 20OU/µg RNA, RNAse 
inhibitor 50U/ml and buffer 10mM. The reaction time cycle was 10min at 25°C, 60 
min at 42°C and 5 min at 94°C. 
2.2.5.2.3 Polymerase Chain Reaction 
The Polymerase Chain Reaction (PCR) was carried out on 10µ1 of the sample obtained 
as a result of the reverse transcriptase reaction, in a total volume of 50µl. The PCR 
reaction contained dNTP at 200mM, specific primer at 0.5gl (50pmol) for each sense 
and anti-sense, ampli taq DNA polymerase at 2.5U/l00µ1,5µi buffer and 3 t1 M902- 
After an initial denaturation at 94°C for 2 minutes, amplifications were performed for 
30 cycles of 94°C for 30 seconds, 55°C for 2 minutes, 72°C for 2 minutes, for ALP, 
osteopontin and osteocalcin primers, 36 cycles of 94°C for 2 minutes, 55°C for 2 
minutes, 72°C for 2 minutes for Cbfa-1 and GAPDH primers, and 35 cycles of 94°C 
for 30 seconds, 59.4°C for 45 seconds, 72°C for 2 minutes, for BSP primer, which 
were followed by 10 minutes at 72°C. 
2.2.5.2.4 Electrophoresis gel 
An electrophoresis gel containing 2% agarose and 5p. 1 ethidium bromide was set up in 
specific wells, into the first of which a DNA ladder was placed, so that the DNA bands 
could be compared against a ladder of known base pairs. Subsequent wells were used 
for each primer sequence for MSCs and MSCs in OS for each day. After the current 
had been past though the gel for 30 minutes the bands were photographed under UV 
light. 
2.2.5.3Biochemical protein assays 
2.2.5.3.1 Culture scheme for protein assays 
1. ALP/DNA: 25,000 cells in 24-well plates, 2 repeats for each of 7 patient 
samples for both control and osteogenic conditions, for days 5,10 and 15 in 
culture. 
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2. ALP/DNA: 250,000 cells in 12-well plates, 2 repeats for each of 5 patient 
samples for both control and osteogenic conditions, after 14 and 28 days in 
culture. 
3. Osteopontin/DNA: 250,000 cells in 12-well plates, 2 repeats for each of 6 
patient samples for both control and osteogenic conditions, for 14 days in 
culture. 
4. Osteocalcin/DNA: 25,000 cells in 24-well plates, 2 repeats for each of 6 patient 
samples for both control and OS, for 15 days in culture. 
5. Osteocalcin/DNA: 250,000 cells in 12-well plates, 2 repeats for each of 6 
patient samples for both control and OS, for 28 days in culture. 
2.2.5.3.2 Alkaline phosphatase assay (ALP) 
The amount of ALP protein produced by the cells within each sample was measured 
using a biochemical assay adapted from Oreffo (Oreffo et al. 1998). As the isoenzyme 
is intracellular and membrane bound (Ecarot-Charrier et al. 1983), the assay was 
performed on the cell lysate. The cells were lysed by replacing the medium with lml 
of distilled water, then freezing them to -70°C and warming them to 37°C twice. The 
assay measures the amount of ALP by assessing the amount of p-nitrophenol cleaved 
from p-nitrophenol phosphate at alkaline pH (1M diethanolamine buffer). The 
resulting colour change can then be measured at 405nm absorbance using the COBAS- 
BIO (Roche, UK) centrifugal analyser. 
2.2.5.3.3 Osteopontin assay 
Osteopontin produced by the cells was detected and quantified using an enzyme 
immunometric assay. As osteopontin is an extra-cellular protein, this assay was 
performed on the medium removed from the cells while in culture. The assay uses a 
monoclonal antibody to bind to the osteopontin, labelled with Horseradish peroxidase. 
A substrate buffer was then added to bind to the monoclonal antibody generating a 
colour. The resulting degree of colour change, measured at 450nm, correlated with the 
amount of osteopontin protein when compared with the generated standard curve. 
2.2.5.3.4 Osteocalcin assay 
The Osteocalcin assay method was adapted from Power (Power & Fottrell 1991), 
whereby the quantity of osteocalcin was determined by a competitive 
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radioimmunoassay, using antibody-coated tubes and 1125 labelled osteocalcin. During 
incubation the osteocalcin in the samples competed with the radioactively labelled 
osteocalcin in the assay for binding sites on the coated tubes. A high osteocalcin 
concentration in the sample led to a low binding of the labelled antibody, resulting in 
an inverse relationship between the amounts of radioactively labelled and sample 
osteocalcin bound to the coated tubes. After the unbound antibody was removed, the 
radioactivity was measured using a gamma counter. The readings were compared with 
a standard curve that was generated from known concentrations of osteocalcin and the 
concentrations of osteocalcin in the samples were calculated. 
2.2.5.3.5 DNA assay 
Although the same numbers of cells were seeded in each well for the protein assays at 
the beginning of the experiments, the growth rate of the cells may have varied between 
well-samples over the culture period, resulting in a difference in cell number. As 
protein production is relative to the number of cells present in culture, standardisation 
for possible variations was necessary to allow comparisons to be drawn between 
different conditions. This was achieved by measuring the total DNA content of each 
sample, as this is proportional to cell number. Thus, the amount of protein produced 
(ALP, osteopontin and osteocalcin) by each sample of cells was divided by the total 
DNA content of that sample, thereby allowing statistical comparisons to be made 
between the different groups. This method of standardising protein measurements to 
allow comparison between samples was used throughout my thesis. 
A DNA assay, based on methods described in the literature (Rago et al. 1990; Rao & 
Otto 1992) was used, in which DNA content was measured on cell lysates using a 
fluorimetric dye, Hoechst 33258. The dye is specific for DNA as it binds to contiguous 
adenine-thymine base pairs resulting in the emission of fluorescence at a wavelength 
of 460nm. After the addition and mixing of Hoechst reagent to the cell lysates, the 
degree of fluorescence was measured using an Ascent plate reader (Labsystems). DNA 
values were calculated as a result of comparisons with known DNA values used to 
create a standard curve. 
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2.2.5.3.5 Statistical analysis 
Production of biochemical proteins was measured to assess the effect of culturing 
marrow-derived cells in OS medium compared with those in standard medium. The 
results were tested for normality using Kolmogorov-Smirnov and Shapiro-Wilk 
statistical tests, but the results were not found to follow a normal distribution. As a 
result non-parametric, Mann Whitney U tests were performed to compare the results of 
the two culture conditions. 
2.2.6 Measurement of Proliferation Rate 
2.2.6.1 DNA assay 
The change in total level of DNA content, measured using the Hoechst 33258 assay as 
described above, was used to assess the proliferation rate of marrow-derived cells over 
time. Firstly, 25,000 cells from seven patients' marrow aspirates were seeded and 
cultured in either standard or OS, with two repeats for each condition, for 15 days. At 
5-day time intervals a total of 28 samples were analysed for total DNA content using 
Hoechst DNA assay, as described above. The proliferation rate of the cells in culture 
was assessed by comparing the DNA content between consecutive days, in each 
condition. Furthermore the effect of OS on the proliferation rate was also assessed by 
comparing the DNA content of samples at the same time point, but cultured in 
different conditions. Non-parametric statistical tests were used to compare the groups, 
as the results were not found to follow a normal distribution. 
A similar experiment was conducted to support the first results, where 250,000 marrow 
cells from 6 patients were cultured over 28 days, in both standard and osteogenic 
medium, using 2 repeats per sample, per condition. After 14 and 28 days the cells were 
lysed and the total DNA content was measured using Hoechst assay. 
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2.3 RESULTS 
2.3.1 Characteristics of bone marrow derived cells 
2.3.1.1 Cell culture - light microscopy observations 
Initially, the isolated bone marrow cells were noted to form a cloudy suspension in the 
culture flasks, however this cleared following two medium changes. From every bone 
marrow aspirate taken, after an average of 7 days in culture, colonies of cells 
containing up to of 500 similar cells were observed to form (see figure 1.1a). 
This initial tendency for the cells to form colonies was only observed in the primary 
marrow cultures. The cells grew in number resulting in confluent cultures after 12 to 
14 days (see figure 1.1b). 
Following each passage, the cells were re-plated at a constant density and after passage 
1 and 2 the cells were observed to become confluent after an average of 10-12 days. 
Subsequent to passage 3, the cells were noted to become confluent after 6-8 days in 
culture. 
The adherent cells were observed to be long and spindle-like in shape, similar to 
fibroblasts and this morphology was observed to persist for 10 passages. 
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Figure 1.1: Light microscopy picture of marrow-derived cells, a) after 7 days in 
culture, showing part of a cell colony with the centre of the colony indicated by the 
yellow arrow, bar = 200µm , 
b) after 14 days, showing a confluent culture. 
Blue arrows show spindle-like cells, bar = 200µm. 
ýº'l 
ý'ý 
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2.3.1.2 Antibody markers for MSCs 
The marrow-derived cells were tested with Stro-1 monoclonal antibody, a marker for 
MSCs. Cells from every patient cultured in standard medium labelled positively for the 
antibody and the spindle shape of the cells could be determined through the immuno- 
fluorescence, as the antibody labels a membrane-bound antigen (see figure 1.2a). 
The cells cultured in OS for 48 hours prior to antibody labelling were noted to change 
in shape, becoming squarer with increased labelling of the cytoplasm (see figure 1.2b). 
The positive control, MG63 osteosarcoma cells, were labelled by the Stro-1 antibody, 
but the intensity of the fluorescence was much less than for the marrow cells and the 
negative control, Saos-2 osteosarcoma cells, were not fluorescently-labelled by Stro-l 
and therefore no photographs were taken. 
Figure 1.2: Stro-1 immuno-fluorescence marker identified marrow-derived cells from 
every sample tested after 48 hour, a) standard medium, spindle-shaped cells 
fluorescently-labelled shown by arrow, b) osteogenic medium, labelled squarer cell 
shown by arrow and c) weakly labelled MG 63 osteosarcoma cells in standard 
medium, shown by arrow, each bar = 1004m. 
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2.3.2 Observations of marrow cells stimulated to differentiate down 
mesenchymal cell lines 
2.3.2.1 Osteoblastic differentiation - Napthol - AS-BI sodium phosphate Histology 
stain 
Osteoblasts are known to produce ALP, which is hound to both the nuclear and cell 
membranes, as well as being present in the cytoplasm. Napthol-AS-131 and fast red 
violet is a histological stain for ALP, hence the occurrence of ALP within the cells was 
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observed as a marker of osteoblastic differentiation. The results from the 5 patients' 
marrow cells were the same. As seen in figure 1.3, there was minimal pink 
discolouration of the cytoplasm of the marrow-isolated cells cultured in standard 
medium. 
In contrast to this, the cells cultured with OS stained positively for ALP after 7 days, as 
seen by the red stain (figure 1.3b). After 14 days in osteogenic culture, the confluent 
cells continued to stain for ALP (figure 1.3c), however the intensity of the stain 
remained less than the osteosarcoma cell control and the occasional cell expressed 
significantly less ALP (figure 1.3d). 
Figure 1.3: Napthol-AS-B1 and fast red violet stain after 7 days in culture conditions, 
a) MSCs in standard medium, bar = 50µm, b) MSCs in osteogenic medium after 7 days, 
bar =50µm, c) MSCs in osteogenic medium after 14 days, bar =50µm & d) Saos-2 
cells after 7 days in culture, bar =50µ=ALP stained red (white arrows), nucleus blue 
(yellow arrows). 
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2.3.2.2 Osteoblastic differentiation - Von Kossa Histology stain 
Von Kossa stain was used as a marker of calcification in the cell cultures, as an 
indication of extracellular mineralisation. For each of the marrow samples there was no 
calcium staining when the cells had been cultured for 28 days in standard medium (see 
figure 1.4a). 
However, when the cells were cultured in osteogenic medium for 21 days there was 
evidence of extracellular calcium. These areas increased after 28 days in culture. 
although the positive osteosarcoma control produces larger areas of mineralisation (see 
figure 1.4c, d). 
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Figure 1.4: Von Kossa stain of marrow isolated cells in culture, a) in standard culture 
after 28 days, bar = 50µm b) in osteogenic culture after 21 days, bar =50µmc) in 
osteogenic culture after 28 days bar =50µm and d) osteosarcoma cell control after 28 
days, bar =50Rmcalcium stained black (blue arrows), cells stained red (yellow arrows). 
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2.3.2.3 Adipocytic differentiation - Oil Red 0 stain 
Oil red 0 histology stain was used to detect lipid within marrow-isolated cells after 7 
days in culture with adipocytic supplements, as compared to standard medium. The 
cells in standard culture conditions were again noted to be long and spindle-like in 
shape, with minimal lipid within the cells (see figure 1.5a). 
However, cells cultured in the presence of adipocytic supplements were observed to be 
larger in size with increased cytoplasm (see figure 1.5b). By day 14 lipid droplets were 
frequency seen within the cytoplasm of the cells cultured with adipocytic supplements. 
These results were consistent for cells isolated from each of the four marrow aspirates 
tested. 
Figure 1.5: Oil red 0 stain for lipid in marrow-isolated cells a) cultured for 7 days in 
standard medium, bar = 50µm, b) cultured for 7 days in adipocytic medium, bar = 50µm, 
c) after 14 days in adipocytic medium, showing lipid droplets within the cell, bar = 50 
pm and d) after 14 days in adipocytic medium, bar = 50µm. Cell nuclei stained blue 
shown by white arrows and lipid stained red shown by yellow arrows, where present. 
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2.3.2.4 Chondrocytic differentiation - Alcian blue/Sirius red stain 
Alcian blue/sirius red was used to stain collagen type I and II organised extracellular 
matrix, which polarises red/green under polarised light. No collagen was found on the 
slides of marrow-isolated cells in standard or osteoblastic medium and a likewise 
negative result was gained from the bovine chondrocyte controls (see figure 1.6a, b, c). 
However, when the marrow isolated cells had been cultured in chondrocytic medium 
for 14 days, the cells were observed to clump together and collagen matrix was seen 
surrounding the clumps. This collagen was arranged in a lattice structure, with fibres at 
90° to each other thus polarising red or green respectively (see figure 1.6d, e). 
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Figure 1.6: Alcian blue/sirius red stain for collagen was used for marrow-isolated 
cells a) cultured for 14 days in standard medium, bar =50µmb) cultured for 14 days in 
osteoblastic medium, bar =50Rmc) bovine chondrocytes after 14 days in culture, bar = 50 
pm and d) after 14 days in chondrocytic medium, bar =50µmand e) after 14 days in 
chondrocytic medium, bar = 50µm. Where present, collagen stained red/green under 
polarised light (white arrows) and cells stained blue (yellow arrows). 
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2.3.3 Effect of osteogenic supplements on monolayer culture 
2.3.3.1 Cells as observed under light microscopy 
Marrow isolated cells were observed under light microscopy growing in standard 
culture and following the addition of OS. As described above, the marrow cells in 
standard culture conditions were long, spindle cells, similar to fibroblasts in monolayer 
culture (see figure 1.7a, b). 
After 5 days in culture with OS, this was noticed to change as the cells became smaller 
and squarer in shape (see figure 1.7c, d). Figure 1.8 shows a clear difference between 
the shapes of the cells in the two different conditions, once the cultures were confluent. 
This change, in the cell shape was noticed with each marrow sample, on addition of' 
OS to the culture conditions. 
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Figure 1.7: Marrow isolated cells under light microscopy in monolayer culture, 5 
days after passage 1, a) in standard medium, bar=200µmb) in standard medium, bar =200 
µm c) osteogenic mediumbar=200µmd) osteogenic mediumbar=200µm Blue arrows 
indicate spindle shaped cells and yellow arrows show cuboidal cells. 
aº 
i 
-S., r -i ýýýý f ý, 
- 
. -. %Iyi 41 j 
,_ 
,- 
1 
b) 
1^y 
/ý j .. 
90 
Chapter 2 Results 
c) 
91 
Chapter 2 Results 
Figure 1.8: Light microscopy pictures of confluent cultures of bone marrow isolated 
cells, a) in standard conditions, bar-200µmb) in osteogenic conditions, bar=200µmBlue 
arrow indicates a spindle shaped cell characteristic of MSCs and yellow arrow shows a 
92 
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2.3.4.1 2.3.3.2 Cell morphology under Scanning Electron Microscopy (SEM) 
The effect of addition of OS to the morphology of marrow cells was further observed 
under SEM (see figure 1.9). Cells cultured in standard medium for 24 hours were 
fibroblast-like in morphology and this persisted during the 7-day culture period. 
In contrast to this, cells stimulated with OS became square in shape, producing 
multiple processes attaching to the therminox and these changes increased over 7 days. 
Figure 1.9: This figure shows cells cultured on therminox under SEM, a) standard 
medium for 24 hours, b) OS for 24 hours and c) OS for 7 days showing squarer 
osteoblastic-like cells. The blue arrows indicate fibroblast-like morphology of MSCs, 
pink arrows show cuboidal cells and yellow arrows show cell processes attaching to 
the therminox surface. Magnification is indicated by bars on figures. 
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2.3.3.3 Results for Gene expression 
Gene expression of bone marrow derived cells in standard medium was compared with 
osteogenic supplemented medium over a 7-day culture period. GAPDH, a 
housekeeping gene normally expressed by human cells, was expressed by every 
sample tested. 
Cbfa-1 was expressed by the MSCs in standard culture for all three of the patients 
tested. To assess the relative expression of Cbfa-1 over this culture period, the 
intensity of cDNA bands on the electrophoresis gel of Cbfa-1 was compared with 
GAPDH, for each sample. For all three patients the expression of Cbfa-1 relative to 
GAPDH increased after the addition of OS, peaking after 3 days and decreasing to a 
minimal level after 7 days in culture (see figure 1.10). 
Osteopontin was expressed slightly by one patient's MSCs in standard medium, but 
was expressed at each time point measured for both patients following culture in OS. 
In contrast to this, cells in standard medium did not express osteocalcin, with 
osteocalcin first being detected after 1 day in OS for one patient sample and after 3 
days for the other (see figure 1.11). 
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Figure 1.10: Pictures of electrophoresis gels showing the effect of the addition of OS 
to the expression of Cbfa-1 and GAPDH by bone marrow isolated cells over 7 days. 
For each gel, yellow arrows indicate gene bands of Cbfa-1 and GAPDI l: 
a) Patient 1: day 0 in standard medium culture (S), and day (d) 1,3,5,7 after culture 
with OS for the gene expression of Cbfa-1 (C) and GAPDI I (G); with Saos-2 
osteosarcoma cell line as positive control for osteoblasts. 
b) Patient 2: Cbfa-1 (wells 2-6) & GAPDH (wells 8-12) gene expression, comparing 
MSCs cultured in OS with the control (S) in standard medium, 
c) Patient 3: GAPDH (wells 2-7) & Cbfa-1 (wells 8-13) gene expression. comparing 
MSCs cultured in OS with the control (S). 
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Figure 1.11: Pictures of electrophoresis gels for the expression of Osteopontin and 
Osteocalcin by bone marrow isolated cells over 7 days (d) in culture. For each gel, 
yellow arrows indicate gene bands of osteocalcin and osteopontin at the first time they 
are seen: 
a) Patient 1: Gene expression with the addition of OS for osteopontin (OP) and 
osteocalcin (OC) compared with standard medium control (S) and Saos-2 positive 
control, GAPDH (G) control, 
b) Patient 2: Gene expression with OS compared with standard conditions (S), for 
osteopontin (wells 3-7), osteocalcin (wells 9-13) and GAPDH (G, well 2). 
a) 
2.3.3.4 The effect of osteogenic supplements on protein production 
2.3.3.4.1 Alkaline phosphatase production over 15 days 
As noted in the method section of this chapter, to allow statistical comparison between 
conditions, the production of ALP for each sample was divided by the total DNA 
content. Thus ALP/DNA was measured for 25,000 marrow-isolated cells cultured in 
monolayer over a 15-day culture period. 
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In standard culture conditions the cells were found to produce a minimal amount of 
ALP. However, following the addition of OS to the culture for 5,10 & 15 days, the 
production of ALP significantly increased (P<0.005), (see figure 1.12). The peak 
increase in ALP was after 5 days in OS culture, following which the protein 
production reduced, although it remained significantly greater than the control 
throughout the culture period. 
There were a number of outliners and extreme results, as seen on the box plot in figure 
1.12. In the majority of cases these were found to be close to the 95% confidence 
bands. However for each of the ALP results after both 5 and 10 days in OS culture, the 
outliner/extreme result was extremely high. As, in each case, only one result fell 
outside the trend these are likely to be freak results. 
Figure 1.12: A box plot comparing ALP expression (U/1)/DNA content (4/ml) for 
marrow isolated cells cultured in OS with control population (DM) over 15 days, 
* P<0.005, ("outliners, *extremes). 
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2.3.3.4.2 Alkaline phosphatase production over 28 days 
The addition of OS to the culture was also found to significantly increase the 
production of ALP/DNA (P<0.05), when a larger cell seeding density (250,000 cells) 
was used and the marrow cells were cultured over a longer culture period (28 days) in 
monolayer, (see figure 1.13). The production of ALP remained minimal over the 
culture period in standard conditions, consistent with the previous experiment, 
confirming that the addition of OS was necessary for increased production of ALP. 
The increase in ALP was greatest 14 days through this culture period, although it 
remained significantly higher for cells in OS through out the culture. As seen in figure 
1.13, there were no outliners or extreme results, suggesting that such results seen in 
figure 1.12 were freaks as discussed above. 
Figure 1.13: Box plot of the effect of OS compared with standard conditions (DM) on 
ALP production by MSCs, * P<0.05. 
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2.3.3.4.3 Osteopontin production by marrow isolated cells in monolayer 
When 250,000 marrow-isolated cells were cultured for 14 days with OS, the synthesis 
of osteopontin increased significantly compared with the control (P<0.05), (see figure 
1.14). 
Figure 1.14: Bar chart comparing osteopontin (ng/ml)/DNA content (µ/m1) for 
marrow cells cultured in OS with control population after 14 days, * P<0.05. 
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2.3.3.4.4 Osteocalcin synthesis after 28 days in culture 
The synthesis of osteocalcin by 250,000 marrow-isolated cells after 28 days in 
monolayer culture was measured and compared for the two culture conditions. The 
cells grown in standard conditions did not produce any osteocalcin, however when 
cultured in the presence of OS a significant amount of osteocalcin was produced (see 
figure 1.15). 
In addition to this, the preliminary experiment's results confirmed that when 25,000 
MSCs were cultured for 15 days in OS, no osteocalcin could be detected. 
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Figure 1.15: Bar chart showing the effect of OS on osteocalcin production after 28 
days in cell culture, * P<0.05. 
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2.3.4 Assessment of Cellular Proliferation Rate 
2.3.4.1 Comparative DNA levels between standard & osteogenic culture 
The total DNA content of marrow-derived cells in monolayer was investigated to 
assess whether the cells were expanding in culture. Following seeding 25,000 cells, the 
DNA content was found to increase significantly between each 5 day interval 
measured for the cells cultured in standard conditions over 15 days (P<0.005), (see 
figure 1.16). 
A similar relationship was found when the seeding density was increased to 250,000 
cells, as the amount of DNA significantly increased between 14 and 28 days (P<0.05), 
(see figure 1.17). When an initial seeding density of 250,000 cells was used, after 14 
days in standard culture, the amount of DNA was greater than for 25,000 cells after 15 
days in culture, as would be expected. 
The DNA results were significantly greater for cells cultured in standard medium 
compared with OS, after 15 days following the lower seeding density and after 28 days 
following the higher seeding density (P<0.05), (see figures 1.15 & 1.16). This suggests 
that DNA levels did not increase at the same rate when marrow-derived cells were 
cultured in osteogenic medium. 
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Figure 1.16: Bar chart illustrating the increase in DNA content when 25,000 cells 
were cultured in standard medium (DM), between 5 and 10 days and between 10 and 
15 days, ^P<0.005. Also, the effect of OS compared with DM was related to a 
significantly greater amount of total DNA after 15 days in standard culture, * P<0.05. 
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Figure 1.17: Bar chart illustrating the increase in DNA between 14 and 28 days, on 
250,000 cells seeded in standard medium (DM), ^P<0.005. Also showing the greater 
total amount of DNA after 28 days in DM culture compared with OS. * P<0.05. 
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2.4 DISCUSSION 
In this chapter, it was hypothesised that MSCs could be isolated from human bone 
marrow aspirates and further identified as MSCs, due to their ability to differentiate 
down different mesenchymal cell lines when stimulated in culture. Furthermore, as the 
main aim of this thesis involves the potential use of MSCs in the repair of bone, the 
majority of the experiments in this chapter concentrated on showing that these 
marrow-derived MSCs could differentiate into cells expressing characteristics of the 
osteoblastic phenotype. Finally, as the MSCs' cell density is very low in marrow, cell 
proliferation was tested in culture. 
2.4.1 Identifying MSCs cell type 
2.4.1.1 Conclusions from cell culture morphology 
When cells were isolated from a 2m1 bone marrow aspirate and were plated in 
monolayer culture, a cloudy suspension was initially observed in the culture flasks, 
however this cleared following two medium changes. Thus this was likely to be due to 
the non-adherent haematological cells, the majority of which were erythrocytes. 
The cells were observed to adhere and form 150-250 colonies per flask, with each 
colony containing up to 500 spindle-shaped cells. This suggests that each colony was 
the result of multiple divisions of a single cell, this behaviour was proposed as 
evidence of the stem cell nature of these cells (Friedenstein et al. 1966). MSCs are 
known to be present at a very low density in bone marrow, about 1 per 105 - 106 
mononucleated cells (Hicok et al. 1998), and so the formation of 200 - 300 colonies 
from a 2m1 marrow aspirate is consistent with this density (Muschler et al. 1997). 
In reviewing the aspirated cell growth, initially, it was observed to be slow, with 
colonies only forming at the end of the first week. However, over the second week in 
culture these colonies coalesced and cells grew to confluence, although the tendency of 
these cells to form colonies was only observed in the primary marrow culture. 
Following each passage, the cells were re-plated at a constant density and the growth 
rate was found to increase after the first 2 passages, but then remained constant to 
passage 5. The cells were further sub-cultured over 10 passages with no obvious 
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change to their morphology. These observations are similar to those described by 
Friedenstein (Friedenstein et al. 1970) and as described with rat MSCs (Goshima et al. 
1991b). 
SEM confirmed that isolated bone marrow cells were fibroblastic-like in morphology, 
which is consistent with the expected morphology of MSCs, but as morphology is not 
specific to cell type further indicators of MSCs were used. 
2.4.1.2 Use of Stro-1 in the identification of MSCs 
All the cells that were isolated from each of the four patients' bone marrow aspirates 
were strongly positive for Stro-1 on immuno-florescence testing. This is evidence that 
the marrow-isolated cells possessed the MSC phenotype, as marrow stromal precursor 
cells are Stro-1 positive cells (Simmons & Torok-Storb 1991). Stro-1 has been used 
previously as a marker for MSCs (Gronthos et al. 1994) and although it is not totally 
specific as it is also present on leucocytes, it does not bind to haematopoietic 
progenitor cells, which may also be present. 
As Stro-1 is a marker of uncommitted precursor cells, it would be expected that the 
intensity of the Stro-1 identification of the cells would decrease, when the MSCs were 
stimulated to differentiate. When MSCs were cultured with OS the shape of the cells 
was noted to change, becoming consistent with osteoblasts. However, the cells 
continued to express the cell surface antigen identified by Stro-1 although, on 
subjective assessment, the fluorescence intensity decreased, which may reflect 
differentiation of the marrow cells into committed osteoblast progenitors, thereby 
lowering Stro-1. 
The positive control, MG-63 osteosarcoma cell line, was less positive than the 
marrow-isolated cells and produced results similar to the OS stimulated cells. This is 
further evidence that the marrow-isolated cells were MSCs and that OS stimulated 
differentiation with relative loss of Stro-1. The negative control Saos-2 was not found 
to express Stro-1. These control results were also as predicted (Stewart et al. 1999), 
thus confirming the accuracy of the experiment. 
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In summary, the marrow-isolated cells used in this thesis were found to be positive for 
Stro-1, a marker of MSCs. 
2.4.2 Differentiation down mesenchymal cell lines - Histological stains 
As it has been suggested that Stro-1 is not a totally specific marker for MSCs and, as 
discussed in Chapter 1: Markers of MSCs section, marker specific to MSCs have been 
difficult to identify, the characterisation of the marrow-isolated cells was further 
investigated by differentiation of the cells down mesenchymal cells lines. 
2.4.2.1 Osteoblasts identified by Alkaline Phosphatase stain 
Alkaline phosphatase (ALP) is known to be expressed by maturing osteoblasts. 
Furthermore, Naphtol-AS-B1 sodium phosphate stain and fast red violet has been used 
previously to stain both human osteoblasts (Matsuyama et al. 1990) and differentiated 
MSCs in culture for the presence of ALP (Ohgushi et al. 1996b). 
The majority of marrow-isolated cells that had been cultured with OS for 7 days 
stained positively for ALP within the cytoplasm and cell membrane. The staining 
correlated with the change in shape as the cells became less spindle-like, which 
suggested a change in phenotype, as characterised by the expression of ALP. It also 
seemed that the majority of the cells were stimulated to produce ALP, rather than a 
small number of the cells expressing large amounts of ALP; the stain differentiated 
between these two circumstances, both of which would lead to an increase in ALP 
protein levels, as detected by biochemical assay. 
It would be expected, following the stem cell theory as discussed in Chapter 1, that 
some cells would retain the stem cell pool, remaining immature. It was found that the 
occasional fibroblastic cells did not stain for ALP despite 14 days culture in OS. This 
suggests that, even in osteogenic conditions, not all the marrow-isolated cells were 
stimulated to differentiate and that cells divided to maintain a progenitor population, 
thereby continuing the overall multipotent nature of the culture. 
In comparison, few of the marrow-isolated cells, cultured for the same time period in 
standard medium, stained slightly positively for ALP and the cells remained 
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fibroblastic in shape. This suggests that, without the influence of OS, the marrow- 
isolated cells did not produce ALP. The Saos-2 osteosarcoma cell line was cultured in 
the same standard conditions as a positive control and, as expected, these cells stained 
for ALP to the greatest extent. 
From these results it can be concluded that the bone marrow-derived cells produce 
ALP, a marker of the osteoblastic phenotype, in response to culture with OS. However, 
the use of a histological stain allows only observational results. 
2.4.2.2 Mineralisation identified by Von Kossa stain 
As the primary function of osteoblasts is to produce bone, this function can be used to 
define the cell type. Mineralisation of tissue samples from in vivo experiments has 
been assessed histologically (Haynesworth et al. 1992b), and electron microscopy 
techniques have also been used on ex-vivo implants to assess mineralisation of the 
extracellular matrix produced by cells (Bab et al. 1988b) in order to characterize the 
osteoblastic phenotype. 
Although mineral deposits have been reported associated with osteoblasts in vitro 
(Binderman et al. 1974), assessing mineralisation of extracellular matrix in tissue 
culture is more difficult. This is the result of less extracellular matrix forming in 
monolayer culture than within tissue. However, when 3-d bone nodules have been 
stained for the presence of extracellular calcification using the von Kossa technique, 
the stain has been shown to correlate with the detection of collagen type I and 
osteonectin by immunochemistry (Bellows et al. 1986). Consequently, von Kossa 
staining has also been used to identify the formation of mineralised nodules in vitro by 
human bone marrow-derived cells (Cheng et al. 1994). 
In this study, cells were seeded at a high density and a long culture period was used to 
encourage stratification of the cells. After 21 days in OS, von Kossa staining indicated 
calcification within the culture, which was observed to have increased by 28 days. The 
extracellular matrix stained to a lesser extent than for the Saos-2 control, although 
mineralisation was also limited in this culture. As discussed, it has been suggested that 
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osteoblasts require a 3-d structure in order to produce a mineralised matrix. Therefore, 
an explanation for the limited mineralisation may be that the cells was cultured on a 
2-d surface. There was no positive staining for mineralisation of the MSCs cultured in 
standard medium, as expected. 
In conclusion, some mineralisation did result from the culture of marrow cells in OS, 
thereby suggesting matrix production by osteoblasts, and the presence of osteoblast 
precursors in cultured marrow-isolated cells. 
2.4.2.3 Adipocytes identified by Oil red 0 
In addition to osteoblastic differentiation, the marrow-isolated cells were also tested 
for adipocytic differentiation, by culturing the cells in medium containing adipocytic 
supplements (Pittenger et al. 1999). These cells were stained using oil red 0 for 
intracellular lipid, which forms large droplets in adipocytes. Although, some lipid was 
present within the marrow-isolated cells cultured after 7 days in standard medium, this 
is often found in cells in culture. The size of cells that had been stimulated to 
differentiate down the adipocytic cell line were large due to increased cytoplasm, 
consistent with adipocytes and contrasted with the spindle shape of the marrow cells 
that persisted in standard culture. Although after 14 days in adipocytic medium, the 
majority of cells were observed to contain multiple large lipid droplets, no change was 
detected in cells in standard culture. 
In conclusion, cells isolated from human bone marrow could be stimulated to 
differentiate into adipocytes, as defined by a large frequency of intracellular lipid 
droplets. 
2.4.2.4 Chondrocytes identified by Alcian blue & Sirius red 
Alcian blue/sinus red were used to stain collagen matrix produced by cells in culture, 
as it detects the lattice arrangement of collagen fibres, which polarises under polarised 
light, as organised in tissue. 
When the marrow-isolated cells were cultured in standard conditions for 14 days, no 
collagen was detected and the cells maintained their spindle-like shape. Similarly, 
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although cells cultured in osteoblastic conditions produced no collagen matrix, they 
were less fibroblastic in morphology after 14 days. However, when marrow cells were 
cultured with supplements known to stimulate chondrogenic differentiation (Johnstone 
et al. 1998), the cells formed clumps and a polarising collagen matrix was observed 
surrounding every clump. Bovine chondrocytes were cultured as a positive control. 
These were not found to produce collagen, which could be due to the culture 
conditions, whereby the cells were grown in monolayer. 
It is noted that alcian blue/sirius red is not specific to collagen type II, which is 
produced by chondrocytes and as osteoblasts produce collagen type I, this stain will 
not differentiate between these two cell types. However, marrow cells cultured in 
osteoblastic conditions did not stain for collagen lattice, but in chondrocytic conditions 
a lattice was observed. In order for these cells to produce an organised collagen lattice, 
the cells need to grow in a 3-d arrangement. Therefore, it seems that the chondrogenic 
supplements stimulated the cells to form clumps and produce an organised collagen 
lattice, suggestive of chondrocytic differentiation. Further work to clarify this would 
require identifying specifically collagen type I or II on cells cultured in either 
osteogenic or chondrocytic medium. 
These results indicate that marrow-isolated cells, when cultured with chondrogenic 
supplements, were stimulated to produce a collagen matrix, consistent with 
chondrocytes. Taken together, my results suggest that marrow-isolated cells can be 
differentiated down the chondrocytic, adipocytic and osteoblastic cell lines, providing 
evidence of their multipotent nature indicating that they are MSCs. 
2.4.3 Further investigation of the differentiation of MSCs into 
osteoblastic cells 
24.3.1 Conclusions from cell culture morphology 
The addition of OS to isolated bone marrow cells in culture resulted in an observed 
change in morphology under light microscopy. The cells changed from long spindle 
cells, recognised to be MSCs, to shorter, brick-shaped cells after 7 days in these culture 
conditions. Osteoblastic cells, either a primary cell line extracted from trabecular bone 
or an osteosarcoma cell line, are square in shape when observed under light 
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microscopy (Aubin & Liu 1996; Liu et al. 1997; Lomri et al. 1988; Malaval et al. 
1999). The observed change in morphology is therefore consistent with the bone 
marrow-derived cells becoming osteoblastic. 
It has been noted that fibroblasts in cell culture can lose their spindle shape resulting in 
flattened cells that may look similar to those seen in these cultures with OS. However, 
if the observed change in morphology was due to this, the cells in standard medium 
would also be expected to change. Thus, since in this experiment cells in standard 
medium maintained their spindle shape, it is suggested that the change in shape was 
due to differentiation. 
2.4.3.2 Conclusions from SEM results 
Similar changes in morphology were observed under SEM. After 24 hours in culture 
on a therminox surface, the cells cultured in OS were cuboidal in shape compared to 
the control culture cells, which remained spindle-shaped. The comparative difference 
in shape increased after 7 days. These findings were consistent with those observed 
under light microscopy. 
In summary, only the isolated bone marrow cells stimulated by OS changed in shape, 
as observed under light and scanning electron microscopy. Although morphology is 
non-specific observational information, this change is consistent with the cells 
differentiating into osteoblasts when cultured in OS conditions. Hence, it can be 
suggested that the isolated bone marrow cells contain osteoblast precursor cells or 
MSCs that can be stimulated to differentiate down the osteoblastic cell line. However, 
osteoblastic differentiation was further defined in the following studies. 
2.4.4 Use of Messenger RNA expression to detect osteoblastic 
differentiation 
2.4.4.1 GAPDH 
GAPDH is a housekeeping gene that is expressed by all human cells. Therefore, it was 
used as a positive control and all the cell samples studied using RT-PCR were found to 
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express GAPDH. This confirmed that mRNA was extracted from each sample and that 
the method used detected this correctly. 
2.4.4.2 Cbfa-1 
Cbfa-1 is an early marker of osteoblastic differentiation, as outlined in the Introduction 
to this chapter, as it acts as a transcription factor for the expression of osteocalcin and 
is essential for the ossification of bone (Ducy 2000). Therefore, it would be expected 
that the Cbfa-1 gene would be transcribed in osteoblast progenitor cells and this would 
persist in differentiating cells, then reduce marked by the cells starting to produce 
osteocalcin. 
All the marrow-derived samples that had been cultured without OS were found to 
express Cbfa-1, which suggests that MSCs express Cbfa-1 when cultured in standard 
conditions. A further explanation of these results would be the presence of osteoblast 
progenitor cells as part of a heterogeneous group of progenitor and stem cells in this 
population. 
Cbfa-1 expression increased on the addition of OS in every sample of cells with the 
expression peaking after 3 days in OS and decreasing to a minimal level after 7 days in 
culture. This suggests that cell signalling stimulated the cells to express maximal 
amounts of Cbfa-1 after about 3 days in OS, which indicates that these cells were 
differentiating into osteoblast progenitor cells. The amount of Cbfa-1 detected then 
decreased by day 7, as levels of the transcription factor reduce with osteoblastic 
maturation, this suggests that the cells were being stimulated to differentiate further 
down the lineage. This proposal was supported by my results that showed that 
osteosarcoma cells, which were used as a positive control for osteoblasts, expressed 
lower levels of Cbfa-1, confirming that differentiated osteoblastic cells express this 
gene to a lesser extent. 
2.4.4.3 Osteopontin 
The effect of OS on the expression of osteopontin was assessed over 7 days in culture 
using RT-PCR. 
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The cells from one patient's marrow cultured in standard conditions expressed 
osteopontin. However the other patient's cells did not express osteopontin until 
cultured with OS. As osteopontin is expressed by proliferating cells (Lian & Stein 
1992), if the first sample of MSCs was dividing more rapidly than the second sample, 
this could account for the expression of osteopontin. A further explanation could be 
that, in addition to MSCs, this cell population included osteoblast progenitor cells 
which express osteopontin (Roach 1994), as suggested above. To clarify this, marrow- 
derived cells from a larger sample of patients need to be studied. 
Following culture with OS, osteopontin mRNA was detected at each time point 
measured. Thus, when MSCs are cultured with OS they change into cells that express 
osteopontin over a 7-day period, which is consistent with differentiation down the 
osteoblastic lineage. It has been suggested that the expression of osteopontin by 
osteoblasts is biphasic, with the first peak relating to proliferation and the second to 
osteoblastic differentiation (Aubin et al. 1995). Therefore, to investigate whether this 
pattern is seen as MSCs differentiate into osteoblasts, further studies of more patient 
samples over a longer culture period would be needed. 
2.4.4.4 Osteocalcin 
Marrow-isolated cells in standard medium were not found to express osteocalcin, 
signifying undifferentiated cells as expected in these cultures. This is consistent with 
the findings that the osteocalcin gene was not found to be expressed by bone marrow 
cells (Falla et al. 1993) or osteoblast progenitor cells (Aubin 1998), in culture. 
Osteocalcin mB. NA from patient 1 was expressed after 3 days in OS culture and after 1 
day for patient 2's sample. Both samples continued to express osteocalcin for the 
remainder of the culture in OS. As gene expression of osteocalcin has been found to 
correlate with cells that form mineralised tissue (Mizuno & Kuboki 2001), these 
results indicate that OS increased osteoblast gene expression. 
In summary, Cbfa-1, osteopontin & osteocalcin can be used as markers of increasing 
osteoblastic differentiation. Furthermore, the sequential expression of these genes, 
following the addition of OS to marrow-derived cells in culture, supports the 
hypothesis that OS stimulates MSCs to differentiate into osteoblasts. 
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The main criticism of these RT-PCR results is that, although they confirm that the 
population of cells cultured in OS express mRNA known to be expressed by 
osteoblasts, the results do not quantify this at cellular level. Therefore, the increase 
could be due to a small number of cells synthesising mRNA, being stimulated by OS 
to produce a larger amount. These cells could be osteoblast progenitor cells present in 
the marrow at aspiration. However, the histological stains provide evidence that, cells 
in standard medium did not produce ALP, in contrast the majority of cells in OS did 
then produce this osteoblastic protein. Taking these results together suggests that the 
majority of marrow-derived cells differentiate down the osteoblastic lineage, when 
cultured in osteogenic conditions. 
2.4.5 Protein production to determine differentiation into osteoblasts 
2.4.5.1 Alkaline phosphatase (ALP) 
The amount of ALP protein was measured quantitatively to assess osteoblastic activity 
in culture. This method has been used to assess osteoblastic maturation of clonal cell 
lines, MC3T3-E1 (Sudo et al. 1983), differentiation of rat MSCs in culture (Owen et al. 
1991) and differentiation of human MSCs down the osteoblastic lineage in vitro, by 
many investigators (Cheng et al. 1994; Jaiswal et al. 1997; Maniatopoulos et al. 1988). 
Although, using histological staining, ALP was shown to be present in the cytoplasm 
of the majority of MSCs cultured in OS after 7 days, the increase in ALP protein levels 
by cells cultured in OS over time could be explained by an increase in the total number 
of cells, rather than an increase in the expression of ALP by individual cells. 
Therefore, as outlined in the method, to standardise the results for the number of cells, 
the total DNA content of each sample was measured. The ALP expression was divided 
by the total DNA content allowing comparisons to be drawn between samples in two 
conditions. The same was true for the other proteins measured in my studies. 
The results of my study showed that minimal amounts of ALP were produced when 
either 25,000 marrow-isolated cells were cultured over 15 days or when 250,000 cells 
were cultured over 28 days in standard medium. Thus, in control conditions, some 
cells produced low levels of ALP, but production did not increase over time. 
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ALP has been used previously to define the stages of differentiation down the 
osteoblastic lineage, as it has been found to be expressed early in the postulated 
sequence of osteoblastic development and has therefore been suggested as a marker of 
osteoblast progenitor cells (Turksen & Aubin 1991). The results of my study are 
consistent with the standard culture containing both MSCs, which do not produce 
ALP, and few osteoblast progenitor cells that produce low levels of ALP. As 
production of ALP remained constant in standard conditions, the cells were not 
differentiating into osteoblasts and the proportion of osteoblast progenitor cells thus 
remained constant. This observation, that ALP positive cells have osteoblastic 
potential, has lead others to isolate such cells from marrow cells for studies into 
osteoblast progenitor cells (Bruder & Caplan 1990; Walsh et al. 2000). 
In this chapter, the addition of OS to 25,000 marrow-isolated cells significantly 
increased the expression of ALP measured after 5 days as compared with the control 
(P<0.005). This significant difference was maintained over the 15-day culture period 
(P<0.005). The expression of ALP peaked at day 5, which is consistent with reports in 
scientific literature that have shown ALP protein expression is an early marker of 
osteoblastic differentiation (Aubin et al. 1995) and, more specifically, MSCs in 
osteogenic culture have been shown to produce significantly higher levels of ALP after 
5 days (Zvaifler et al. 2000). 
When a larger number of MSCs (250,000) were cultured in the presence or absence of 
OS the same response was confirmed as, after 14 days (first time point measured) in 
osteogenic conditions, cells expressed a significantly higher level of ALP (P<0.05). 
The significant increase in ALP production was maintained until the end of a 28-day 
period (P<0.05), although the amount of ALP produced by the cells in OS decreased. 
The expression of ALP has been shown to occur before mineralisation of bone matrix 
and hence its presence has been implicated in initiating this process (Hui et al. 1997). It 
would therefore be expected that, following the peak of ALP production (within the 
first week in OS culture in these studies), the cells would be primed for mineralisation. 
ALP is also used as a clinical marker of bone turnover and the amount of protein can 
be measured in serum (Eyre 1997). However, ALP protein production is not specific to 
osteoblastic cells, as it is also expressed by fibroblasts and chondrocytes (Johnstone et 
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al. 1998). As a result of this, production of other proteins produced by osteoblasts was 
also measured in my study. 
2.4.5.2 Osteopontin 
Osteopontin is produced by osteoblasts during embryonic intramembraneous and 
endochondral ossification (Dodds et al. 1995). It has also been shown to be produced 
by osteoblasts ahead of the mineralisation front, where it forms part of the extracellular 
matrix prior to bone formation (Roach 1994). Therefore, it is a useful marker of 
osteoblastic differentiation and function and as a result of this, production of 
osteopontin protein was measured in my study. 
After 14 days in culture, MSCs that had been exposed to OS expressed significantly 
more osteopontin than the control (P<0.05). In view of the peak in ALP production 
before this point, the osteopontin detected is likely to coincide with osteoblastic matrix 
production prior to mineralisation. Serial osteopontin measurements over a longer 
period of time would be needed to confirm whether MSCs differentiating into 
osteoblasts also produce osteopontin in a biphasic pattern as has been suggested for 
osteoblast progenitor cells (Aubin et al. 1995), as suggested for the RT-PCR results. 
Although significantly larger amounts of osteopontin were measured after the cells had 
been cultured with OS, un-stimulated MSCs also produce low levels of the protein 
after 14 days, which infers that the mRNA result (see above) was not an anomaly, but 
rather that MSCs produce low levels of osteopontin or that the cell population 
contained a few osteoblast progenitor cells. To investigate this further, also the 
production over time of osteopontin by MSCs in standard conditions needs to be 
studied. 
Despite osteopontin being produced by osteoblasts, it is non-specific to this cell type as 
it is also produced by chondrocytes (Dodds et al. 1995; Liu et al. 1994). However, 
these osteopontin results provide further evidence that isolated bone marrow cells can 
been stimulated to differentiate down the osteoblastic lineage by OS. 
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2.4.5.3 Osteocalcin 
Osteocalcin is extracellular protein that is produced by mature osteoblasts and is 
uniquely associated with mineralised tissue (Aubin 1998; Malone et al. 1982). 
Consequently it is a more specific marker of osteoblasts than other protein assays used 
in this study. For example, it is not produced by chondrocytes (Nakase et al. 1994), 
improving its validity as marker of osteoblastic differentiation of MSCs. 
Marrow-isolated cells cultured in standard conditions did not produce osteocalcin, 
signifying the lack of osteoblasts in this culture. This contrasts with the low levels of 
ALP and osteopontin produced by the cells in control conditions, which may be 
explained by the presence of a small number of osteoblast progenitor cells that express 
ALP and osteopontin, in the bone marrow-isolated cells in standard conditions. 
However, osteocalcin is not produced by osteoblast progenitor cells, but by 
differentiated osteoblasts. 
Marrow-isolated cells cultured for 28 days in OS were found to express significantly 
higher levels of osteocalcin than cells in standard conditions (P<0.05), although the 
actual levels of osteocalcin were low. Therefore for MSCs to synthesise osteocalcin in 
culture OS was necessary. 
The production of osteocalcin by rat MSCs commenced after 21 days in OS (Peter et 
al. 1998). As no osteocalcin was detected when 25,000 MSCs were cultured for 15 
days in OS, it is likely that the low protein levels present when 250,000 cells were 
seeded was due to the short culture period. However, further research is necessary to 
clarify this. 
The detection of proteins produced by cells is a more reliable marker of cell phenotype 
than mRNA expression. Additionally the use of protein assays allows protein levels to 
be easily quantifiable permitting comparison between groups. 
In summary, marrow-isolated cells cultured in OS produced significantly higher levels 
of ALP, osteopontin and osteocalcin proteins than similar cells cultured in standard 
conditions, which confirms that cells isolated from bone marrow were stimulated to 
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differentiate into osteoblasts and that the isolated marrow cells contained osteoblast 
progenitor cells or MSCs. 
In conclusion, the results of my studies in this chapter indicate that marrow-isolated 
cells could be differentiated down the mesenchymal cell lineages of osteoblasts, 
adipocytes and chondrocytes, which, in turn, therefore indicate that MSCs were 
initially isolated from human bone marrow. This concurs with the Stro-1 identification 
of the isolated marrow cells. 
2.4.6 Cellular proliferation rate 
2.4.6.1 DNA content 
The total DNA content of marrow-isolated cells was compared over time in culture to 
assess whether these cells could be expanded in culture. Although the assay did not 
determine between alive and dead DNA, as dead cells do not adhere in culture the 
majority would have been removed with medium changes. Thus, DNA levels were 
equated to cell number and an increase in total DNA was used to assess cell growth. 
When 25,000 MSCs were cultured for 15 days, the amount of DNA measured for each 
condition increased significantly between each 5-day interval (P<0.005). The same 
increase in DNA was noted between 14 and 28 days, when 250,000 cells were initially 
cultured (P<0.05). These results confirm that the cells were increasing in DNA 
content, hence expanding in number in culture. 
The amount of DNA for the cells cultured in standard medium was greater than for OS 
after 15 days (25,000 cells seeded) and 28 days (250,000 cells) in culture (P<0.05). 
This suggests that the proliferation rate of marrow-derived cells is reduced when 
cultured in OS. Cellular proliferation has been found to reduce when cells differentiate 
(Stein et al. 1990) and my findings are consistent with this inverse relationship 
between proliferation and differentiation. Therefore these results, assessing cell 
proliferation, further indicate that cells grown in OS were differentiating. 
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CHAPTER 3 
Tissue Engineering of Bone using Mesenchymal Stem Cells on a 
Hydroxyapatite Scaffold 
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3.1 INTRODUCTION 
3.1.1 Background to chapter 
As discussed in Chapter 1, bone loss, following tumour excision, fracture, or the need 
to fill bone defects during revision arthoplasty surgery or joint fusions, requires the use 
of bone grafts. However, the key source of grafts, autologous bone graft, has its own 
associated problems of donor site morbidity and limited amount available per patient. 
Despite these problems autograft is currently considered to be the `gold-standard', 
because of its osteoinductive and autologous nature. Allograft on the other hand, 
although possessing the structural properties of bone, has a greatly reduced 
osteoinductive nature as a result of processing, which removes progenitor and blood 
cells and, depending on the degree of cleaning used, can destroy growth factors. This 
processing is necessary to prevent immune rejection of the graft and reduces the risk of 
transmission of pathogens (Goldberg & Stevenson 1987). 
As a consequence of these limitations, much research has been carried out into 
synthetic bone graft substitutes, but with limited success (Shah 2000), (see Chapter 1). 
This chapter investigates whether a biological bone graft substitute can be formed in 
vitro. 
3.1.2 Tissue engineering 
In vitro cell culture has traditionally used a flat environment to research the behaviour 
of cells. In these conditions the cells attach themselves to the culture surface in a single 
layer, becoming orientated in one direction. This is an artificial situation when 
compared with the 3-dimensional (3-d) environment in vivo, where cells are 
surrounded by other cells and extracellular matrix. 
Tissue engineering is becoming a growing field of research, whereby cells are grown 
in situations that aim to recreate their natural environment more closely. The objective 
of this is to generate a 3-d cellular structure from cells in vitro, that could be implanted 
to reconstruct diseased or absent tissue that would not normally repair, thus restoring 
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function (Oreffo & Triffitt 1999). It was suggested in my Chapter 1 that skeletal tissue 
engineering requires cells on a scaffold with bioactive factors. 
3.1.3 Cells 
The advantages of using MSCs for the tissue engineering of bone are firstly, that 
MSCs can easily be harvested by bone marrow aspiration and secondly, their 
propensity for self-renewal as a source of osteoblastic cells, as shown in Chapter 2. 
Alternatively, mature differentiated cells could be used. However, osteoblasts cannot 
easily be harvested, as this requires the extraction of cells from trabecular bone 
(Bellows et al. 1986). Bone harvesting would also cause more donor site complications 
than marrow aspiration. Furthermore, differentiated cells have a determined half-life, 
without the ability for self-renewal, which in the case of MSCs, is maintained by a 
progenitor cell pool. 
Previous studies have implanted whole marrow in vivo to increase bone healing 
(Connolly et al. 1991 a; Delloye et al. 1998). However, marrow contains a mixture of 
cell types and an array of growth factors, which have the potential to influence cell 
behaviour. This influence can be reduced, since a large number of MSCs can be 
culture expanded from a small volume of marrow. Therefore, only a small amount of 
marrow is needed, reducing donor site morbidity and this would also allow autologous 
cells to be used in potential clinical applications. Therefore, marrow-isolated, culture 
expanded MSCs were used in this study. 
3.1.4 Scaffold 
In order to achieve robust 3-d cell growth, a scaffold substrate is required and the 
result of its interaction with the cells should generate tissue. Furthermore, the scaffold 
acts as a carrier for implantation of cells in vivo. The ideal properties of a scaffold for 
tissue engineering bone are: 
" 3-d scaffold, to facilitate 3-d cell growth 
" Biocompatibility, to minimize inflammatory response 
" Reabsorbability, to allow its replacement 
" Biodegradabily, without harmful effects 
119 
Chapter 3 Introduction 
" Support of cell attachment, to allow carriage/transfer 
" Osteoconductivity, to encourage integration between donor and host 
tissue 
" Porosity, for capillaries ingrowth and vascularisation to prevent central 
necrosis 
" Material should allow maximal, uniform loading and retention of cells 
" Structural properties, similar to biological tissue 
" Ease of handling by the surgeon, at a single procedure, in theatre 
" Cheap (Bruder et al. 1994b) 
To meet these requirements, the scaffold needs to be tailored to the cell type and tissue. 
Hence, for the tissue engineering of bone, the aim of the scaffold structure is to 
resemble that of cancellous bone. The scaffold needs to support the growth of 
osteoblasts and provide mechanical support when packed into a tissue defect, but also 
allow the diffusion of nutrients and the ingrowth of capillaries. As bone has a very 
high extracellular matrix to cell ratio, the scaffold used needs to replace this 
extracellular matrix, supporting the cells until they produce their own matrix. 
3.1.5 Scaffold types 
Below are a list and descriptions of different possible scaffold types. 
3.1. S. 1 Biological scaffolds 
Allograft is known to become more osteogenic if impregnated with bone marrow prior 
to implantation (Burwell 1964), making this the most basic type of tissue engineering. 
However, this still requires the use of allograft, which has disadvantages associated 
with it (see Chapter 1). Below are other biological materials that have been considered 
for use as scaffolds. 
3.1.5.1.1 Demineralised bone matrix 
Demineralised bone matrix (DBM) (allograft stored in hydrochloric acid for 48 hours), 
has been found to be somewhat osteoinductive, as it induced the differentiation of 
MSCs into osteoblasts and, although not as beneficial as autologous bone graft, has 
been shown to heal segmental bone defects in rabbits (Tuli SM & Singh AD 1978) and 
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rats (Einhorn et al. 1984). DBM is known to contain a mixture of bioactive factors, 
such as BMPs, TGFß and FGF. 
In comparison, the mineral remaining in allograft seems to reduce the effect of these 
bioactive proteins in the graft. Thus, it seems that decalcification allows closer 
interaction between these proteins and host cells, increasing their osteoinductive effect. 
However, the use of DMB relies on the supply of allograft, which is limited. 
One of the considerations for any bone graft substitute is the ease of handling of the 
material during a surgical operation. A further disadvantage of DMB is that it is 
difficult to handle and lacks structural support of allograft. 
3.1.5.1.2 Collagen 
Collagen is the most abundant extracellular protein in the body and in bone, and has 
therefore been suggested to be a potentially useful scaffold for tissue engineering. The 
first collagen-based material to be used in surgery was catgut-sutures, shown to have 
low immunogenity and to be highly biodegradable, to the extent that it may be 
reabsorbed before healing is completed. 
For cells to survive, divide and differentiate in culture, it is necessary for them to 
attach to the culture surface. When collagen is used as a substrate for cell culture, cells 
attach to the collagen via attachment proteins such as fibronectin (Kleinman et al. 
1981). It is possible that this cell attachment could direct growth and differentiation. 
It is noted that when osteosarcoma cells were grown on a collagen coated surface the 
proliferation rate and synthesis of osteocalcin increased (Masi et al. 1992). This 
suggests that collagen may be a potentially useful medium on which to grow bone. 
However, when MSCs have been cultured within a collagen matrix, they behave 
similarly to fibroblasts, contracting and reducing the matrix size, as in scar tissue 
(Awad et al. 2000). Thus it has been suggested that MSCs differentiate into fibroblasts 
in collagen. Additionally, collagen is viscous in structure and would offer little 
structural support to a bone defect. For these reasons collagen was not used in these 
experiments. 
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3.1.5.1.3 Fibrin 
Fibrin is a constituent of clot, formed from fibrinogen and thrombin mixed. As such, it 
plays a vital role in wound healing, by forming a network for the migration of 
fibroblasts and acts as a haemostatic barrier. It has also been shown to promote bone 
healing when injected into an osteotomy site (Schlag & Redl 1988). It has been shown 
that fibroblasts cultured within a fibrin clot adhere and proliferate (Gandossi et al. 
2000). Therefore, fibrin may be a useful scaffold in which to transfer cells into tissue 
defects. 
However, its effects on MSCs are not known and it is possible that, like collagen, 
fibrin will stimulate fibroblastic differentiation, as it is chemotactic for fibroblasts in 
vivo. Furthermore, as a fibrin clot is semi-solid in structure, it is more difficult to 
handle both in the laboratory and potentially so for the surgeon in theatre and also it 
would not afford structural support to a bone defect. 
3.1.5.2 Ceramics 
Ceramics include plaster of Paris, a calcium sulphate material, which was first used as 
a temporary bone substitute in 1892, although with limited success (Peltier 2001). 
Other ceramics that are suggested to be useful in the tissue engineering of bone are 
described below. 
3.1.5.2.1 Coral 
Coral has been investigated as a scaffold for bone growth, as it has a highly 
interconnected porous structure, high compressive breaking strength and is rapidly 
biodegraded. Calcium carbonate coral ceramic is derived from the exoskeleton of coral 
porites and has been shown to support growth and differentiation of marrow derived 
MSCs on the addition of dexamethasone in vitro (Petite et al. 1996). 
However, when coral ceramics were compared to hydroxyapatite (HA), both loaded 
with bone marrow cells and implanted subcutaneously into synergic rats, bone bonded 
directly to the HA, but there was less ingrowth of bone into the coral and an immune 
reaction with phagocytosis of the coral was also observed (Ohgushi et al. 1992). This 
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reaction could represent a foreign body reaction to coral resulting in reduced 
biocompatibility. 
3.1.5.2.2 Bioglass 
Bioglass is another calcium phosphate-based ceramic that has been studied for 
potential bone bonding uses in dental surgery, where it has been shown to be 
osteoconductive for implanted osteoblasts (Piattelli et al. 2000; Xymos et al. 2000). 
3.1.5.2.3 Biphasic ceramic 
A mixture of HA and tricalcium phosphate (TCP) is known as biphasic ceramic. Both 
HA and TCP support the growth of cells in vitro (Uchida et al. 1987) and in vivo 
(Shimazaki & Mooney 1985). TCP is absorbed faster than HA once implanted into an 
animal - at 24 weeks after implantation 46% of TCP has been degraded, compared 
with 27% of HA (Renooij et al. 1985; Shimazaki & Mooney 1985). 
Many studies have examined the osteogenic properties of HA/TCP in research into 
MSCs (see Chapter 1). When HA/TCP (60/40%) was loaded with bone marrow or 
isolated MSCs and implanted subcutaneously into an immuno-compromised animal, 
bone was noted to form within the ceramic (Goshima et al. 1991 a; Nakahara et al. 
1992). HA/TCP with MSCs have been shown to improve healing of segmental bone 
defects in dogs (Bruder et al. 1998b). However, in vitro MSCs cultured on HA/TCP 
only differentiated into osteoblasts in the presence of dexamethasone and vitamin D 
(Toquet et al. 1999). 
3.1.5.2.4 Hydroxyapatite (HA) 
As calcium phosphate is the major component of inorganic bone, materials based on 
this have been used as synthetic bone graft substitutes (see Chapter 1). Furthermore, 
HA ceramics have also been investigated for use in the delivery of osteogenic cells and 
bioactive factors to sites of bone loss. 
HA can be converted from the calcium carbonate exoskeletons of coral by means of a 
thermal chemical exchange reaction to form a porous scaffold, which resembles 
cancellous bone (White & Shors 1986). Although physically similar to bone, HA does 
not possess the same mechanical strength and, therefore, cannot be used for load- 
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bearing support. However, once bone ingrowth starts the strength of the graft increases 
(Ohgushi et al. 1989a). 
In vivo it has been shown that HA loaded with bone marrow and implanted 
subcutaneously into a syngenic rat produced bone 2 weeks after implantation (Inoue et 
al. 1997; Yoshikawa et al. 1992) and that there was no inflammatory response to the 
implant, confirming its biocompatibility (Okumura et al. 1991). The same results were 
obtained when cultured bone marrow derived MSCs were similarly implanted on HA 
(Yoshikawa et al. 2000). 
When MSCs were previously cultured with dexamethasone, increased bone formation 
was observed 1 week after subcutaneously implantation (Yoshikawa et al. 1996). 
Without the influence of HA, bone only formed when MSCs were cultured with 
dexamethasone, prior to implantation in a diffusion chamber intraperitoneally (Gundle 
et al. 1995). An explanation for these findings is that dexamethasone conditions MSCs 
for osteoblastic differentiation, possibly by differentiating them into committed 
osteoblast precursor cells prior to implantation, resulting in more rapid bone formation 
on HA and bone formation where it otherwise would not occur, such as in an 
intraperitoneal diffusion chamber (Haynesworth et al. 1992b). These results indicate 
that MSCs on HA form bone when influenced by other factors such as growth factors 
in vivo or dexamethasone in vitro. 
3.1.6 Effect of surfaces on cells 
It has been established that certain properties of materials can affect the proliferation, 
metabolism, attachment, matrix synthesis and differentiation of cells grown on them. 
The response by cells varies with cell maturity and can be altered by conditions. The 
key properties of materials that are known to affect cells are: 
" Chemical composition 
" Surface energy 
" Surface roughness 
" Surface topography 
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Chemical composition affects the absorption of factors from fluid into the surface 
altering it and thus the cellular response. For example, if fibronectin binds to the 
surface, it mediates cell attachment and HA coated with fibronectin has been shown to 
increase MSCs retention in the ceramic (Dennis et al. 1992). A detrimental effect of 
this chemical conditioning of the material surface by extracellular fluid is leaching of 
ions from metal implants, where the degree of corrosion is proportional to tissue 
response (French et al. 1984). 
Surface energy relates to the composition of the material as its energy affects the rate 
of factor absorption and wetability of the scaffold. Surface roughness has also been 
shown to effect cell behaviour. Bone has been observed to form on rough-surfaced 
porous HA without cell loading, but not smooth walled HA, when cells were 
implanted intramuscularly in dogs (Yuan et al. 1999). Therefore, surface roughness 
appears to have a significant effect on the formation of bone, with rough surfaces 
tending to promote bone formation, whereas smooth surfaces increase the formation of 
fibrous tissue. This may be the result of increased protein attachment to the larger 
surface area of a rough material. 
Surface topography, a grooved surface has been shown to allow condensations of 
osteoblasts to collect resulting in bone formation in vitro (Gray et al. 1996; Gray 
1998). This effect may be due to osteoblastic stimulation, as the grooves may imitate 
osteoclast cutting-channels formed in matrix by osteoclasts, which is followed by 
osteoblastic matrix synthesis in the process of bone turnover. 
It is also noted that HA with a porous surface, increases bone formation (Ripamonti et 
al. 1992); (Yamasaki & Saki 1992) and this may also be due to osteoblasts collecting 
in the pits. Furthermore, the size of the micro-pores seems to have an effect on the 
differentiation of MSCs, with a smaller pore size (50-200µm) increasing bone 
induction in ceramics in vivo, to a greater extent than 400µm-500µm pores (Eggli et al. 
1988; Ripamonti et al. 1992). As the smaller pores also correspond to the diameter of 
osteoclast cutting-channels, which are about 50-100µm in diameter, these smaller 
pores may mediate increased osteoblastic differentiation and bone matrix production, 
as seen in living bone. 
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A further explanation for the reaction between osteoblasts and a porous surface may be 
that the pore size reflects that within cortical bone, also known as the Haversian 
canaliculi-lacunae system. These pores are much smaller than in trabecular bone, with 
the lacunae measuring on average 12 x 24 pm and the canuliculi are even smaller (Qin 
et al. 1999). 
3.1.7 Review of scaffold type to be used in this study 
As illustrated, both HA and HA/TCP are potentially useful scaffolds for bone 
regeneration. However, as the rate of bone induction was greater in the HA ceramic 
when loaded with bone marrow and implanted subcutaneously in a rat (Eggli et al. 
1988). 
Bone has been shown to bond directly to calcium phosphate ceramic in vivo, 
demonstrating its osteoconductivity (Okumura et al. 1997). Additionally, HA coating 
on metal prosthetic implants is known to stimulate osseointegration of the prosthesis 
into bone and it is used therapeutically for this effect (Furlong & Osborn 1991). HA 
has also been shown to be bioactive in vivo and it fulfils a number of the property 
requirements for tissue engineering of bone: biocompatibility, osteoconductivity and 
porosity. Hence, the effect of using HA without the influence of growth factors, on the 
differentiation of MSCs in vitro will be investigated in this chapter. 
In my thesis, the HA scaffold used had interconnecting macro-pores, similar in 
structure to that of trabecular bone. This structure would also allow the growth of cells 
throughout the scaffold and the ingrowth of capillaries into the construct following 
implantation into a patient. 
As noted above, a rough, micro-porous surface of HA has been shown to induce bone 
formation. The micro-pores in the HA scaffold used in my thesis were of a similar size 
to those of the canaliculi-lacunae, measuring on average 10µm, with the intention that 
this may also increase osteoblastic activity. 
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3.1.8 Bioactive factors 
Bioactive factors that have been considered are those such as BMPs, which were first 
discovered in demineralised bone matrix (Urist 1965). However, it has been shown 
that doses many times greater than physiological levels are needed to exert an 
osteogenic effect clinically (Boyne et al. 1997; Howell et al. 2002). The use of bovine 
BMP would cause concern due to the possible transmission of prions and the long- 
term effects of administering these doses of rhBMP to patients also still needs to be 
assessed fully. 
Although the proportions of multiple growth factors present in vivo cannot easily be 
re-created in vitro, following implantation of the tissue engineered construct, the cells 
would be subject to a physiological environment. Hence, if tissue can be generated in 
vitro without bioactive factors, maturation will increase on implantation in vivo. For 
these reasons, in my study, the differentiation of MSCs into osteoblasts and production 
of extracellular bone matrix on HA was tested without the use of bioactive factors. 
3.1.9 In this chapter 
The aim of this chapter was to investigate whether MSCs could grow on HA and 
whether this surface would stimulate cellular differentiation down the osteogenic 
lineage. Thereby, committed, lineage specific osteoblastic cells could be tissue 
engineered on HA scaffolds for potential implantation aiding rapid bone repair. 
As discussed above, for MSCs to be used in the tissue engineering of bone, a suitable 
carrier needs to be investigated. There is some evidence from the in vivo studies 
described above that HA may encourage differentiation of MSCs, however this has not 
been investigated in vitro, without the effect of osteogenic factors that are present in 
vivo. Thus, this will be investigated in this chapter. Additionally, for HA to be a useful 
carrier of MSCs, the cells need to be able to grow on the HA scaffold and so 
proliferation of cells was tested using Alamar Blue and DNA assays. 
To study the effect of HA, bone marrow isolated MSCs were cultured on an HA 
surface and compared with cells grown on culture plastic in vitro. These two surfaces 
were used to measure whether growth on an HA surface was associated with an 
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increase in production of osteoblastic proteins. For MSCs to be used for tissue 
engineering of bone, a structure that can be used to fill bone defects is necessary, thus 
MSCs were also cultured on porous HA scaffold and cell proliferation and osteoblastic 
differentiation were both assessed. As this 3-d structure may affect cellular behaviour 
these results were compared to a control plastic scaffold with a similar structure. 
Evidence for osteoblastic differentiation of the cultured cells was observed under light 
microscopy and scanning electron microscopy (SEM), as described in Chapter 2. 
Transmission electron microscopy (TEM) was used to assess the ultrastructure of the 
cells and extracellular matrix production on the scaffold. Biochemical assays were 
used to measure the levels of osteoblastic proteins produced by the cells, as detailed in 
Chapter 2. 
3.1.10 Hypothesis 
The hypotheses tested this chapter were: 
1. MSCs isolated from human bone marrow will grow on an HA surface or 
scaffold in vitro; 
2. MSCs differentiate into osteoblasts without the influence of OS when cultured 
on either HA discs or porous HA scaffolds in vitro. 
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3.2 MATERIALS and METHODS 
3.2.1 Materials 
General 
Cell culture materials and assays as listed in Chapter 2 
Alamar blue assay (Serotec BUFO12B) 
Hydroxyapatite porous pieces (Plasma Biotal): cylinders 12mm height x 10mm 
diameter, sterilised by gamma irradiation 
Titanium discs 10mm diameter coated with HA (Plasma Biotal), sterilised by gamma 
irradiation 
SEM as listed in Chapter 2 
TEM 
Propylene oxide (Agar Scientific R1080) 
Hard resin: 
Vinyl cyclohexanedioxide 20g (Agar Scientific R1047) 
Noneryl succinic anhydride 52g (Agar Scientific R1055) 
Diglycidylether of polypropyleneglycerol 8g (Agar Scientific R1073) 
Dimethylaminoethanol 0.8g (Agar Scientific R1067) 
3.2.2 MSC culture 
Twelve human bone marrow aspirates were taken from patients after informed 
consent, from which the MSCs were separated and cultured in monolayer, as 
previously described in Chapter 1. The MSCs were again observed to form colonies of 
cells in culture. Once the primary cultures became confluent, the cells were trypsinised 
and expanded until passage 4, when enough cells from each of the aspirates had been 
grown to seed onto 2-dimensional (2-d) HA discs and 2-d plastic controls, as well as 
3-d HA scaffolds and 3-d plastic controls. All procedures were carried out in the 
laminar flow cell culture hood using a no-touch technique and cells were cultured at 
37°C and 5% CO2 throughout. 
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In summary, to assess the effect of a HA surface on proliferation and differentiation, 
MSCs were initially cultured on HA coated discs and compared with MSCs grown on 
a plastic control. Differentiation of MSCs into osteoblasts was examined by observing 
and measuring levels of osteoblastic proteins produced over time for cells on both HA 
and control surfaces. 
3.2.3 2-Dimensional Hydroxyapatite Discs 
Firstly, HA discs, sterilised by gamma irradiation, were each seeded with 25,000 
MSCs in a volume of 50µ1 of medium, onto the centre of the disc. An identical method 
was used to seed the control cells onto tissue plastic in a 24 well plate. After 2 hours of 
incubation and before the cells dried out, each well was flooded with 2m1 of medium, 
which was then changed every other day. Standard medium (content as detailed in 
Chapter 2) was used throughout the experiments of this chapter, unless otherwise 
stated. This method was used to assemble discs and controls for the proliferation 
experiments, differentiation assays and for SEM. 
3.2.3.1 Measure of Cellular proliferation 
3.2.3.1.1 Levels of DNA 
HA discs and six plastic controls were each seeded with 25,000 MSCs and the DNA 
content was measured, after 5,10 and 15 days in culture, using DNA Hoeschst assay 
as described in Chapter 2 Method. This was repeated with MSCs separated from six 
patients' aspirates. The DNA levels were then compared statically between the two 
surfaces as a further marker of cell growth. 
3.2.3.1.2 Absorbance of Alamar blue assay 
The cellular proliferation rate was measured using Alamar blue assay, adapted from 
published methods (Nakayama et al. 1997; Nikolaychik et al. 1996; Nociari et al. 
1998). 
Alamar blue assay was used to compare the proliferation rate between MSCs seeded 
onto HA discs and the control. Six HA discs and six plastic disc controls were each 
seeded with 25,000 MSCs. These sample groups were repeated for three patients' 
marrow aspirates giving a total of 18 test discs for each group. The cells were cultured 
for 15 days, with Alamar absorbance being measured every 5 days. 
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To measure Alamar blue absorbance, the medium was removed from the cells and 
replaced with 0.5m1 of 10% Alamar blue assay in phenol-free medium. A similar 
amount of Alamar blue was also placed in an empty well to act as a control. After the 
cells had been incubated for 3 hours, 2 repeats of l00µ1 of Alamar blue were removed 
from each well and the absorbance was measured at 570nm for each sample and 
control. The control absorbance (background) was subtracted from the result of each 
sample. The cells were then washed twice with phosphate buffered saline, fresh 
medium was added and the cells continued in culture. 
3.2.3.2 Observational study of cellular differentiation on HA 
3.2.3.2.1 Under scanning electron microscopy (SEM) 
In a separate study, the difference in morphology of MSCs grown on HA discs, 
therminox discs in standard medium (negative control for osteoblastic differentiation) 
and therminox discs in OS (positive control, OS constituents as described in Chapter 2) 
was observed under SEM. For this study, MSCs were cultured on 3 discs for each of 
the culture periods: 1,7 and 14 days, for each of the conditions noted above. This was 
repeated for MSCs derived from 2 patients. 
The cells were seeded using the method described above, although a cell density of 
20,000 cells was used. Following this, discs were processed for SEM (see Chapter 2 
Method). The cellular morphology of MSCs on HA was assessed after 1,7 and 14 
days in culture and compared with MSCs cultured on therminox discs, in standard and 
OS medium. 
3.2.3.3 Measure of protein assays, an indicator of osteoblastic differentiation 
3.2.3.3.1 ALP 
The amount of ALP produced by the cells was used as a measure of osteoblastic 
differentiation, using a biochemical assay for p-nitrophenol cleaved from p-nitrophenol 
phosphate (see Chapter 2 Method). For each of the protein assays 25,000 MSCs from 
six patients were seeded onto each of six HA discs and six plastic controls, for each 
time point measured. Cells were cultured for 5,10,15 and 30 days, at which points the 
level of ALP and total DNA content of each sample was measured (see Chapter 2 
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Method). The amount of ALP per disc was standardised for a variation in the increase 
in cell number over the culture period, by dividing the ALP measurement of each 
sample by total DNA content, thus allowing comparisons to be made between ALP 
production on HA and control discs at each time point. 
The experiment was repeated using eight HA discs with 250,000 cells per disc and 
ALP and DNA levels were measured in the same way after 14 and 28 days. 
3.2.3.3.2 Osteopontin 
Osteoblastic differentiation was also assessed by measuring the production of 
osteopontin. For this study marrow aspirates from six patients were used as 250,000 
MSCs were cultured on six HA discs and six plastic controls for 14 days and this was 
repeated on six further HA discs for 28 days. The level of osteopontin protein was 
measured using an enzyme immunometric assay (see Chapter 2 Method) and, as 
before, the readings were divided by total DNA content to allow comparison. 
3.2.3.3.3 Osteocalcin 
The osteocalcin assay detailed in Chapter 2 was used as a further marker of 
osteoblastic differentiation, by comparing protein levels between cells grown on HA 
discs and controls when 250,000 cells were cultured for 14 days. This was repeated 
with five patients' aspirates. DNA content was again measured for standardisation. 
3.2.4 3-Dimensional Porous Hydroxyapatite Scaffold 
The second part of this study investigated the effect of growing MSCs on porous 3-d 
HA scaffolds. The scaffolds were cylindrical in shape with a height of 12mm and 
diameter of 10mm and had a 70% void volume. They had an interconnected porous 
structure of 1mm macroscopic pores and 10µm microscopic pores. For each of the 
experiments, cells were seeded at a density of lx106 cells per scaffold in 0.5m1 of 
standard medium. The cells were incubated for 2 hours and then flooded with medium, 
which allowed the cells to start to attach to the scaffold without the medium 
evaporating dry, avoiding cell lysis. 
132 
Chapter 3 Methods 
3.2.4.1 Measurement of cellular proliferation 
3.2.4.1.1 Alamar blue assay 
Marrow aspirates were taken from eight patients and an alamar blue assay was 
performed on eight sets of HA scaffolds cultured with 1x106 cells for 5,10, and 15 
days, as described above. Alamar blue assay was similarly performed on MSCs grown 
on plastic scaffolds, which had been seeded with the same number of cells for the same 
culture period, as a comparison. 
3.2.4.1.2 DNA levels 
In the same way as for HA discs, the total DNA content of cells cultured on six HA 
scaffolds seeded with 1x106 MSCs was measured after 5,10 and 15 days. 
3.2.4.2 Observational study of the cells on HA scaffolds 
3.2.4.2.1 Light Microscopy 
In a separate study, after 5 days in culture, the HA scaffolds were stained with 
toluidine blue, by covering the scaffold in the stain for 3 minutes before washing with 
distilled water. This stained the cells blue, allowing them to be visualised under light 
microscopy using a high-powered halogen light source. 
3.2.4.2.2 SEM 
In a further study, an HA scaffold was cultured with MSCs for each of 5,7 and14 
days. These samples were repeated with cells from each of 3 patients. Thus, after each 
time-point, 3 scaffolds were processed for SEM, using the method described in 
Chapter 2. The morphology of the cells on the HA scaffolds was observed under SEM 
and compared between the 3 time-points. 
3.2.4.2.3 Transmission Electron Microscopy (TEM) 
MSCs from 3 patients were each cultured on 3 separate HA scaffolds for 28 days after 
which they were processed for TEM. 
The initial processing for TEM was as for SEM (see Chapter 2 Method), until the stage 
of drying the samples in alcohol, where for TEM the graded stages started at 70% 
alcohol and increased to 100% ethyl alcohol. Following this the samples were dried in 
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propylene oxide for 10 minutes before embedding in resin. Hard resin was made using 
the ingredients listed in the Materials section. Each HA scaffold was placed in a 
container full of resin and was left in a vacuum chamber overnight to increase resin 
penetration. Sections measuring lmm were cut using a peripheral diamond cutter. 
Areas containing scaffold were re-embedded in resin. Thin sections were then cut 
using an ultra-microtome with a diamond blade, placed on copper grids and observed 
under TEM (Philips CM12). 
3.2.4.3 Protein assays of osteoblastic differentiation 
The differentiation of MSCs into osteoblasts was also quantified by the degree of 
protein production by the cells. An HA scaffold was seeded with 1x106 cells for each 
of eight patients' MSCs aspirates. This was repeated for each culture period and test, 
and biochemical assays were used to measure ALP and osteocalcin production. 
3.2.4.3.1 ALP 
The production of ALP by cells was measured after 5,10 and 15 days in culture (see 
Chapter 2 Method). The total DNA content was also measured to allow 
standardisation, as for the HA discs. 
3.2.4.3.2 Osteocalcin 
Osteocalcin production by cells cultured on the 8 sets of HA scaffolds was measured 
after 15 days in culture. Osteocalcin levels were measured using a radioimmunoassay, 
as described in Chapter 2 Method. The total DNA content of the samples was 
measured to standardise the results, as before. 
3.2.5 Use of 3-Dimensional Porous Plastic Polymer control 
A 3-d control with the same shape as the porous HA scaffolds but in an inert material 
was used as a comparison. As polyurethane has been used in tissue engineering 
research as a porous membrane for culture of hepatocytes (Pahemik et al. 2001), it was 
used as the control (Kurosawa et al. 2000). Porous polyurethane plastic cylinders with 
the same pore structure and dimensions as the HA scaffolds were seeded with 1x 106 
MSCs from the same patients and identical culture methods used for the HA (see 
above) were employed. 
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In summary, control scaffolds were also stained with toludine blue and observed under 
light microscopy after 5 days in culture. Again, the proliferation rate was assessed after 
5,10 and 15 days, using Alamar blue assay. 
3.2.6 Statistical tests 
The results of the protein assays after each time point were tested for normality using 
Kolmogorov-Smirnov and Shapiro-Wilk statistical tests, but as results did not follow 
normal distributions, non-parametric statistical tests (Mann Whitney U) were applied. 
A P-value <0.05 was taken to be significant throughout the studies. 
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3.3 RESULTS 
3.3.1 MSCs cultured on 2-Dimensional Hydroxyapatite Discs 
3.3.1.1 Assessment of cellular proliferation rate on HA discs 
3.3.1.1.1 DNA levels 
The total DNA content of MSCs grown over 15 days was measured at 5-day intervals. 
The amount of DNA from the cultured control cells increased between day 5 and 10 
and between day 10 and 15 in culture (P<0.005). However, over the same culture 
period the DNA content of MSCs on HA remained constant. There was found to be 
significantly higher levels of DNA in the control compared with the HA culture after 
15 days (P<0.05). Conversely, the level of DNA measured after 5 days in culture was 
significantly greater for MSCs cultured on HA (P<0.05), (see figure 2.1). 
Figure 2.1: Bar chart showing total DNA content when 25,000 MSCs were cultured 
on HA discs compare to plastic control over 15 days, * P<0.05. 
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3.3.1.1.2 Alamar blue assay results 
The absorbance measured by Alamar blue assay on the HA surface was significantly 
higher after 5 days compared to 10 days in culture (P<0.005). The rate increased again 
after 15 days in culture, although this was not found to be significant on statistical 
testing (see figure 2.2). 
Figure 2.2: Bar chart showing proliferation rate of MSCs on HA discs measured by 
Alamar blue over 15 days, * P<0.005. 
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3.3.1.2 Observational study of MSCs differentiation on HA 
The first part of this study examined the response of MSC's to culture on I IA discs by 
comparing cells cultured over 14 days on HA with the control, with and without OS, 
which stimulates osteoblastic differentiation of MSCs, as shown in Chapter 1. 
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3.3.1.2.1 SEM Results 
SEM was used to compare MSCs over 2 weeks in culture on HA discs with the 
therminox control with and without OS. As shown in figure 2.3, MSCs in standard 
medium on therminox were characteristically spindle shaped, whereas the cells in 
culture with OS started to change shape after 1 day, becoming squarer. However, 
MSCs in standard medium maintained their fibroblastic morphology over the total 
culture period (see figures 2.3a, 2.4a, 2.5c & 2.6a). 
The morphology of the cells cultured on HA discs changed over the culture period, 
becoming less fibroblastic and more osteoblastic (see figure 2.7) and similar in shape 
to the cells cultured on the control cultured with OS (see figure 2.5b). MSCs on HA at 
day 7, were observed to have multiple philapodia, suggesting cell attachment to the 
HA surface (see figure 2.5a). 
The cells spread diffusely over the all culture surfaces (see figure 2.3). The number of 
cells was noted to increase over time, as shown by comparing figures 2.3,2.4 & 2.6. 
MSCs coated the HA surface attaching to each other by day 14, but cells on therminox 
did not become as densely packed (see figure 2.6). 
When visualised under SEM at low magnification, MSCs grown on HA discs where 
less distinct than those on therminox (see figure 2.3). At higher magnification the cell 
membranes seem to be embedding themselves in the HA surface (see figure 2.8). 
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Figure 2.3: Day 1: MSCs cultured on a) therminox in standard conditions, b) 
therminox with OS and c) HA discs, bar = 100µm. Blue arrows indicate cells with 
spindle morphology, pink arrows show squarer cell shape and yellow arrows show cell 
processes attaching to the surface. 
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Figure 2.4: Day 7: MSCs cultured on a) therminox, b) therminox with OS and c) HA 
discs, bar = 100µm. Blue arrows indicate cells with spindle morphology, pink arrows 
show squarer cell shape and yellow arrows show cell processes attaching to the 
surface. 
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Figure 2.5: Higher magnification at day 7: SEMs of MSCs cultured on a) HA discs: 
cuboidal shaped cells with multiple processes yellow arrows, b) therminox with OS: 
cuboidal shaped c) therminox in standard conditions: spindle shaped cells. 
Magnification is indicated by bar on each picture. 
a) 
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Figure 2.6: Day 14: MSCs cultured on a) therminox, b) therminox with OS and c) HA 
discs, bar = 100µm. Blue arrows indicate cells with spindle morphology, pink arrows 
show squarer cell shape and yellow arrows show cell processes attaching to the 
surface. 
143 
Chapter 3 Results 
C 
Nvý 
'ý,. ý 
I 
, rF 
. _ä.: ß 
144 
Chapter 3 Results 
Figure 2.7: These SEM shows changes in the shape of MSCs cultured on HA discs in 
standard conditions, after a) 1 day: spindle shape, b) 7 days: cuboidal shape & c) 14 
days: dense cell covering. Bars on each picture indicate the level of magnification. 
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Figure 2.8: MSCs cultured on 1 IA discs in standard medium, note the embedding of 
the cells into the I IA (blue arrows) after a) I day bar -- 50µm & h) 7 days bar 5µm. 
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3.3.1.3 Protein assays of osteoblastic differentiation 
3.3.1.3.1 ALP production 
ALP was measured as a marker of the presence of active osteoblasts in culture at time 
intervals during a 30-culture period. As the cells may not have increased in number at 
the same rate, the total DNA content of the samples was measured and used to 
standardise protein results, as in Chapter 1. The results were found not to follow a 
normal distribution on Kolmogorov-Smirnov and Shapiro-Wilk testing, thus non- 
parametric statistical tests were applied in the form of a Mann Whitney U test. 
When 25,000 cells were cultured on HA surface as compared to a tissue culture plastic 
control there was no significant difference in the amount of ALP/DNA produced by 
the cells over 30 days (P>0.05). Therefore, the experiment was repeated with a higher 
cell density, 250,000 cells per sample. When the cell number was increased the 
production of ALP/DNA on HA was found to be significantly greater than on the 
control after 14 & 28 days (P<0.005), (see figure 2.9 & 2.10). 
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Figure 2.9: ALP production and DNA content when 250,000 cells were cultured on a 
2-d surface, showing the means, standard deviations (s. d. ), and p-values resulting from 
Mann Whitney U statistical tests. 
Conditions Day ALP/DNA mean 
(U/1/mg/ml) 
ALP/DNA 
s. d. 
MWU 
p-value 
Plastic 2-d 14 10.4 9.7 
HA 2-d 14 60.5 26.5 0.001 
Plastic 2-d 28 25.7 8.7 
HA 2-d 28 10549.5 9858.2 0.001 
Figure 2.10: Bar charts showing the production of ALP/DNA for MSCs grown on the 
plastic control (blue) compared with HA discs (red) after a) 14 days and b) 28 days, 
*P<0.005. 
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The quantity of osteopontin protein was measured after 14 days in culture comparing 
HA discs with the control. The production of osteopontin/DNA by MSCs was 
significantly greater for cultures on HA than on plastic (P<0.005), (see figure 2.11 & 
2.12). 
Similarly to the findings with the ALP results, the expression of osteopontin 
significantly increased after 28 days in culture compared with 14 days (P<0.05), (see 
figure 2.13). 
Figure 2.11: Osteopontin (OPN) production/DNA content when 250 000 cells were 
cultured on HA discs as compared with tissue culture plastic, showing means, s. d., and 
p-values between plastic and HA surface, from Whitney U statistical test. 
Conditions Day OPN/DNA mean 
(ng/ml) 
OPN/DNA 
s. d. 
MWU 
p-value 
Plastic 2-d 14 14.8 7.2 
HA 2-d 14 119.2 59.9 0.004 
HA 2-d 28 4312.0 5781.0 0.01 
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Figure 2.12: Bar charts showing the production of osteopontin/DNA for MSCs grown 
on the plastic control (blue) compared with HA discs (red) after 14 days, *P<0.005. 
Error Bars show 95.0% Cl of Mean 
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Figure 2.13: Bar charts showing the production of osteopontin/DNA for MSCs grown 
on HA discs (red) after 14 days compared with 28 days, *P<0.05. 
Error Bars show 95.0% Cl of Mean 
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3.3.1.3.3 Osteocalcin production 
Osteocalcin production was measured as a further marker of osteoblastic extracellular 
matrix production. Osteocalcin/DNA was produced when the higher density of MSCs 
(250,000) was cultured for 14 days on HA discs, but cells at the same higher density 
on the plastic control did not produce any osteocalcin (see figure 2.14). 
Figure 2.14: Osteocalcin production by MSCs on a HA surface compared with 
control after 14 days in culture, *P<0.05. 
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3.3.2 MSCs on 3-Dimensional Porous Hydroxyapatite Scaffold 
3.3.2.1 Assessment of proliferation rate on scaffolds 
3.3.2.1.1 DNA level results 
The DNA content of MSCs cultured on HA scaffolds did not significantly increase 
over the 15-day culture period (P>0.05). This is similar to DNA results for MSCs 
cultured on 2-d HA see results above (figure 2.1). 
Following standardisation for the initial number of cells seeded on each of the 
substrates, the DNA content of the cells grown on HA scaffolds was significantly 
greater than when either HA discs or plastic controls were used after each time point 
measured (see figure 2.15). 
Figure 2.15: Comparisons between DNA content of MSCs cultured on HA scaffolds, 
HA discs and 2-d plastic over 15 days, *P<0.005. 
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3.3.2.1.2 Alamar blue assay results 
Alamar blue absorbance was significantly greater when MSCs were cultured on the 
HA scaffold compared to the plastic control over 10 days (P<0.005). However, the 
Alamar blue results were very low over the first 10 days in culture on the plastic 
scaffold and by 15 days no absorbance could be detected (see figure 2.16). 
The Alamar blue absorbance did not increase significantly over time for the MSCs 
cultured on HA scaffolds (see figure 2.17), similarly to the MSCs on HA discs (see 
results above, figure 2.2). 
The Alamar blue absorbance from MSCs cultured on the HA scaffold was compared 
with the results from the HA discs, following standardization for initial cell seeded 
density. The absorbance was shown to be significantly greater for the MSCs grown on 
HA scaffolds compared to the HA discs after 10 days in culture (P<0.005), (see figure 
2.17). 
Figure 2.16: Showing the proliferation rate of MSCs HA compared to porous plastic 
scaffold over time, *P<0.005. 
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Figure 2.17: Comparison between the proliferation rate of MSCs on porous HA 
scaffolds and HA coated discs over the 15-day culture period, by calculating Alamar 
blue absorbance per million cells seeded, *P<0.005. 
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3.3.2.2 Observational studies of MSCs grown on HA scaffolds 
In the first part of this chapter the response of MSCs cultured on 2-d HA surface was 
compared to tissue culture control. In this part, the behaviour of MSCs grown on 
porous HA scaffolds in standard culture medium (OS were not used in any of the 
following experiments) were observed and protein production was measured. 
Figure 2.18 shows the HA scaffold used as viewed under light microscopy, 
demonstrating its macro-porous structure and interconnecting pores. It is suggested 
that these pores would allow the adhesion of cells throughout the structure and would 
allow the diffusion of nutrients throughout the scaffold maintaining the cells both in 
cell culture and initially following implantation. Following which, the interconnecting 
pores would facilitate the ingrowth of capillaries and osteogenesis. 
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3.3.2.2.1 Light microscopy observations 
The porous HA scaffolds were stained with toluidine blue after 5 days in culture, 
showing that MSCs were adhering and growing on this culture surface (see figure 
2.19). At higher magnification the individual cells could be observed and after 5 days 
the fibroblastic shape could be determined (see figure 2.20). 
A porous plastic scaffold with the same structure as the porous HA was used as a 
control. However, when the plastic scaffold control was stained with toluidine blue 
after a similar time period cells could not be seen attaching to the surface, only 
evidence of cell debris. As a consequence of this result and the Alamar blue readings it 
was felt that the plastic scaffold was not a reliable substrate for cell growth. 'I'herelhre. 
for the remaining experiments the results for MSCs cultured on 3-d I IA scaflolds were 
compared with 2-d HA, which acted as a control for the 3-d structure. 
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Figure 2.18: A picture of the porous HA scaffold, bar = 1000µm. 
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Figure 2.19: After staining with toluidine blue, cells were observed adhered to all 
surfaces of the HA scaffold, as seen by the darker areas in this photograph after 5 days 
in culture. 
"Mori 
Figure 2.20: Fibroblastic-shaped cells characteristic of MSCs seen on part on porous 
HA scaffold after staining with toluidine blue after 5 days in culture, bar = 250µm. 
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3.3.2.2.2 SEM results 
The MSCs were observed at a higher resolution under SEM, showing the surface of 
the HA, morphology and adhesion of the cells. After 5 days in culture, MSCs were 
observed to adhere to the HA scaffold, forming clusters and maintained their 
characteristic spindle-like shape (see figure 2.21). 
Over the following 15-day culture period the MSCs were noted to change from spindle 
shaped cells becoming more brick-like (see figures 2.22 & 2.23). Cells were observed 
to produce multiple processes attaching them to the HA surface and neighbouring 
cells. Round cells were also seen characteristic of active osteoblasts (see figure 2.22). 
By day 14 cells had covered the HA surface forming a carpet of adherent cells (see 
figure 2.23). 
Figure 2.21: SEM of MSC on HA scaffold after 5 days, showing fibroblastic cells 
(yellow arrows) spread over the HA surface, magnification bar = 200µm. 
ýý 
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Figure 2.22: SEM of MSCs on porous HA after 7 days, a) showing brick-shaped cells 
(blue arrows), round cells (green arrows) and cell processes attaching them to HA 
(pink arrows), bar = 100µm, b) at higher magnification, arrows indicating cells as 
before and bar = 50 µm. 
a) 
I,. 
b) 
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Figure 2.23: SEM of MSCs cultured on porous HA for 14 days, a) showing cells with 
multiple processes (pink arrows), bar =I 0µm, b) cells covering the HA surface, bar = 
10µm. 
a) 
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Figure 2.24: Cells containing nucleus (N) attaching to the edge of HA scaffold (E) by 
cell processes (P) after 28 days in culture. Bar = 0.5µm. 
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Figure 2.25: Cells cultured on HA scaffold for 28 days, showing cell processes 
(large 
arrows) and containing nuclei (N), mitochondria (small arrows), endoplasmic 
reticulum (arrowheads) and glycogen (G). There is also evidence of collagen fibrils 
(C) 
between cells. Bar = 2µm. 
Figure 2.25 
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3.3.2.4 Protein assays of osteoblastic differentiation on HA scaffold 
3.3.2.4.1 ALP Results 
Protein assay levels were divided by total DNA to standardise the results for each 
sample, as for HA discs in the first part of this chapter. The results did not follow a 
normal distribution so non-parametric statistical tests were used to compare the 
conditions. 
The production of ALP/DNA by MSCs grown HA scaffolds increased significantly 
over the 15-day culture period (P<0.05), (see figure 2.26). 
The relative expression of ALP/DNA between cells cultured on HA scaffolds and HA 
discs. Cells cultured on HA discs expressed a greater amount of ALP than cells on HA 
blocks (P<0.005), (see figure 2.27). 
Figure 2.26: Box plot showing that the production of ALP/DNA increases with time 
in culture, * (P<0.05). 
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Figure 2.27: ALP/DNA over 15 days on 2-d compared with 3-d HA 
Conditions Day ALP/DNA 
(U/I/mg/ml) 
ALP/DNA 
s. d. 
MWU 
p-value 
HA 3-d 5 0.4 1.3 
HA 2-d 5 13.9 6.4 0.002 
HA 3-d 10 1.25 0.6 
HA 2-d 10 11.1 4.8 0.003 
HA 3-d 15 1.9 0.7 
HA 2-d 15 16.5 7.4 0.003 
3.3.2.4.2 Osteocalcin on 3-Dimensional HA 
The production of osteocalcin/DNA was not found to be significantly different for 
MSCs cultured on HA scaffold compared to HA discs after 14 days in culture (see 
Figure 2.28). However, the production of osteocalcin/DNA was significantly greater 
on 3-d HA compared to the 2-d plastic control, after 14 days in culture (see figure 
2.28). 
Figure 2.28: Expression of osteocalcin/DNA by MSCs cultured on 3-d porous HA 
compared to 2-d HA discs and 2-d plastic control, after 14 days in culture * P<0.005. 
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3.4 DISCUSSION 
For MSCs to be successfully used to tissue-engineer bone, in addition to differentiating 
into osteoblasts it is necessary to grow the cells on a suitable carrier, thus as discussed 
in this chapter's Introduction, a porous HA scaffold was tested. The aim of Chapter 3 
was to test whether MSCs isolated from human bone marrow would grow on an HA 
surface and whether this surface would stimulate differentiation into osteoblasts 
without the influence of OS, which was found to be needed for such differentiation in 
standard culture conditions in Chapter 2. 
3.4.1 Cellular proliferation rate conclusions 
3.4.1.1 2Dimensional HA discs 
3.4.1.1.1 DNA as a measure of proliferation 
To test the first hypothesis in this chapter, that MSCs isolated from bone marrow will 
grow on a HA surface in vitro, the total DNA content of cells cultured on HA discs 
was measured over 15 days and compared with the plastic control. As discussed in 
Chapter 2 Discussion, although the assay does not distinguish between alive and dead 
DNA, as dead cells would be removed, DNA levels suggest cell number and DNA 
levels over time can be used to assess cell growth. 
In summary, the results show that when bone marrow isolated MSCs were cultured on 
the 2-d plastic surface, the DNA content increased significantly over the 15-day period 
(P<0.005). Although this indicates that the cells were proliferating in this environment, 
as only three-time points were measured it is difficult to comment further on the grown 
pattern. The growth of a cell population would be expected to follow a sigmoid curve, 
with the proliferation rate reaching a plateau as growth becomes limited by 
environmental factors. Hence, these results may indicate that this point was not 
reached. 
In contrast, there was not found to be a significant increase in DNA content of MSCs 
on the HA discs between days 5 and 15 in culture. However, the DNA content of 
MSCs cultured on HA was significantly greater than on plastic after 5 days (P<0.05). 
This suggests that over the first 5 days in culture MSCs grow more rapidly on HA, but 
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plateau between days 5 and 15, with the DNA content of MSCs on plastic being 
significantly greater by day 15 (P<0.05). 
The study of growth of osteoblasts in vitro has shown that there is an inverse 
relationship between proliferation and differentiation (Aronow et al. 1990; Malaval et 
al. 1999; Oreffo et al. 1998). The maturation of osteoblasts has been defined as 
occurring over three phases of growth: proliferation, matrix maturation and 
mineralisation (Stein et al. 1990). Proliferation genes (c-fos and c-myc) have been 
shown to be expressed over the first 5 days of osteoblastic culture (Lian & Stein 1992) 
and osteoblastic proteins start to be produced after 8-10 population doublings when 
osteoblast progenitor cells are cultured in vitro (Malaval et al. 1999). Thus, during 
osteoblastic growth, proliferation occurs first and this reduces as the cells differentiate 
and produce matrix that is mineralised. 
Therefore, an explanation for the observed increase in DNA (cell number) relative to 
the control, over the first five days, when MSCs were cultured on HA, is that this 
represents the initial proliferative phase. The lack of further increase in DNA over the 
remaining period, in contrast to the control, is consistent with the later differentiation 
phase of osteoblasts, at which point proliferation is reduced. 
3.4.1.1.2 Alamar blue as a measure of proliferation 
Cell growth was further assessed by the use of Alamar blue assay, which is an indictor 
of cellular redox state. As culture medium is reduced as a result of cellular metabolism, 
division and growth, the blue to red colour change of Alamar blue is proportional to 
the degree of reduction, thus indicating cellular activity. This assay has been shown to 
correlate well with other methods of measuring proliferation, MTT assay (Back et al. 
1999) and trypan blue exclusion (Gazzano-Santoro et al. 1997). Thus it has been 
widely used as a quantitative measure of the proliferative activity of cells in culture 
(Ahmed et al. 1994; Nakayama et al. 1997). Alamar blue assay also has the advantage 
that it is non-toxic to cells and can be applied without cell death to cells in culture, 
unlike the MTT assay, with the result that it can be used serially on the same sample of 
growing cells over time. Furthermore, it allows measurement of cell viability, unlike 
cell counts or DNA assays that also include dead cells and was therefore used in my 
study as a further measure of proliferation. 
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In my study it was observed that Alamar blue absorbance was significantly greater 
when MSCs had been cultured for 5 days on HA discs compared with 10 days 
(P<0.005), following which point there was no significant change over the remaining 
culture period. Thus, cell proliferation on the HA surface peaked at 5 days in vitro, 
following which it reached a plateau, reflecting the DNA levels (see above). The 
plateauing is consistent with the study of osteoblastic cell growth in culture, which has 
been found to go through an initial proliferation phase followed by cell differentiation 
(Lian & Stein 1992; Malaval et al. 1999; Stein et al. 1990). Therefore my results of the 
growth of MSCs suggest that after 5 days on HA the proliferation rate decreased, 
which is consistent with osteoblastic differentiation of cells. 
3.4.1.2 3-Dimensional porous HA scaffold 
3.4.1.2.1 DNA as a measure of proliferation 
Following seeding of MSCs on HA scaffolds, the levels of DNA were measured over 
15 days in vitro and were found to remain constant, similarly to the results for MSCs 
grown on HA discs (see above). Both these results are in contrast to those for MSCs 
cultured on plastic and suggest that the MSCs only proliferated during the first 5 days 
in culture on HA. The lack of a further increase in cell number over the following 10 
days in culture correlates with cell differentiation on HA, as discussed above. 
DNA measurements per number of cells seeded were significantly greater for MSCs 
cultured on the 3-d HA scaffold as compared with the 2-d HA disc at each time point 
measured (P<0.005). This suggests that the porous nature of the scaffold, which 
increases its surface area, allows more rapid cell division. 
3.4.1.2.2 Alamar blue as a measure of proliferation 
Alamar blue absorbance measured on MSCs cultured on HA scaffolds were found to 
be significantly greater than on the plastic scaffold control (P<0.005). However, the 
absorbance levels from cells on the plastic control were very low and immeasurable at 
15 days. This impliesthat MSCs were unable to grow on this substrate and, as a result of 
this finding, plastic scaffolds were not used for the remaining experiments in this 
chapter. 
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The proliferation rate indicated by the level of Alamar blue absorbance by MSCs did 
not change significantly over 15 days in culture on the HA scaffold. An explanation of 
this is that, as the DNA levels were constant on the scaffolds and greater than on the 
corresponding discs over the culture period and as the Alamar blue results for MSCs 
grown on HA discs was maximised after 5 days in culture, the Alamar blue results on 
the HA scaffold may have been greatest during the first 5 days in culture in order to 
achieve the increased levels of DNA by day 5. Further experiments would be needed to 
measure Alamar blue levels over the first 5 days in culture on HA scaffolds to test this 
theory. 
In response to the hypothesis stated at the beginning of this section, MSCs were able to 
grow and proliferate on an HA surface and HA scaffold in vitro. 
3.4.2 Osteoblastic differentiation on 2-Dimensional HA discs 
To test the second hypothesis of this chapter, that MSCs differentiate into osteoblasts 
without the influence of OS when cultured on HA in vitro, MSCs were cultured on HA 
discs and osteoblastic differentiation was assessed by comparing the cell morphology 
and osteoblastic protein production with MSCs cultured on the control surface. 
34.2.1 Conclusions from SEM results 
SEM was used to assess the change in cellular morphology of the MSCs cultured on 
the HA discs over the 14 day period compared with the controls. It was observed that 
MSCs attached to the HA via cellular processes and that the number of cells increased 
over the culture period until, by day 14, the HA was covered in cells. This confirms 
that HA is a viable surface for the growth of MSCs, reflecting the proliferation results. 
After one day in culture on HA, the cells were long spindle-shaped, similar to MSCs 
cultured in standard medium on therminox and resembling fibroblasts. However, after 
7 days in culture on HA, the cell shape changed with cells becoming brick-shaped, 
which is characteristic of osteoblasts (Aubin & Liu 1996; Liu et al. 1997; Lomri et al. 
1988; Malaval et al. 1999). In contrast, although grown under the same culture 
conditions, MSCs on the control surface remained fibroblastic in shape (see Results). 
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Similarly to the observed cellular morphology on HA, MSCs cultured with OS on 
therminox became cuboidal shape, as suggested in Chapter 2 to reflect osteoblastic 
differentiation. However, cells cultured on HA possessed multiple cell processes, 
attaching them to the surface and neighbouring cells. The observed increased density 
of cell processes on HA suggested that MSCs preferentially adhere to HA. 
Furthermore, when MSCs were cultured on the HA surface they seemed to embed the 
edges of their cell membrane into the HA. As there is embryological evidence that cell 
attachment is necessary for differentiation (Pechak et al. 1986), this interaction 
between MSCs and HA surface may be an initiating factor for osteoblastic 
differentiation. 
3.4.2.2 Use ofproteins to assess osteoblastic activity 
As ALP, osteopontin and osteocalcin proteins are produced by osteoblasts, as a 
measure of osteoblastic differentiation the levels of these proteins produced by the 
cells cultured on HA discs was compared with on the control surface. In order to test 
the hypothesis that MSCs differentiated into osteoblasts without the influence of OS 
when cultured on HA, OS was not used in any of the protein assay experiments. 
Protein levels measured in the experiments of this chapter were divided by the total 
DNA content of the cells to standardise the readings and allow comparison, as 
discussed in Chapter 2. 
3.4.2.2.1 Measurement of ALP protein production 
ALP is a marker of osteoblast progenitor cells and osteoblasts, thus production of this 
protein was used as an indicator of osteoblastic differentiation (see Chapters 1 and 2). 
Initially, when HA discs and controls were seeded with 25,000 cells measurement of 
ALP levels after 5,10,15 and 30 days in culture did not indicate a significant 
difference between the two groups. 
As a result of this, in order to expand any difference between the two groups, the 
experiment was repeated using a larger cell density (250,000 cells) over a longer 
culture period (28 days). This resulted in the measurement of a significantly greater 
production of ALP by the MSCs cultured on HA compared with the control, after both 
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14 (P<0.05) and 28 days (P<0.005). The production of ALP by MSCs on HA increased 
over the 28 days, suggesting that either more cells were stimulated to differentiate or 
that individual cells increased their production of ALP. However, MSCs seeded on the 
control continued to produce low levels of ALP over the same time. As MSCs seeded 
on HA produced significantly larger amounts of ALP, suggests that the cells were 
continuing to differentiate into osteoblasts. 
3.4.2.2.2 Osteopontin protein production 
Production of osteopontin extracellular protein was measured as a second marker of 
osteoblasts (Nakase et al. 1994), (see Chapters 1 and 2). A higher initial density of 
cells was used for this assay, as osteoblasts produce extracellular proteins once the 
cells have reached confluence. 
Osteopontin production was significantly greater by the samples of 250,000 cells 
cultured on HA discs than by cells on the control surface, after 14 days (P<0.005). 
Furthermore, the production of osteopontin on the HA increased significantly over 28 
days. Both the higher initial level of osteopontin, as compared to the control, and the 
continued production on HA are indicators of expression of osteoblastic phenotype by 
the MSCs. As osteopontin is an osteoblastic extracellular matrix protein, this is may 
reflect growth of the osteoblasts into matrix maturation phase. 
3.4.2.2.3 Osteocalcin protein production 
Osteopontin is not totally specific to osteoblasts, as noted in Chapter 2, thus 
osteocalcin levels were also measured. As osteocalcin is an extracellular protein that 
binds calcium to the matrix thereby facilitating mineralisation, it is a more precise 
marker for osteoblasts. When osteocalcin levels were compared between the MSCs 
cultured for 14 days on HA discs and the control, those on HA produced osteocalcin, 
which was not detected on the control. This confirms the presence of active osteoblasts 
entering the mineralisation phase, resulting from MSCs culture on the HA and lack of 
such production on the control is consistent with the maintenance of undifferentiated 
MSCs in this culture. 
The notable change in cellular morphology and the production of proteins 
by cells is 
consistent with that of the osteoblastic phenotype, in comparison 
to the control. This 
170 
Chapter 3 Discussion 
therefore supports the first part of the second hypothesis of this chapter that MSCs 
differentiate into osteoblastic cells without the influence of OS when cultured on HA 
discs in vitro. 
3.4.3 Osteoblastic differentiation on 3-d porous HA scaffolds 
In order to test whether MSCs would also differentiate into osteoblasts on porous HA 
scaffolds, throughout the following experiments cells were cultured in standard culture 
medium without additional OS. 
3.4.3.1 Light microscopy as a assessment of morphology 
On examination under light microscopy, the MSCs were observed to attach themselves 
and grow on all surfaces of the porous HA, confirming it as a useful substrate for MSC 
culture. The larger surface area allowed a greater number of cells to attach and grow in 
a smaller volume. At higher magnification, after 5 days in culture it was observed that 
the shape of individual cells was fibroblastic and remained similar in shape to the 
original MSCs. 
A control scaffold of polyethylene plastic foam, with the same macro-porous structure 
as the porous HA was chosen, on which it was intended to culture MSCs and against 
which the results from HA were to be compared. However, few cells could be seen on 
the scaffold under light microscopy staining and, as stated above, the proliferation 
rates of MSCs on this scaffold were very low. It was therefore concluded that the cells 
would not grow on this scaffold and the results could not be used, as intended, as a 
control for the porous HA. Hence, instead, the levels of osteoblastic markers produced 
by MSCs cultured on 3-d HA scaffolds were compared with those of 2-d HA, which 
acted as a control for the 3-d structure. 
3.4.3.2 Conclusions from SEM 
As was observed on HA discs under SEM, MSCs attach to the surface of the 
HA 
scaffold by multiple processes. It was observed that the cells cultured on the scaffolds 
changed shape over the 14-day culture period became cuboidal and resembled 
osteoblasts (Aubin & Liu 1996) (Benayahu et al. 1994). Round cells, suggestive of 
active osteoblasts were also observed (Yoshikawa et al. 1996). 
The cell density was 
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observed to increase greatly over time as scattered cells proliferated to cover 
completely the surface with osteoblastic cells by day 14. 
3.4.3.3 Conclusions from TEM 
Under TEM, MSCs cultured on HA scaffolds were observed to contain intracellular 
rough endoplasmic reticulum and mitochondria after 28 days, evidence of 
metabolically active cells (Bab et al. 1988b). Early organised collagen fibrils were 
observed adjacent to cells, demonstrating that the cells produced collagen and this was 
arranged into a matrix. Both observations suggest the presence of functioning 
osteoblasts. 
3.4.3.4 ALP protein production 
ALP production increased significantly over the 15-day culture period. As ALP is a 
marker of the osteoblast phenotype, this suggests that MSCs differentiated into 
osteoblasts over 15 days on HA scaffolds. 
However, the levels of ALP were significantly lower on porous HA compared to HA 
discs. As discussed in the Introduction, materials on which cells are grown alter the 
cell physiology, thus, although both HA substrates should have the same composition, 
surface roughness and energy, the variation in topography between disc and porous 
scaffold may influence the production of ALP. 
Using these ALP results alone as an indication of osteoblastic differentiation, suggests 
that MSCs differentiated to a greater extent on HA discs compared to HA scaffolds. 
However, for a bone graft substitute to be useful for implantation to heal a bone defect, 
it needs to enable nutrients to diffuse through it to maintain living cells, which can 
form bone. In this experiment the HA scaffold would allow this and the protein results 
indicate that MSCs on this HA scaffold produced increasing levels of ALP indicative 
of osteoblastic differentiation. 
3.4.3.5 Osteocalcin protein production 
Osteocalcin was not found to be produced to any greater extent by MSCs cultured on 
porous HA as compared to those cultured on HA discs, although production on 
both 
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forms of HA was significantly greater than on the control (P<0.005). MSCs grown on 
an HA scaffold produce osteocalcin, confirming the results observed under TEM, that 
the cells are differentiating into osteoblasts and producing extracellular matrix proteins 
that have the potential for mineralisation. 
In conclusion, MSCs cultured on both HA discs and the HA scaffold produced 
significantly greater amount of osteoblastic proteins compared to the control. This 
suggests that it is the HA rather than the 3-d environment that is stimulating 
osteoblastic differentiation. Although the production of ALP was less on the scaffold 
compared to the disc, MSCs cultured on both HA substrates were shown to produce 
osteocalcin, indicating differentiation into active osteoblasts in vitro. These results 
confirm the second hypothesis and suggest that the porous HA scaffold would be 
favourable for use in tissue engineering of bone. 
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CHAPTER 4 
A Novel Bioreactor for the Tissue Engineering of Bone 
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4.1 INTRODUCTION 
4.1.1 Background to this chapter 
Although bone has a good capacity for healing, critical sized bone defects will not heal 
without intervention, as discussed in Chapter 1. Bone tissue is mechanical supportive 
thus a 3-d structure is needed to repair such defects. The advantage of tissue 
engineering, as discussed in Chapter 1, is that biological material is used to repair these 
defects. These tissue-engineering principles could be applied to a porous scaffold that 
should allow cell growth through it and result in a suitable 3-d cellular structure. The 
capacity for healing would be increased by the presence of osteoinductive cells within 
the tissue grafts. These constructs could then be packed into a bone defect in vivo. 
In the experiments in Chapter 2, it was shown that MSCs could be isolated from 
human bone marrow aspirates and had the potential to differentiate into osteoblasts 
when cultured in vitro with OS. In Chapter 3 it was shown that MSCs could be 
successfully cultured on porous HA in stationary culture and that the cells 
differentiated into osteoblasts without the addition of OS, confirming that HA 
scaffolds could be used as a substrate for tissue-engineered bone. Further to this, this 
chapter investigates whether the use of a novel bioreactor increases the potential of 
MSCs on a HA scaffold to be used for the tissue engineering of bone. 
4.1.2 The use of bioreactors 
A bioreactor is a tissue culture vessel in which culture conditions can be controlled 
over the entire culture period. Bioreactors have been used by the pharmaceutical and 
biotechnology industries to enable the production of large quantities of cells, bacteria, 
and protein products such as factor VIII, erythropoietin, antibodies and vaccines. 
Research has increased considerably in this area over the last decade, however the 
applications for bioreactor use in the field of tissue engineering are just in their 
infancy. 
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4.1.3 Advantages of bioreactor culture 
Cells grown in stationary tissue culture require serial passaging to produce large 
numbers, which is a labour intensive process. In contrast, bioreactors allow continuous 
culture, which produces a larger number of cells than in static culture. Furthermore, by 
creating a more efficient environment for the transfer of nutrients and waste, 
bioreactors can support higher growth rates than can be maintained in static culture 
conditions. 
4.1.4 Types of bioreactor 
Bioreactors can be classified into three groups: Homogenously agitated bioreactors, 
Agitated systems and Heterogeneous bioreactors. 
Homogenously agitated bioreactors aim to maintain a constant uniform 
physiochemical environment, for example roller bottles, which are used to produce 
vaccines and cell suspensions. 
Agitated bioreactors allow a uniform environment within the bulk liquid, although 
gradients occur across the constructs. These systems include Rotating Wall Vessels 
(RWV) as first designed by NASA to simulate the effects of microgravity on the 
muscular skeletal system, as experienced in space (Klement & Spooner 1993). These 
bioreactors suspend cells by rotating the inner of two chambers and inducing 
secondary airflow in the outer chamber, keeping cells in constant freefall of 
microgravity (Schwarz et al. 1992). This reduces mechanical stresses allowing cells to 
grow unrestricted by gravity. 
As a result, agitated bioreactors have been used by NASA to protect cells from shear 
forces of launch and landing, allowing cell culture to be studied in space. Furthermore, 
when these systems were tested on Earth, it was shown that cells formed aggregations 
and structures resembling tissue and consequently, RWV have been studied using 
3-d 
cell models for tissue engineering cartilage (Freed et al. 1993) and bone 
(Granet et al. 
1998). Under these conditions it was found that the proliferation rate of cells 
increased, 
as did protein production specific to the cell types. 
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RWV have also been shown to simulate the in vivo cellular environment as cells 
produce proteins otherwise not produced in vitro. For example, human colon 
carcinoma cells produce carcinoembryonic antigen when cultured in this environment 
(Jessup et al. 1997). Therefore, this culture method supported the tumour cell function 
that normally only occurs in vivo, allowing possible treatments for certain cancers to 
be studied in vitro. 
Heterogeneous bioreactors comprise the remaining systems that have been designed 
for the culture of specific cell types. These use scaffolds, membranes and controlled 
flow rates to produce gradients with the aim of generating tissue, such as dermal skin 
and vascular grafts. It is within this group that the bioreactor used in my study can be 
classified. 
4.1.5 Response of bone to environmental factors 
The relationship between the structure and function of bone was first suggested by 
Julius Wolff "Every change in the function of a bone is followed by certain definite 
changes in the internal structure architecture and external conformation in accordance 
with mathematical principles" (Wolff 1892). 
Since then, it has been observed that bone atrophy occurs after prolonged periods of 
bed rest. Hence, mechanical loading of the skeleton is crucial for bone development 
and metabolism, with increased mechanical loading increasing bone formation and 
decreasing bone resorption (Morey & Baylink 1978). Conversely, the absence of 
mechanical stimulation causes a reduction in bone matrix protein production, 
mineralisation and bone formation (Sessions et al. 1989). At a cellular level, load- 
induced bone modelling has been shown to be mediated by prostaglandin production, 
which recruits progenitor cells and osteoblasts (Pead & Lanyon 1989). Therefore, 
mechanical stimulation affects bone remodelling. 
More recently, the importance of fluid flow on bone metabolism has been 
investigated. 
The effect of altering the fluid flow through a canine tibia was studied using a venous 
tourniquet model. Increasing the venous pressure in the tibia increased the extracellular 
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fluid flow resulting in increased new bone formation, indicating that extravascular 
perfusion enhances bone formation (Kelly & Bronk 1990). 
In cortical bone, interstitial fluid flows from capillaries in Haversian canals through the 
canuliculi-lacunar complex to supply osteoblasts and osteocytes, driven by hydrostatic 
pressure as well as mechanical loading. The Haversian canals are 20-30µm in diameter 
and extend along the longitudinal length of cortical bone and lacunae continue from 
Haversian lamellae, measuring 11 - 14µm in transverse diameter and extending in the 
long axis of the diaphysis for an average length of 24µm (Qin et al. 1999). The size of 
the diameter of the micro-pores within the HA scaffold used in my thesis, reflected the 
structure of cortical bone (see Chapter 3, Introduction). 
Variation in interstitial fluid flow through bone effects mechanical loading signals 
altering cellular activity. The effect of fluid flow on osteoblasts has been investigated 
in vitro and increased flow results in the release of autocrine and paracrine factors that 
stimulate osteoblast activity. Prostaglandin E2 (PGE2) production by osteoblasts in 
vitro has been shown to increase when cells are exposed to shear fluid flow (Reich & 
Frangos 1991). The increase in PGE2 also mediates increases in secondary messengers 
cyclic adenosine monophosphate (cAMP) and inositol trisphosphate (1P3), which have 
also been shown to be up-regulated by fluid flow specifically in osteoblasts (Reich et 
al. 1990; Reich & Frangos 1991). 
Increases in these secondary messengers cause the release of intracellular calcium from 
endoplasmic reticulum (Hung et al. 1995). Intracellular calcium modulates actin 
cytoskeleton, which stimulates gene expression of c-fos, produced by proliferating 
osteoblasts and COX-2, a key enzyme in the production of prostaglandins. Intracellular 
calcium is also important in the formation of connections between the cytoskeleton and 
integrins, which aid osteoblastic interaction with the extracellular matrix and in turn 
regulate cell function and differentiation (Chen et al. 2000). Intracellular calcium is 
therefore vital in mediating the response of osteoblasts to fluid flow. 
Nitric oxide (NO) stimulates osteoblast activity and inhibits osteoclast resorption, as 
levels of NO are undetectable in stationary rat calvarial cell culture, but production of 
178 
Chapter 4 Introduction 
NO rapidly increases in response to fluid shear stress (Johnson et al. 1996). Hence, this 
is a further mechanism by which osteoblast activity is affected by fluid flow. It has 
also been shown that osteopontin gene expression increases in response to fluid forces 
(Owan et al. 1997). 
In summary, a culture environment where fluid flow is used to reproduce the 
physiological environment may increase osteoblast activity and the generation of bone 
extracellular matrix via the pathways outlined. 
4.1.6 Design of the bioreactor 
In short, the aim of my bioreactor was to allow MSCs to grow through an HA scaffold, 
encouraging MSCs to differentiate into osteoblasts and produce an extracellular matrix 
by perfusing the scaffolds with a pulsatile flow of medium. Each of the criteria 
discussed below were considered in the design of my bioreactor: 
" Grow viable cells 
" Encourage cell proliferation 
" Stimulate MSCs to differentiate into osteoblasts 
" Allow extracellular matrix production 
" Encourage cellular penetration of scaffold 
4.1.6.1 Grow viable cells 
Various physical and environmental criteria need to be met for the successful growth 
of cells in vitro. At an elementary level, these criteria include a supply of glucose, 
amino acids, electrolytes, water, oxygen and carbon dioxide (CO2). Insufficient supply 
of oxygen can become the limiting factor for cell growth within a scaffold, as oxygen 
has to diffuse through the scaffold in static culture. As a result, cells at the centre of the 
construct are susceptible to low oxygen levels, which leads to cell apoptosis. This was 
avoided in my bioreactor, as the porous scaffolds were perfused with oxygenated 
medium. 
In static cell culture the medium was changed twice a week, with the aim of 
maintaining nutrient levels. However, in this bioreactor design, medium flowed 
through the scaffold culture, providing a constant supply of sterile nutrients. As 
medium flowed through the system once, the reservoir was refilled every 2-3 
days 
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and the outflow container emptied, also preventing contamination or denaturing of 
constituents within it. It is also necessary for any feeding or sampling from the 
bioreactor to be aseptic to prevent contamination and infection. 
The appropriate environment to stimulate cell growth was achieved by placing the 
bioreactor system within an incubator at 37°C and 5% CO2 under sterile conditions. 
An open system was used, allowing air into the feeding reservoir to displace the used 
fluid and ensure that the medium remained oxygenated. In addition to this, silicone 
tubing used would allow diffusion of gas into it and, to facilitate this, the tubing was 
placed under the fan within the incubator. 
4.1.6.2 Encourage cell proliferation 
Ideally tissue-engineered bone would only require a small sample of autologous cells, 
thus avoiding the need for large quantities of donor tissue to be harvested. Although 
MSCs are infrequent in bone marrow they have a large capacity for proliferation and 
this capacity needs to be utilised to expand the cell numbers, for MSCs to be used in 
tissue engineering. This can be achieved in monolayer culture and human MSCs have 
been shown to maintain their phenotype for more than 20 passages (Jaiswal et al. 
1997), but this process is both time consuming and labour intensive. As noted, the 
dynamic conditions of a bioreactor increase the efficiency of mass transfer of nutrients, 
so allowing greater continuity of cell growth. Thus, as MSCs can potentially be 
expanded in my bioreactor, these cells were studied rather than differentiated 
osteoblasts. 
In static culture conditions, the cell growth rate is dependant on diffusion for the 
supply of oxygen and nutrients. As the cells proliferate, their mass increases and the 
corresponding scaffold porosity decreases, resulting in a limited supply of oxygen and 
nutrients reducing cell growth. Therefore, if the supply of nutrients and removal of 
waste can be maintained over time by increased mass transfer to all parts of the 
scaffold, which it is suggested would be achieved by culturing in my bioreactor 
system, cell growth can continue unabated resulting in the formation of tissue. 
The aim of my bioreactor design was to increase cell proliferation by addressing these 
limitations of static culture. RWV systems allow cell proliferation to continue 
for 
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longer periods of time than cells in static culture (Granet et al. 1998) and a perfusion 
system has been shown to increase osteosarcoma cell proliferation in culture (Mueller 
et al. 1999). My bioreactor design maintains a constant supply of nutrients to the cells 
through the scaffold, by perfusing with fresh oxygenated medium with the aim of 
maintaining cell proliferation. 
4.1.6.3 Stimulate MSCs to differentiate into osteoblasts 
In Chapter 3 it was shown that MSCs could be cultured in static conditions on HA 
scaffolds, with a similar structure to trabecular bone and micro-porous size similar to 
the cortical bone system, and that MSCs differentiated into osteoblasts. Although there 
was osteoblastic differentiation using this culture method, greater osteoblastic activity 
producing extracellular matrix, is required in order to generate bone tissue. In this 
study osteoblastic differentiation and function of MSCs on HA in the bioreactor will 
be compared with MSCs seeded on the same HA scaffolds and cultured in stationary 
tissue culture conditions, referred to as static conditions in this chapter. 
Trabecular bone is well perfused by blood and within cortical bone osteoblasts line 
Haversian canals, which contain capillaries. Thus, osteoblasts and osteocytes are 
supplied with oxygenated blood in vivo. Additionally it has been shown that, 
preferentially MSCs differentiate into osteoblasts in well-oxygenated tissue (Bab et al. 
1988b). The perfusion of well-oxygenated medium was therefore passed through the 
HA-MSC culture in this bioreactor to encourage osteoblastic differentiation. 
It has been shown that fluid flow stimulates osteoblastic function in vivo, as described 
above. Furthermore, the perfusion of medium increased osteosarcoma cell viability and 
protein production on 3-d collagen after 21 days in vitro (Mueller et al. 1999). 
Therefore, the flow of medium through the HA scaffold recreates the physiological 
environment which is hypothesised in this chapter, to stimulate cell signalling resulting 
in an increase in osteoblast differentiation and activity. 
It has been shown that oscillatory fluid flow increases the biological response of 
osteoblastic cells, measured by increased intracellular calcium and osteopontin gene 
expression (You et al. 2001). In living bone, the flow of fluid results 
from vascular 
pressure, but also varies with mechanical loading. Thereby, with walking, 
the 
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physiological flow produced is pulsatile and this was simulated in the bioreactor by the 
use of a peristaltic pump. 
In a study of osteoblasts on a scaffold it was observed that, although initially cell 
numbers increased with flow rate, a flow greater than lml/min was detrimental to cell 
viability (Porter et al. 2001). This pattern is explained by the initial increase in flow 
increasing the supply of nutrients and removal of waste from the cells, but as flow rate 
increases further the shear forces on the cells increase correspondingly preventing 
further cell proliferation. Therefore, the flow rate of 0.1ml/min was initially used in my 
study to enable cell proliferation. 
4.1.6 .4 Allow extracellular matrix production 
It is proposed that in my perfusion bioreactor, the flow of fluid will stimulate 
differentiation and activity of osteoblasts, thus increasing the production of 
extracellular matrix. Furthermore, the slow perfusion rate will allow the organised 
deposition of extracellular matrix on the HA scaffold. Since HA is the major inorganic 
component of bone, it would provide a suitable substrate for the facilitation of 
osteoblastic extracellular matrix. As a result of the porous nature of the scaffold, the 
extracellular matrix should form within the pores, producing a tissue-like structure. 
4.1.6.5 Encourage cellular penetration of scaffold 
The porous structure of the HA allows MSCs to grow on surfaces through the scaffold. 
However, penetration of the scaffold by cells needs to be stimulated by the culture 
method or cells are likely to remain on the top of the scaffold. The flow of medium 
through the porous scaffold may stimulate cell migration, increasing cellular 
penetration of the scaffold. Furthermore, culture in this bioreactor system should 
ensure a supply of nutrients to the centre of the scaffold, thereby allowing cells to 
remain viable throughout the depth of the scaffold. 
4.1.7 In this chapter 
MSCs have been shown to be precursors of osteoblasts and are present 
in bone marrow 
(see Chapter 1). As a result they can differentiate down the osteogenic 
lineage and 
potentially produce bone. As MSCs also have a great propensity to replicate and 
proliferate, these cells are important in fracture healing. 
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The aim of this chapter was to design a novel bioreactor for the culture of MSCs on 
HA scaffolds, which would encourage the differentiation of MSCs and production of 
bone extracellular matrix. The design of the bioreactor utilised the theory that if 
nutrients flowed over cells through a porous scaffold, it may increase the 
differentiation of MSCs into osteoblasts at a greater rate than in static culture 
conditions. This was studied by observing the cell morphology under SEM (as in 
Chapter 3, measuring osteoblastic mRNA and protein production and assessing the 
presence of an extracellular matrix under TEM. 
In addition to providing efficient mass transfer of nutrients, the design of my 
bioreactor should increase the penetration of MSCs through the porous scaffold and 
allow a uniform distribution of cells on a 3-d scaffold. Thus improving the constructs' 
3-d cellular structure and making it ideal for tissue engineering applications. Evidence 
of cell penetration through the HA scaffolds was assessed by cross-sectioning the 
scaffolds and counting cell numbers under SEM. 
4.1.8 Hypothesis 
This chapter investigates the use of a novel bioreactor system for the culture of MSCs 
on HA scaffold in 3-d environment. Therefore the hypotheses tested in this chapter 
were: 
1. MSCs, cultured on porous HA in the bioreactor, penetrate through the scaffold 
to a greater extent, than when cultured in a static environment. 
2. MSCs, cultured on porous HA in a perfusion system of the bioreactor, 
differentiate into osteoblasts and produce extracellular matrix. 
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4.2 MATERIALS and METHODS 
4.2.1 Materials 
Cell culture materials as Chapter 2 
Porous HA block as Chapter 3 
Standard culture medium used in the bioreactor, as detailed in Chapter 2, containing: 
Dubeccos Modified medium-low glucose (Sigma D6429) 
10% foetal calf serum (Sigma F7524) 
Penicillin 50U/ml (Sigma (Sigma P0906) 
Streptomycin 50p /ml (Sigma (Sigma P0906) 
Bioreactor: 
Pump (Watson Marlow 102R) 
Silicone tubing, 3.2mm wall thickness (Merck 910 0016 016) 
RNA materials as Chapter 2 
ALP & DNA assays as Chapter 2 
Type I procollagen radio-immunoassay (Orion Diagnostica 68569) 
4.2.2 Cell culture 
The MSCs were isolated from ten human bone marrow aspirates and cultured in 
standard monolayer conditions up to passage 3, as described in Chapter 2. No 
osteogenic supplements were used during any part of this chapter's experiments. 
4.2.3 Seeding cells on scaffold 
The MSCs were trypsinised, counted using a haematocytometer and 1x106 cells were 
seeded in 0.25m1 of medium onto each porous HA scaffold, as described in Chapter 
3. 
The seeded scaffolds were incubated at 37°C, 5% C02 for 2 hours to allow the MSCs 
to adhere to the HA, but without the medium evaporating as this would cause the cells 
to die. This was to allow the cells to adhere to the surface and prevent them 
from being 
washed off the scaffold during transfer. After this half the scaffolds were 
transferred to 
the bioreactor chamber and submerged in medium. While the remaining 
HA scaffolds 
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were submerged in medium in well-plates and cultured in the same incubator. This 
method was used to set up each experiment in this chapter, with the same number of 
scaffolds being cultured in the bioreactor or static culture. 
4.2.4 Bioreactor culture 
The HA scaffold's porous structure provided a large surface area for the cells to cover 
and in my bioreactor all the cells on the scaffold were in contact with medium, as 
medium flows through the scaffold. The flow rate was controlled by a peristaltic pump 
and could be varied, but a rate of 0.1ml/min (144ml/24hr or 6ml/hr) was tested, as 
discussed in the Introduction to this chapter. The medium was pumped through 
silicone tubing from a reservoir, through the bioreactor chamber and out into an 
outflow container. The flow of medium maintained a fresh supply of nutrients and the 
removal of waste. 
The whole system was cultured in aseptic conditions within an incubator at 37°C and 
5% CO2. The reservoir of medium within the incubator was warmed to 37°C and 
refilled every two days. This maintained a constant flow of medium, but preventing 
large volumes of stagnant medium being held in the incubator, which would be 
susceptible to the risk to contamination (see figure 3.1). 
4.2.5 Assessment of penetration of cells through scaffold 
4.2.5.1 SEM processing and analysis 
To assess the penetration of cells through the HA scaffolds in the bioreactor as 
compared with static culture, cells from 6 patients' aspirates were each seeded on 4 
HA scaffolds, as described above. Each of these scaffolds was then cultured for 
7 or 14 
days, in either the bioreactor or in static tissue culture. Thus for the SEM experiments 
to assess cell penetration, there were a total of 6 scaffolds cultured in each condition, at 
each time-point, resulting in a total of 24 scaffolds. Following each culture period 
the 
scaffolds were processed for SEM (see Chapters 2 and 3 Methods). The tops of 
the 
scaffolds were initially observed under SEM. 
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Figure 3.1: Diagram of Bioreactor System 
1. Air inlets into both in-flow and out-flow flasks 
2. Feeding flask containing sterile medium 
3. Chamber barrel containing material with cells on scaffolds 
4. Outflow flask to collect used medium. 
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4.2.5.2 HA in cross section 
The processed HA scaffolds were then cut centrally, through the longitudinal axis, 
from top to bottom using a diamond circular saw. This enabled the penetration of the 
cells through the cross section of the HA to be determined. The cut sections were 
remounted uppermost on metal stubs, recoated with gold/palladium for 2 minutes and 
observed under SEM. The total number of cells present within an 855µm width, 
through the depth of the cross section were counted under SEM at a magnification of 
150 times, at which individual cells would be seen (see figure 3.2 in Results section for 
an illustration of this). To assess cell penetration, the number of cells present within 
the cross sections was compared for the two conditions at each time-point. 
4.2.5.3 Penetration through the HA 
The cross sections through each of the HA scaffolds were then divided into five layers 
at 2mm intervals through the longitudinal axis of the sections (see figure 3.4 in Results 
section for an illustration of these areas). The number of cells within each of these 
layers, within the 855µm width, was counted under SEM at the same magnification as 
before. Therefore, the area within which the number of cells was counted was 855 x 
2000µm at each layer. This was repeated for three similar areas within each layer, such 
that an average number of cells could be calculated. The penetration by cells into each 
layer of the HA scaffolds was then compared for the two conditions, at each time- 
point. 
4.2.6 Measures of differentiation of MSCs in the bioreactor 
4.2.6.1 SEM 
The MSCs cultured in the bioreactor were assessed for osteoblastic differentiation 
initially by observing the morphology of the cells under SEM after 7 and 14 days, as 
compared with control cells grown on the same scaffold in static culture. Five 
HA 
blocks were cultured, as described above, for each condition. The medium 
for the cells 
in static culture was changed twice a week. After the culture periods were completed 
the scaffolds were processed for SEM. Following this cells on the scaffolds were 
observed under SEM and recorded. 
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4.2.6.2 TEM 
The ultrastructure of the cells and extracellular matrix production was compared for 
MSCs cultured in the bioreactor with the control conditions, using TEM. For this, HA 
scaffolds were again seeded with 1x106 MSCs and cultured in either condition for both 
14 and 28 days, following which the scaffolds were processed for TEM (see Chapter 3 
Method). Two patient's aspirates were used for each condition at each time point. 
Following initial TEM processing and embedding in resin, 1mm sections through the 
HA scaffolds were observed under light microscopy. This allowed an overall 
comparison between the two conditions. Areas observed to contain cells were then re- 
embedded in resin and thin sections were cut using an ultra-microtome diamond knife. 
The thin sections were placed on copper grids. The HA samples for each day and 
condition were then observed under TEM and photographed. 
An energy dispensive x-ray analysis (EDAX) probe was used to assess the chemical 
components of deposits seen between cells. 
4.2.6.3 Messenger RNA expression by RT-PCR 
The presence of specific mRNA sequences was examined within MSCs cultured on 
HA in the bioreactor for 1,2 &4 days, and similarly in the static control. After each 
culture period cells were removed from the scaffolds by incubating them in 2ml of 
10% trypsin for 10 minutes at 37°C. Then the cells were washed with phosphate 
buffered saline and centrifuged in an additional l Oml of medium. The supernatant was 
removed from the cell pellet and these were stored at -70°C. Following thawing the 
RNA was extracted from the samples and analysed by reverse transcriptase polymerase 
chain reaction (RT-PCR) (see Chapter 2 Method). The RNA sequences probed for 
were ALP, osteopontin, Bone sialoprotein (BSP) and osteocalcin, known markers of 
osteoblasts, and Cbfa-1, suggested to be a marker of osteoblast precursor cells. For 
details of the gene sequences except BSP, refer to Chapter 2 Method. 
BSP: 5' AAC GAA GAA AGC GAA GCA GAA GTG 3' 
3' CTG ACC ATC ATA GCC ATC GTA GCCT 5' 
(Phinney et al. 1999) 
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4.2.6.4 ALP protein assay 
The protein readings were standardised for each sample as before, by dividing protein 
levels by total DNA content, assayed by Hoechst assay (as described in Chapter 2). 
The assay used measured the levels of ALP by the amount of p-nitrophenol that had 
been cleaved from p-nitrophenol phosphate (see Chapter 2 Method). 
MSCs from 8 patients' were cultured on 8 porous HA in the bioreactor and in static 
culture for 1,5,10 & 15 days. The resulting ALP/DNA results were compared 
between the two conditions at each time point. 
4.2.6.5 Type Iprocollagen protein assay 
When collagen type I is derived from type I procollagen the carboxyterminal 
propeptite group (PICP) is removed. Thus, the concentration of PICP is proportional to 
recently synthesised type I collagen and bone activity (Nacher et al. 1999). The amount 
of PICP in each sample was measured using a competitive radioimmunoassay, where a 
known amount of I125 labelled PICP was added to the samples and PICP rabbit 
antiserum antibody was then added. The labelled and unlabelled antigens compete for 
binding sites on the antibodies, thus the bound labelled antigen was inversely 
proportional to the initial amount of unlabelled PICP in the samples. The amount of 
labelled bound PICP was measured using a gamma counter and the actual PICP 
measurements were calculated from a standard curve of known concentrations. 
The amount of PICP/DNA was measured for MSCs cultured on HA in the bioreactor 
for 5,10 & 15 days and compared with the results from similar scaffolds in static 
culture. MSCs from 6 patients' aspirates were used in each group. 
4.2.7 Statistical analysis 
The results from the culture in the bioreactor were compared to the control. The results 
for the assessments of cell penetration into the HA scaffolds and differentiation of 
MSCs using ALP and PICP were not found to follow a normal distribution, 
consequently non-parametric statistical tests, namely Mann Whitney 
U, were used to 
assess the significance between the two groups. 
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4.3 RESULTS 
4.3.1 Penetration of cells through HA scaffold 
4.3.1.1 Assessment of cell numbers in cross section 
The total numher of cells present on the cross-sectioned surtäce of the I IA scaffolds 
was compared from those cultured in the hioreactor compared with static conditions. 
The number of cells within the cross sectional surface was determined by counting 
cells within an 8»µm wwidth (see figure 1.2). The number of cells penetrating through 
the I IA scaffolds that had been cultured in the hioreactor was significantly greater than 
for static culture. after both 7& 14 days (P<0.05). (see figure 3.3). 
Figure 3.2: A cross-sectioned porous I-IA scaffold illustrating the 855pun width within 
which the number ol'cells were counted, under SF M. The cell number within this 
width vN as compared between hioreactor and static culture conditions. Bar =1 mm 
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Figure 3.3: Total number of cells on the cross sectional surface through HA scaffolds 
(counted within a 8551im width), comparing static with bioreactor culture after 7 and 
14 days, * P-value <0.05 between static and bioreactor cell numbers. 
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4.3.1.2 Assessment of cell numbers at different depths through the HA 
To further detail the penetration of cells through the HA scaffold, the cross sectional 
surface was divided into five layers, as described in the Method and illustrated in 
figure 3.4. The number of cells that had penetrated into each of these five layers 
through the cross-sectioned HA scaffold was compared between the two conditions 
(see figure 3.5). 
The average number of cells that had penetrated into layers 2,3 &4 of the HA was 
significantly greater when cultured in the bioreactor than in static culture after 7 days 
(P<0.05), (see figure 3.5a). After 14 days in culture the cell penetration into layers 3& 
4 remained significantly greater for scaffolds in the bioreactor compared with the static 
system, with the addition of a significantly greater number of cells within the first 
layer in the bioreactor as compared to static culture (P<0.05), (see figure 3.5b). 
Figure 3.6 show the HA scaffolds at 6mm depth (layer 3) for the two culture 
conditions after 7 days in culture, under SEM. In the bioreactor system, a network of 
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fibroblastic shaped cells formed on the HA at this depth, after 7 days. However in 
contrast, no cells were seen but there was evidence of cell debris at this depth in the 
Porous I IA, after 7 days in static culture (see figure 3.6h). By 14 days cells cultured in 
the hioreactor covered a large area of the scaftöld (see figure 3.7a). Conversely, after 
the same time in static culture there were no cells and less evidence of cell debris at 
this level (see figure 3.7h). 
Alter 14 days in the hioreactor a larger number ofcells were observed on the top of the 
I IA scaffolds, as shown in figure 3.8. 
Figure 3.4: A photograph indicating the how penetration through the IIA scat'tolds* 
cross-sectional sur! hce was assessed. The black lines illustrate an 855µm width that 
was divided through the longitudinal axis into tive depths by 2mm intervals. The 
numbers of cells were counted within each laver, an area of 855 x 2000µm. and 
compared liar the two conditions. Rar =I nim. 
Elvers, 
ý, _ , 
lit ? mm each 
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Figure 3.5: Comparing the average number of cells counted within each layer of the 
cross section of the HA, for the two culture conditions, a) After 7 days in culture, b) 
After 14 days in culture, *P-value <0.05. 
a) 
600- 
500- 4) 
m 
400- 
300 -  
t0   200- 
  (D 
V 100- 
0   
1- 0-    " 
a I 
-100- 
0 
200 - 
2345 
layers through block 
b) 
600- 
500- 
400- 
"   
m 300 - "k 
m U 
U) 200- U 
d     
100- 
0 
L. 0-    
. 93 
-100- 
C 
-200 - 
11 1 
1 234 5 
layers through block 
conditions 
  Static 
  Bioreactor 
Error Bars show 95.0% Cl of Mean 
DoULines show Means 
conditions 
Static 
Bioreactor 
Error Bars show 95.0% Cl of Mean 
DoVLines show Means 
193 
Chapter 4 Results 
Figure 3.6: SEM cross sectional pictures of static and bioreactor cultures to compare 
penetration at 6mm depth (layer 3) through HA scaffold after 7 days in a) the 
bioreactor and b) static culture. Yellow arrows indicate cells and pink arrows indicate 
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Figure 3.7: SEM cross sectional pictures of static and bioreactor cultures to compare 
penetration at 6mm depth (layer 3) through HA scaffold after 14 days in a) the 
bioreactor and b) static culture. Yellow arrows indicate cells and pink arrows indicate 
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Figure 3.8: Cells over the surface of the HA scaffold after 14 days cultured in a) static 
culture and b) the bioreactor, with yellow arrows indicating cells. Bar = 500µm. 
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4.3.3 Assessment of differentiation of MSCs in the bioreactor 
4.3.3.1 Observations of SEM Morphology 
The cellular differentiation was initially assessed by observing cell morphology under 
SEM. The cells were observed to form multiple processes with the HA surface, 
indicating attachment of the cells (see figure 3.9). After 7 days in culture in the 
bioreactor, a layer of spindle-shaped MSCs formed over the HA scaffold (see figure 
3.1 Oa). The cell density increased forming a mesh over the HA, and by 14 days the 
majority of the cells changed becoming cuboidal in shape (see figure 3.11 a). 
However, after 7 days in static culture fewer cells were observed and there was 
evidence of cell debris on some parts of the scaffold (see figure 3.1 Ob). By day 14, 
cells that had been grown in static culture also changed in morphology into squarer 
shaped cells, but the degree of coverage of the scaffolds was much less than for those 
cultured in the bioreactor. An example of this is seen in figure 3.11 b, where a ridge of 
HA scaffold on the right of the picture is totally covered with a mosaic of cuboidal 
cells, however there are few cells within a pore to the left of the picture and cell debris 
was again observed in these areas. 
The cell morphology was also studied at higher magnification. After 7 days in culture 
in the bioreactor the cells were typically spindle in shape. however by 14 days the cells 
became squarer (see figure 3.12). 
Figure 3.9: SEM picture showing cell processes attaching cells to the HA, with part 
of a cell shown by a blue arrow and processes shown with pink arrows. Bar = 5µm. 
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Figure 3.10: SEM of MSCs grown on HA in each condition showing the relative cell density and morphology after 7 days in a) the bioreactor and b) static culture. Yellow 
arrows indicate spindle-shaped cells and pink arrows cell debris, bars = 100µm. 
b) 
40 14 - 
198 
Chapter 4 Results 
Figure 3.11: SEM of MSCs grown on HA in each condition showing the relative cell 
density and morphology after 14 days in a) the bioreactor (bar = 100µm) and b) static 
culture (bar = 50µm). Blue arrows show cuboidal-shaped cells and pink arrows 
indicate evidence of cell debris. 
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Figure 3.12: Morphology of cells following culture in the bioreactor after a) 7 days 
showing spindle-shaped cells, yellow arrows, bar = 20µm and b) 14 days showing 
cuboidal cells, blue arrows, bar = 10µm. Cell processes shown with pink arrows. 
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4.3.3.2 Observations of TEM results 
Initially the HA scaffolds were observed under light microscopy to find the density 
and distribution of cells on the scaffolds. Figure 3.13 shows a large number of cells 
filling the pores of the HA scaffolds following culture in the bioreactor for 28 days. At 
higher magnification individual cells can be seen spanning across gaps in the HA (see 
figure 3.13b). However following the same culture time in static culture, a dramatic 
difference in cell numbers on the HA was observed (see figure 3.14). At low 
magnification no dense cellular areas were seen, although at higher magnification 
some cells were noted around the HA. For each scaffold areas of higher cell density 
were identified and further examined under TEM. 
Cells were shown attaching to the HA scaffold when cultured in the bioreactor under 
TEM (see figure 3.15). After 14 days of culture in the bioreactor cells with multiple 
cell processes and containing rough endoplasmic reticulum were observed (see figure 
3.16). After 28 days in the bioreactor, cells were also noted to contain lysosomal 
bodies and vesicles (see figure 3.17); others contained large amounts of intracellular 
glycogen and rough endoplasmic reticulum (see figure 3.18). Additionally, 
intracellular lipid droplets were observed in some of the cells that had been cultured in 
the bioreactor (see figure 3.19a and 3.20a). Furthermore, after 28 days in the bioreactor 
extracellular matrix of collagen fibres were produced (see figure 3.19 & 3.20). 
Periodicity of the collagen fibres was seen, although this was faint (see figure 3.19b & 
c). 
Adjacent to some areas of organised collagen matrix, mineralised crystalline deposits 
were observed (see figure 3.21 a). The composition of these areas was found to contain 
calcium and phosphate on energy dispensive x-ray analysis (EDAX) probing, with a 
ratio of 1.8 (see figure 3.21b & c). 
In static culture however, after 14 days in culture cells were too infrequent to be seen 
under high magnification of TEM. At 28 days cells were seen, containing intracellular 
organelles (see figure 3.22) and some evidence of collagen formation on one of the 
scaffolds (see figure 3.23), but this was uncommon compared to those cultured 
in the 
bioreactor. 
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Figure 3.13: HA scaffold (yellow arrows) following 28 days in the bioreactor, viewed 
under light microscopy showing large numbers of cells filling the pores (stained brown 
by osmium, blue arrows) a) bar = 500µm b) bar = 100µm. 
a) 
h) 
rf"_, 
202 
Chapter 4 Results 
Figure 3.14: HA scaffold (yellow arrows) following 28 days in static culture, viewed 
under light microscopy showing fewer cells (stained brown by osmium, blue arrows) 
a) bar = 500µm b) bar = 100µm. 
a) 
olddlaft Afthh, 
b) 
, 'ý 
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Figure 3.15: TEM of cells around HA scaffold following culture in the bioreactor 
showing a cell with nucleus (N), surrounding the HA (H). Bar =1.5µm. 
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Figure 3.16a: Cells with nuclei (N) containing nucleoli and endoplasmic reticulum 
(arrowheads) after 14 days culture in the bioreactor. Cell processes (arrows) are in 
abundance. Bar = 3µm. 
Figure 3.16b: Higher magnification of cells after 14 days in the bioreactor showing 
nucleus (N), various stages of lysosornal body formation (L) and rough endoplasmic 
reticulum (arrowheads). Bar = 1.5µm. 
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Figure 3.17: After 28 days in bioreactor culture, cellular ultrastructure additionally 
shows lysosomal bodies (arrows), rough endoplasmic reticulum (arrowheads) and 
intracellular glycogen (G). Cell processes are again evident. Bar = 3µm. 
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Figure 3.18a: After 28 days in bioreactor culture, a cell containing much endoplasmic 
reticulum (arrows) and glycogen (G). Bar = 3µm. 
Figure 3.18b: A higher magnification of the same cell, highlighting the rough 
endoplasmic reticulum (arrow) and glycogen (G). Bar = 0.6µm. 
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Figure 3.19a: After 28 days in bioreactor culture there is evidence of collagen (C) 
associated with the cells. These cells are observed to contain lipid droplets (arrows) in 
additions to other organelles as seen previously in figure 3.16. Bar = 3µm. 
Figure 3.19b: Collagen fibres (C) seen at higher magnification, showing evidence of 
early periodicity (arrows). Bar = 1µm. 
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Figure 3.19c: Higher magnification of early collagen fibrils in the areas between 
cells. The periodicity of the collagen fibres (arrows), although faint, can still be seen. 
Bar = 250nm. 
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Figure 3.20a: Further illustrations of HA scaffolds cultured with MSCs in the 
bioreactor for 28 days. A number of cells are seen stacked together and extracellular 
collagen matrix (arrowheads) is noted between them. Several cells contain nuclei (N) 
and another contains glycogen (G) in close proximity to lipid droplets (L). 
Bar= I µm. 
Figure 3.20b: Higher magnification of an area between two cells with nuclei (N), 
showing collagen (arrowheads) formation. Mitochondria (M) are seen in these cells. 
Bar = 0.5µm. 
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Figure 3.20c: Showing early collagen (C) between two cells again after 28 days on a 
separate HA sample in the bioreactor. Bar = 0.51im. 
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Figure 3.21 a: Shows high magnification of a cell producing collagen (C) in close 
contact with a mineral deposit (Mn), after 28 days in the bioreactor. Arrows show the 
cell membrane and the cell contains an organelle suggestive of a mitochondrion (M). 
Bar = 200nm. 
Figure 3.21b: Shows lower magnification of cells in close contact (arrows) with a 
similar deposit as seen in figure 3.21a. The pointer indicates the area that was probed 
with the EDAX. Bar = 0.5µm. 
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Figure 3.21c: Shows the spetra as analysed by the EDAX probe of the area indicated 
in figure 3.21 b. Note the high content of calcium and phosphate. 
213 
ICS-FES-01 17: 48: 1G 
RATE- 2BCFS 
FS- 9000NT 
A -am27, -2000 
EDAX READY 
TIME- 20OLSEC 
PRST- 20OLSEC 
Figure 3.21c 
sr 
ý r' 
. ý, . y-: i ý. 
. 213 A 
336CHT 2.40KEV 1OeV%ch R EDPIX 
Chapter 4 Results 
Figure 3.22: In static culture, after 28 days cells were observed to contain a nucleus 
(N) and rough endoplasmic reticulum (arrow). Bar =1 µm. 
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Figure 3.23a: After 28 days in static culture on HA, there was the suggestion of 
collagen formation between cells (arrows). Bar =1µm. 
Figure 3.23b: At higher magnification the cells were observed to contain rough 
endoplasmic reticulum (arrowheads) in addition to nuclei (N), but these cells possessed 
fewer cell processes than those cultured in the bioreactor (see figure 14). Bar = 0.4µm 
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4.3.3.3 Messenger RNA RT-PCR results 
The housekeeping gene GAPDH was expressed by all MSCs cultured with HA 
irrespective of culture condition (see figure 3.24). 
The mRNA expression of Cbfa-1 was measured for MSCs cultured in the bioreactor 
compared with the static control, as a marker of differentiation down the osteoblastic 
lineage. MSCs on HA in both conditions expressed Cbfa-1 at 1,2 &4 days in culture 
(see figure 3.24a). In the bioreactor system the relative intensity of expression was 
greatest after the first day and reduced by day 4. However, in static culture the 
expression of Cbfa-1 was less intense initially but remained constant over the 4 days. 
ALP expression was maximal after 1 day in bioreactor culture and decreased by day 4. 
However, it increased over the culture period in static culture, being maximal after 4 
days in these conditions. 
Osteopontin intensity varied slightly as it increased after day 2 in the bioreactor, but 
was greatest after day 4 in static culture (see figure 3.22b). 
The intensity of osteocalcin expression was lower compared with the other mRNA 
tested. It was expressed after day 2 in both static and bioreactor culture and there was 
no apparent difference in expression between conditions. 
MSCs cultured on HA expressed bone sialoprotein (BSP) after 1 day in either culture 
conditions (see figure 3.24c). 
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Figure 3.24: Gene expression of MS('s cells cultured over 4 days on HA in the 
hioreactor compared with the static culture control. a) GANAI & Cbfa-1, h) ALP & 
osteopontin & c) osteocalcin & I3SP, yellow arrows indicate DNA hands. 
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4.3.3.4 Comparisons of ALP protein production 
The ALP synthesised by MSCs on HA scaffolds cultured in the two conditions over a 
15-day culture period was compared, as an indicator of osteoblastic differentiation. 
The ALP/DNA results for the two conditions were compared for each time point. ALP 
levels were too low to be detected by the assay after 1 day in static culture, although 
significant amount were measured in the cells cultured for 1 day in the bioreactor. 
Subsequent to this, MSCs cultured on HA in the bioreactor system were found to 
produce significantly more ALP/DNA at 5,10 & 15 days in culture (P<0.005), (see 
figure 3.25). The production of ALP by the MSCs cultured in the bioreactor peaked 
after 10 days in culture, however in static culture the ALP continued to increase 
throughout the culture period. 
Figure 3.25: The production of ALP/DNA over the 15-day culture comparing static 
and bioreactor (dynamic) culture conditions, * P-value <0.005. 
1500- 
0 culture conditions dynamic culture 
static culture 
looo- ' 
os 
a 
c 
ß 
ä 500- 
000- 11 
day 1 day 5 day 5 day 10 day 10 day 15 day 15 
day in culture 
218 
Chapter 4 Results 
4.3.3.5 Comparisons of Type I Procollagen protein (PICP) levels 
The amount of PICP/DNA cleaved from the peptide, by MSCs cultured on porous HA 
in the bioreactor after 5,10 & 15 days, was compared with the static culture control. A 
significantly larger amount of PICP was produced by the MSCs in the bioreactor after 
10 days in culture (P<0.05) and no PICP was detected in the cells after 5 days in static 
conditions (see figure 3.26). 
Figure 3.26: Box plot of the PICP production by MSCs cultured on porous HA within 
the bioreactor compared to static culture over 15 days, * P<0.05. 
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4.4 DISCUSSION 
The aim of Chapter 4 was to design a novel bioreactor to aid the culture of MSCs on 
HA scaffolds and to encourage the differentiation of MSCs with the production of 
osteoblastic extracellular matrix. The design of the bioreactor was based on the theory 
that if nutrients flowed over cells through a porous scaffold, it may increase the 
differentiation of MSCs into osteoblasts at a greater rate than observed in static culture 
conditions as demonstrated in Chapter 3. Furthermore, this flow of medium was also 
suggested to increase the penetration and survival of cells through the scaffold, thereby 
tissue-engineering a 3-d construct. , 
4.4.1 Penetration of cells through the HA scaffold 
4.4.1.1 Cell numbers in cross section 
The first of this chapter's hypotheses proposed that MSCs cultured in my bioreactor 
would penetrate through a porous HA scaffold to a greater extent compared to static 
culture. The result of measuring the number of cells through cross-sectioned HA 
scaffolds confirmed this after both 7 and 14 days, (P<0.05). This leads to the 
conclusion that the flow of medium through the HA does increase the penetration of 
the cells and allows their survival for 14 days. 
4.4.1.2 Cell counts at increasing depths through the HA scaffold 
To assess further the cell penetration through the scaffold, the cross-sectioned 
HA was 
divided into 5 layers at intervals of 2mm depths. When each of these layers was 
assessed, it was observed that after 7 days in the bioreactor, cells had penetrated all the 
way through the HA, maintaining a large cell number to 8mm depth. Furthermore, 
penetration of MSCs to 4,6 and 8mm through the porous HA cultured 
in the bioreactor 
was greater than in static culture, after 7 days (P<0.05). As cells continued to 
be 
observed through the scaffolds after 14 days in the bioreactor, this culture system 
maintained cells throughout the scaffold confirming that cells penetrated the 
HA and 
received enough nutrients and oxygen to remain viable. 
In static culture after 7 days, however, very few cells penetrated 
beyond the first 2mm 
into the HA scaffold. Explanations for these findings are that, 
in static culture, 
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penetration into the HA was slow and limited. Moreover, there was evidence of cell 
debris presence at 6mm depth when observed under SEM, which suggests that cells 
present in the centre of the scaffold were unable to survive. This was likely to be due 
to an insufficient supply of nutrients, which relies on diffusion in static culture 
conditions. 
After 14 days in static culture, cells had penetrated slightly further through the 
scaffold, to a depth of 4mm but, like the findings at day 7, more MSCs were seen 
through the remaining layers (6-8mm) when cultured in the bioreactor (P<0.05). 
The number of cells present within the top layer of the HA scaffolds did not vary 
significantly between the two conditions after 7 days. This is because the cells seeded 
onto the HA in static culture would have initially adhered to the surface of the 
scaffolds and proliferated to cover the local area of the HA. Furthermore, similar cell 
survival would be expected as supply of nutrients should be adequate in each 
condition. Additionally it should be noted that, as the number of cells counted within 
the top layer varied considerably and the graph had large error bars caution is required 
in interpretating this result. 
After 14 days there was no significant difference in the number of cells in the second 
layer (4mm) between the two culture conditions, but significantly more cells in the top 
layer (2mm) of the bioreactor culture. This suggests that some of the cells from the top 
of the static culture scaffold have moved down through the scaffold into the second 
layer. This may be the result of cell migration, although, a further explanation could be 
that cells proliferated within the top layer and spread to the second by 14 days in static 
culture. However, as large error bars were also present on the graph for the second 
layer, this result needs to be cautiously interpreted. 
Furthermore, as cell debris was observed at the deeper layers of static cultured HA 
after 7 days, but less debris was evident by day 14 following static culture. This 
suggests that cells penetrated the static cultured scaffold early, possibly at the time of 
seeding, but in static culture these cells were unable to survive. As there was no 
further 
evidence of cell debris by day 14, this indicates that once in static culture cells 
did not 
move through the scaffolds. 
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The increased cell penetration in the bioreactor was likely to be the result of cell 
division and movement, due to the flow of medium stimulating the migration of cells 
through the porous HA scaffold. Once within the scaffold the flow of fresh nutrients 
maintained these cells, allowing them to survive and proliferate covering the surface. 
Further investigation is needed to study the methods of cell movement through the 
scaffolds in the two culture conditions. 
Therefore, the bioreactor system increased the density of cells through the HA scaffold 
forming a 3-d cellular construct. Thus, this method would increase the potential for the 
use of this MSC-HA scaffold in clinical bone grafting procedures. 
4.4.3 Assessment osteoblastic differentiation of MSCs 
4.4.3.1 Observations under SEM 
The second hypothesis tested in this chapter was that the bioreactor culture system 
stimulated the differentiation of the MSCs into osteoblasts. This was initially assessed 
by comparing the morphology of cells in the two culture environments under SEM. By 
day 14, the morphology of the cells cultured on HA in the bioreactor was observed to 
change from spindle-shaped cells, characteristic of fibroblasts, to plump, cuboidal 
cells, typical of osteoblastic morphology (Holtrop 1990). 
MSCs grown in static culture were also shown to have altered morphology by day 14, 
as seen previously in Chapter 3. In both culture systems cells formed multiple 
attachments to the HA via cell processes. The change in shape is therefore suggested to 
be due to the HA, as shown in Chapter 3, although the rate of change seemed to 
be 
more rapid when cells were cultured in the bioreactor. 
4.4.3.2 Observations under TEM 
Prior to observing the cells under TEM, the scaffolds were viewed under 
light 
microscopy. The results of this illustrated a dramatic difference 
in the numbers of cells 
on the HA depending on culture conditions. This also supported the results of 
the cell 
penetration study (see above). When the constructs had been grown 
in the bioreactor 
cells were seen to fill the pores of the scaffold, however after a similar culture 
period 
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The increased cell penetration in the bioreactor was likely to be the result of cell 
division and movement, due to the flow of medium stimulating the migration of cells 
through the porous HA scaffold. Once within the scaffold the flow of fresh nutrients 
maintained these cells, allowing them to survive and proliferate covering the surface. 
Further investigation is needed to study the methods of cell movement through the 
scaffolds in the two culture conditions. 
Therefore, the bioreactor system increased the density of cells through the HA scaffold 
forming a 3-d cellular construct. Thus, this method would increase the potential for the 
use of this MSC-HA scaffold in clinical bone grafting procedures. 
4.4.3 Assessment osteoblastic differentiation of MSCs 
4.4.3.1 Observations under SEM 
The second hypothesis tested in this chapter was that the bioreactor culture system 
stimulated the differentiation of the MSCs into osteoblasts. This was initially assessed 
by comparing the morphology of cells in the two culture environments under SEM. By 
day 14, the morphology of the cells cultured on HA in the bioreactor was observed to 
change from spindle-shaped cells, characteristic of fibroblasts, to plump, cuboidal 
cells, typical of osteoblastic morphology (Holtrop 1990). 
MSCs grown in static culture were also shown to have altered morphology by day 14, 
as seen previously in Chapter 3. In both culture systems cells formed multiple 
attachments to the HA via cell processes. The change in shape is therefore suggested to 
be due to the HA, as shown in Chapter 3, although the rate of change seemed to be 
more rapid when cells were cultured in the bioreactor. 
4.4.3.2 Observations under TEM 
Prior to observing the cells under TEM, the scaffolds were viewed under light 
microscopy. The results of this illustrated a dramatic difference in the numbers of cells 
on the HA depending on culture conditions. This also supported the results of the cell 
penetration study (see above). When the constructs had been grown in the 
bioreactor 
cells were seen to fill the pores of the scaffold, however after a similar culture period 
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in static culture fewer cells were seen. As the cells formed a mesh filling the pores of 
the HA following culture in the bioreactor, it is probable that an extracellular matrix 
would form between the cells. In the case of osteoblasts this would be bone and 
therefore, my bioreactor would be useful for the growth of tissue 
TEM was then used to examine the cell ultrastructure and the extracellular matrix 
produced by cells cultured on the HA in both static and bioreactor culture. Although 
cells were seen in close contact to the HA, it was difficult to examine their attachment 
as the electrons from the microscope caused the HA crystals to break up, resulting in 
the scaffold and cells moving under the beam. As under SEM, the cells were observed 
to possess many cell processes, suggesting that MSCs attach to HA. 
Cells cultured on HA in the bioreactor for 14 days contained many organelles 
including mitochondria, which produce cellular ATP and are associated with fatty acid 
and protein synthesis. Large amounts of endoplasmic reticulum (ER) were also 
observed within these cells and at higher magnification this was shown to be rough 
ER, due to the ribosomes seen studding it. The main function of rough ER is to 
produce secretory proteins, which would include extracellular proteins such as 
osteopontin and isoenzymes such as ALP. This suggests that the cells cultured in the 
bioreactor for 14 days were consistent with active cells producing proteins. 
After 28 days the cells were also noted to contain large amounts of intracellular 
glycogen, which is uses as intracellular energy stores and are commonly seen adjacent 
to rough ER in liver cells (Ham 1974). These observations indicate that the cells were 
metabolically active, which is typical of functioning osteoblasts (Holtrop 1990). 
Intracellular lipid droplets were observed in some of the cells cultured for 28 days in 
the bioreactor. Small lipid inclusions are found in most animal cells (Ham 1974). Lipid 
can be an important storage method for cells in culture and the larger amounts seen in 
cells grown in the bioreactor indicates that the cells were well supplied with nutrients. 
Furthermore, after 28 days in the bioreactor, there was evidence of collagen production 
throughout each of the scaffolds studied. Notably this was seen between cells and 
it 
was organised, in some cases with periodicity and early striations observed on the 
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fibrils. As collagen matrix matures it becomes organised with striations of the fibres, 
the thickness of the collagen then increases forming the basis of osteoid that is 
mineralised to produce bone. There was evidence that the collagen produced by cells 
in my bioreactor was starting to mature. However, experiments over a longer culture 
period would be required to further examine extracellular matrix maturation. 
There was also evidence of mineral formation that, on EDAX probing, had average 
calcium to phosphate ratio of 1.8. As the ratio of HA, the inorganic component of 
bone, is said to be 1.67 this may represent mineralisation, thereby clarifying the 
presence of functioning osteoblasts. However, although the mineral was observed 
adjacent to collagen matrix, the matrix was not as dense and mature as would be 
expected adjacent to mineralisation. Furthermore the mineral was observed to have 
crystal shaped structures around its edge, which is not characteristic of mineralised 
extracellular matrix. As the background EDAX absorbance ratio was also high, this 
suggests that the EDAX ratio of this mineral may actually be slightly lower, signifying 
HA scaffold. Nevertheless, this mineral was not typical of the HA scaffold when 
observed under TEM, although cell processes were seen attaching to it as they tend to 
do to HA. 
In conclusion, further experiments are necessary to test whether this mineral was 
produced by the cells or whether was derived from the HA scaffold. In addition to this, 
as 28 days is early for mineralised osteoblastic extracellular matrix, supplementary 
culturing in the bioreactor over a longer time period should be studied. 
In static conditions, after 14 days in culture on HA, there were not enough cells present 
to be visualised under TEM, as observed when scaffolds were placed under light 
microscopy. In comparison to the bioreactor culture this is explained by a lower 
penetration and proliferation rate found in cells in static conditions. 
After 28 days in static culture metabolically active cells were observed, as seen by the 
presence of organelles and rough ER (Bab et al. 1988a) and there was evidence of 
collagen production on one of the scaffolds. However, the extracellular matrix was 
less 
frequent than that observed when the cells were cultured in the bioreactor. 
This would 
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be expected from the lower density of cells observed under light microscopy prior to 
TEM. 
In summary, these results highlight that culture in the bioreactor stimulated MSCs to 
become active, producing early extracellular matrix of osteoblasts to a greater extent 
than in static conditions. 
4.4.3.3 Messenger RNA 
The gene expression of ALP, osteopontin, BSP and osteocalcin, all markers of 
osteoblasts, and Cbfa-1, a marker of osteoblast precursor cells, by MSCs cultured on 
HA in the two conditions was assessed by RT-PCR. The success of the technique used 
was confirmed, as the housekeeping gene GAPDH was expressed by every sample in 
both conditions. 
Cbfa-1 is a transcription factor that is necessary for the expression of osteocalcin and 
can therefore be used as a marker of MSCs differentiating into osteoblast progenitor 
cells (Ducy et al. 1997; Ducy 2000). The expression of Cbfa-1 increased until day 4 in 
static culture, whereas it reduced after 1 day for cells grown in the bioreactor. This 
result indicates that in both cases the MSCs differentiated down the osteoblastic cell 
line and that this occurred at an earlier stage in the bioreactor culture relative to the 
static control. 
ALP and osteopontin were also expressed earlier by MSCs cultured on HA in the 
bioreactor relative to static culture. This also suggests that MSCs cultured in the 
bioreactor differentiated into osteoblasts earlier than in static conditions. Osteocalcin 
was expressed in both culture conditions increasing until day 4. The weak expression 
is due to it being a late marker of mature osteoblasts. Similarly there was no notable 
difference in BSP between the two conditions. Osteocalcin, as discussed in Chapter 2 
Results, is distinctively associated with mineralised bone tissue (Aubin 1998) and BSP 
is an attachment protein for collagen that is found exclusively in bone (Oldberg et al. 
1988b). In summary, this is evidence of the presence of the osteoblastic phenotype 
within the cultures, with expression of certain osteoblastic markers occurring earlier in 
bioreactor culture. 
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4.4.3.4 ALP protein production 
Protein production is a more accurate marker of cell phenotype than mRNA as, 
although transcription is necessary for protein synthesis, it does not ensure that the cell 
will produce the protein. Therefore, ALP protein levels were measured in addition to 
mRNA synthesis. 
Production of ALP was used, as it is a marker of the osteoblastic phenotype (see 
Chapter 1) and as it was shown to increase as MSCs differentiated into osteoblasts in 
Chapter 2. After 1 day in static culture, the levels of ALP were too low to measure, 
however significant amounts were measured for cells cultured in the bioreactor. 
Following this, the amount of ALP synthesised by the cells was significantly greater 
after 5,10 and 15 days, for those cultured in the bioreactor compared to the static 
culture control (P<0.005). As the levels were standardised for DNA content, this is 
likely to be the result of greater ALP production at a cellular level in bioreactor 
conditions. Overall, these results show that use of the bioreactor increased the rate of 
differentiation and osteoblastic activity of the MSCs, which furthermore supports the 
ALP mRNA results. 
As described in the Introduction to this chapter, my bioreactor was designed to 
simulate the conditions of osteoblasts in vivo with the aim that this would stimulate 
cell differentiation and production of bone. The greater increase in osteoblastic 
function at a more rapid rate by the MSCs cultured on HA compared to static culture, 
maybe the direct result of the bioreactor system stimulating osteoblastic 
differentiation. 
However, this increased rate may also be due to the increased mass transfer of 
nutrients as a result of the use of a bioreactor, as seen when osteosarcoma cells were 
cultured in suspension in a RWV (Granet et al. 1998). Hence in my bioreactor, the 
quality of nutrient supply may have promoted cellular activity allowing cells to 
proliferate, whereby increasing cell differentiation as stimulated by the HA scaffold, as 
shown in Chapter 3. Conversely, in static conditions the supply of nutrients to cells 
within the scaffold by diffusion may have limited cell growth and thus differentiation. 
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4.4.3.5 Type IProcollagen (PICP) protein production 
Type I procollagen is produced by osteoblasts, following which it is converted into 
type I collagen by the removal of the carboxyterminal propeptite (PICP), which allows 
organisation into fibrils forming the basis of osteoid. Thereby, the concentration of 
PICP found is proportional to the levels of recently synthesised type I collagen. 
Detection of PICP has been described as the technique of choice for quantification of 
type I collagen synthesis by active osteoblasts in vitro (Nacher et al. 1999). Therefore 
in this study, PICP levels were measured as a specific protein marker of osteoblastic 
extracellular matrix production, the result of MSCs differentiating into osteoblasts. 
It was found that PICP was produced between 5 and 15 days, when MSCs were 
cultured on HA in the bioreactor. In contrast, PICP was not detected until after 10 days 
in static culture. At this point, levels of PICP produced in the bioreactor were 
significantly higher than in static conditions (P<0.05), indicating that the bioreactor 
MSCs had been stimulated to differentiate into osteoblasts and synthesise extracellular 
matrix earlier. However, after 15 days, there was no significant difference between the 
amounts of PICP produced by cells in the bioreactor compared with the control, 
suggesting MSCs in static culture, had differentiated and also started producing 
extracellular matrix like those in the bioreactor. These results confirm the observations 
under TEM, whereby cells cultured in the bioreactor produced larger amounts of 
collagen matrix, earlier in culture. Although it was also demonstrated, by these results 
and under TEM, that MSCs cultured on HA in static culture would produce collagen, 
suggesting differentiation into osteoblasts as shown in Chapter 3. This differentiation 
occurred at a slower rate than when cultured in the bioreactor. 
4.4.4 Design of this bioreactor 
Suggested benefits of the use of my bioreactor in tissue engineering of bone include: 
1. A perfusion system which increased cell penetration through a scaffold and 
improved 3-d growth, 
2. Flow through the scaffold increased the efficiency of nutrient and waste 
exchange, allowing increased survival of penetrated cells, 
3. Peristaltic flow of medium simulating the physiological environment of 
bone, 
to stimulate the differentiation of MSCs into osteoblasts. 
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The aim of tissue engineering is to produce a tissue-like structure by growing cells on 
a scaffold that can be easily handled by a surgeon, for implantation as a graft to heal a 
tissue defect in a patient. Unlike previous bioreactors where the cell-scaffold 
constructs are moved, my bioreactor design enabled the stable housing of a 3-d 
scaffold, through which medium could perfuse. This produced suitable tissue-like 
osteoblastic cells, which could be differentiated from autologous or allogenic marrow 
cells. 
The increased rate of differentiation of MSCs into osteoblastic cells was suggested to 
be due to the simulation of the physiological environment of osteoblasts in living bone. 
However, the increased osteoblastic activity, measured by protein and extracellular 
matrix production may also have been due to the increased mass transfer in this 
system. Although in either case, the system increased differentiation, which was its 
overall aim. 
The flow through the bioreactor would not have been linear, as turbulence occurs when 
fluids flow through a tube and this would have been further increased by the presence 
of the scaffolds. The resulting shear forces generated within the bioreactor chamber 
would have had an effect on the cells, however the flow would still have increased the 
supply of nutrients to the cells. Furthermore, the penetration of cells through all 
surfaces of a porous HA increased, indicating that the turbulence did not adversely 
effect cell movement. 
4.4.5 Bioreactor for commercial use 
For this bioreactor to be used commercially, various additional points would need to be 
addressed. These include the assurance of the quality of the cell-scaffold constructs by 
monitoring the tissue grown for cellular structure and function to retain reproducibility. 
Indeed before commercial use for engineering graft material for patients, further 
animal studies would be needed to clarify the histological result of implanting such 
constructs into a bone defect. Further, for patient use the bioreactor components need 
to either have to be fully sterilised or disposable to prevent infection. The system 
should be automated as far as possible, but trained clinical staff would also 
be needed 
to operate the bioreactors. 
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CHAPTER 5 
Storage of Fresh Mesenchymal Stem Cells Isolated from Bone 
Marrow 
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5.1 INTRODUCTION 
5.1.1 Background to this chapter 
As shown in Chapter 2, human bone marrow is a source of mesenchymal progenitor 
cells (MSCs) which, following isolation, can be differentiated into osteoblasts under 
appropriate conditions in culture. Therefore, bone marrow can be used as a source of 
autologous osteoblasts for potential implantation on compatible osteoconductive grafts 
to fill bone defects. One such potential use of MSCs on a graft material (HA) was 
investigated in Chapter 3, where it was found that bone marrow-isolated cells cultured 
on HA differentiated into osteoblasts. This provides a basis for tissue-engineered bone. 
Furthermore, in Chapter 4 this tissue-engineered bone was shown to be improved by 
culture in my bioreactor. However, as these techniques rely on a source of MSCs 
isolated from bone marrow, either autologous cells from patients or allogenic from a 
donor, this chapter will investigate a means of preserving such cells. 
Cell viability can be maintained under culture conditions, but this is a labour intensive 
method of sustaining the cells' metabolic demands and, while in culture, the cells are 
also at risk of infection and biological variation due to genetic drift. So, to enable the 
clinical use of these tissue-engineering applications of MSCs, methods for storing the 
cells between harvest and delivery to the patient are necessary to avoid long-term 
tissue culture. As biological material has a limited shelf life and is open to 
contamination, simple refrigeration at 4°C is unsatisfactory, other methods of 
preserving and storing MSCs need to be investigated. One such method is 
cryopreservation which is an easy and effective means of storing biological material in 
liquid nitrogen as, below -120°C, cells have no metabolic needs and can therefore 
be 
stored for years. 
5.1.2 Cryopreservation 
Cryobiology is the study of life at low temperatures and cryopreservation is the 
maintenance of biological material in a state of suspended animation at cryogenic 
temperatures. The temperature of liquid nitrogen is -196°C and cells can 
be stored in 
this environment by the process of cryopreservation. This was first pioneered 
for the 
storage of spermatozoa in 1949 (Polge et al. 1949). Since then, cryostorage 
has been 
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found to be a suitable method of storage for a variety of living cells including cord 
blood, bone marrow, reproductive cells, and tissues such as skin, cornea and heart 
valves. Further research has made the current clinical practice of storing 
haematopoietic stem cells from autologous bone marrow possible, before engraftment 
following marrow ablation (Rowley SD 1992b). 
In cooling the cells to sub-zero temperatures cells are at risk of lethal freezing or cold 
shock - cellular damage induced by rapid cooling without protection. However, 
cryopreservation methods limit this (Morris et al. 1983) and can allow up to 95% of 
cells to recover after resuscitation. Viability of the cells is measured by their ability to 
function to the same degree as prior to preservation, for example to produce a protein 
to the same extent. 
Cryopreservation is a complex process that is still not fully understood, but follows the 
theory that cellular metabolism stops when all the water in the system is converted to 
ice (Rowley SD 1992b). It is the process of ice formation that needs to be controlled to 
prevent damage to the cells. During the process of cryopreservation, the temperature 
falls from 37°C to -196°C, and 95% of the cells' water can be lost. Concentrations of 
electrolytes increase both intracellularly and extracellularly, deforming cells, and ice 
can form inside cells disrupting the intracellular structures, rendering the cells non- 
viable. 
There are two main methods of cryopreservation: freeze-thaw, either by slow or rapid 
cooling, and vitrification (Walcerz & Karow 1996). 
5.1.2.1 Freeze-thaw - Slow cooling 
The aim of this method is to freeze the extracellular fluid without ice formation inside 
the cells. During the process of slow cooling, large changes in the solution 
concentrations occur with the effect of causing mass transfer between the intracellular 
and extracellular compartments, which can damage the cell membranes; freezing 
occurs in the extracellular fluid before the intracellular fluid, due to the former 
compartment being relatively dilute. As ice forms, water is removed from the 
extracellular fluid, increasing its concentration and causing water to move out of the 
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cells due to the osmotic pressure gradient. Slow cooling allows water to diffuse out of 
the cells, thereby maintaining the osmotic equilibrium during freezing, but resulting in 
cell dehydration and shrinkage, which, if the volume of a cell shrinks by greater than 
40%, can cause permanent cell damage. Therefore, the composition and temperature of 
these compartments must be carefully controlled throughout the process to avoid 
injury to the cells due to intracellular ice formation and solution affects. Cryoprotective 
agents (CPAs) and controlled cooling rates are used to achieve this. This slow cooling 
method with glycerol as CPA was used to cryopreserved the first cells (Polge et al. 
1949). 
5.1.2.2 Freeze-thaw - Rapid cooling 
In contrast, if the cell suspension is cooled rapidly there is no time for the solute 
concentrations to cause an effect and instead ice forms uniformly. However, this 
method increases the likelihood of water remaining within the cells, as freezing occurs 
rapidly without time for diffusion from the intracellular to the extracellular space. 
Thus, the concentration of the intracellular fluid remains low, increasing the formation 
of intracellular ice and cell rupture. 
5.1.2.3 Vitrification 
Vitrification is the process by which liquids solidify, or vitrify, without crystallization 
during cooling. This is a less complicated method of cryopreservation, but more 
difficult to achieve. The transition from a disorganised liquid into an organised crystal, 
such as ice, requires the molecules to align, which takes time. If the temperature is 
lowered rapidly, there is no time for crystals to form, thereby preventing the formation 
of ice throughout the cell suspension when cooled to liquid nitrogen temperatures. 
Therefore, this method causes minimal disruption to cellular organisation, as the lack 
of ice in the system means that solute concentrations will remain constant; there will 
be no mass flow and no changes in cell volume. 
However, to achieve this constantly, very high concentrations of CPAs are needed and, 
at these high concentrations, CPAs can have a toxic effect on cells. Therefore, the 
principal difficulty in designing vitrification procedures is finding a CPA that 
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permeates cell membranes in a mixture that is sufficiently concentrated to allow 
vitrification without being toxic. 
5.1.2.4 Cryoprotective agents (CPAs) 
CPAs are substances that protect cells against injury that result from the solidification 
of water and lipid during cryopreservation. They are water soluble, non-toxic to cells 
in lower concentrations and can be classified into two main types: those agents that 
permeate cells, including glycerol and dimethyl sulphoxide (DMSO), and those that do 
not, including starches and sugars. 
The exact mechanism by which these agents work is not fully understood. The first 
type of CPAs are most commonly used and work by diffusing across the cell 
membranes, increasing the concentration and reducing the freezing point of the 
intracellular fluid, thereby reducing the osmotic gradient across the cell membrane 
which otherwise causes cell dehydration and shrinkage. The increased solutes in the 
intracellular fluid also help to reduce the freezing point of the intracellular fluid, 
thereby further reducing the likelihood of ice forming within cells. Intracellular CPA, 
in addition to reducing the osmotic pressure across the cell membrane, also diffuses 
into cells replacing the volume of water lost by dehydration. As CPAs diffuse across 
the cell membranes at a slower rate than water, slow cooling allows time for the 
equilibrium of the fluids and reduces cell rupture. 
Other CPAs improve cryopreservation by remaining in the extracellular fluid, 
osmotically altering the compartments. This makes the extracellular fluid hypertonic 
relative to the intracellular concentration and therefore dehydrates the cells. The 
addition of CPAs to the extracellular fluid also reduces the freezing point of this 
fluid, 
allowing crystals to form slowly as the suspension is cooled. As the extracellular water 
freezes, the concentration of the fluid increases and so, draws more water out of the 
cells by osmosis. Severe cell shrinkage is therefore more likely to occur using 
CPA 
that remains outside the cells. 
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5.1.2.5 Cooling & Freezing 
The cell membrane is an effective barrier to ice formation therefore, if the CPA has 
diffused into the cell without damage to the membrane, ice will be excluded from the 
cells as the temperature is reduced. Ice forms as the extracellular fluid is cooled, 
increasing the concentration of the compartment. If the temperature is lowered slowly 
there will be time for water to diffuse out of the cells, maintaining the osmotic 
equilibrium. However, if the cooling rate is too fast, water is unable to diffuse out of 
the cells, causing cells to be supercooled and increasing the probability of intracellular 
ice formation and cell death. It has been proposed that susceptible cells will not survive 
direct transfer from 37°C to zero and need to be cooled slowly 1°C/min (Morris et al. 
1983). 
This suggests that slow cooling increases cell viability, but experiments have shown 
that very slow cooling can also be damaging. Survival rates as a function of cooling 
produces a bell-shape curve, with 0.5 to 2.5°C/min as the optimum. 
5.1.2.6 Resuscitation 
From the low temperature of liquid nitrogen in which cells are stored, cells are warmed 
quickly to above melting point to minimise the damage due to recrystallisation of 
extracellular fluid and devitritication - the growth of intracellular ice crystals. By 
rewarming the cells rapidly the time needed for crystal formation is avoided. However, 
if warming is too fast large osmotic gradients can be generated that cause large 
amounts of water movement across the membrane, damaging the cell. The optimum 
rate of rewarming to balance the risk of cell damage has yet to be established and 
further research is needed. 
CPA that has entered cells during their cooling also needs to be removed as, if it 
remains in the cells as the mixture thaws, the intracellular solute concentration will 
be 
greater than the extracellular, causing water to diffuse into the cells, resulting 
in 
swelling and cell rupture (the membrane is unable to stretch to any great 
degree). CPA 
is removed by the addition of warm medium in serial dilutions, allowing 
the CPA to 
diffuse out of the cells. Equilibration is necessary following each addition 
of medium, 
as CPA moves cross the cell membrane at a slower rate than water. 
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5.1.3 The method of cryopreservation used 
Current cryopreservation processes cannot be applied universally to all cell types, as 
each cell type has an optimum-cooling rate defined by the permeability of the cell 
membrane to water. Furthermore, as the ability of cells to tolerate increasing 
concentrations of CPA varies, the highest concentration of CPA tolerated should be 
used to provide maximum protection without toxicity, although increasing 
concentrations require more complex methods of dilution on resuscitation for removal 
of CPA. Therefore, the method of cryopreservation used needs to be investigated for 
each cell type to determine protocols that allow maximum cell viability following 
resuscitation. This chapter studies the effect of cryopreservation on MSCs using two 
similar methods, with the only difference between them being the rate of cooling of the 
cells suspended in CPA. Comparing the specific effects of different types of 
cryopreservation is outside the remit of this chapter and requires further investigation. 
In previous experiments, haematopoietic stem cells present within umbilical cord 
blood were first concentrated to reduce the volume that needs to be stored and then 
cryopreserved, with good cell recovery rates (Quillen & Berkman 1996). As MSCs are 
similarly present in very low density in bone marrow, in my study the fraction of 
marrow containing these cells will be separated using the Ficoll® separation method, 
as described in Chapter 2, prior to cryopreservation, also reducing the storage space 
required. 
Furthermore, erythrocytes (red blood cells) present in bone marrow do not behave like 
mononucleated cells during cryopreservation and, following this process, if 
reimplanted into humans, can cause a toxic reaction proportional to the concentration 
of CPA used (Rowley SD 1992a). Although in my study, the number of erythrocytes 
that were cryopreserved was reduced by using Ficoll® separation, further means of 
removing erythrocytes may be necessary before the cells were implanted 
into patients 
to prevent such a toxic reaction. This could be achieved by culturing the resuscitated 
cells in vitro, as erythrocytes and cells containing CPAs do not survive 
in these 
conditions. 
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Due to the acknowledged low density of MSCs in bone marrow, to obtain a sufficient 
number of cells for tissue engineering applications, it would also be necessary to 
culture expand the MSCs. Thus, the bone marrow fraction, containing MSCs, would be 
resuscitated before the patient needed the engineered tissue-graft. Cells would be 
culture expanded and seeded onto the osteoconductive scaffold, where the cells would 
adhere and produce extracellular matrix. Following which the graft would be 
implanted. 
A further advantage to cryopreservation storage of freshly isolated MSCs is that it 
provides a store of cells, if the primary culture becomes infected during expansion, 
preventing the need for a second bone marrow aspirate to be harvested in this situation. 
Therefore, in this chapter, a study was made of whether MSCs can be stored 
immediately after harvesting without loss of viability. 
In this study, the method of cryopreservation involved the use of a CPA that diffuses 
into the cells to protect them during the freezing process. The vitrification process was 
not used in this study, as it requires high concentrations of CPA, which can be toxic to 
cells. Further, as CPA toxicity increases with time and increased temperature, in my 
method, exposure of the cells in the freezing mixture to room temperature was kept to 
a minimum. 
As noted above, it is necessary to keep a balance in the slow cooling method, between 
cooling too slowly or too quickly. Although a longer cooling time reduces cell 
damage, this is in direct conflict with the need to limit cell exposure at higher 
temperatures to reduce CPA toxicity. As a result, two slightly different procedures of 
cooling MSCs were used in two experiments in this chapter. The first cooled the 
samples quickly to -70°C following the addition of CPA. Although this minimises 
the 
exposure time and reduces the toxic effects of CPA, it increases the risk of intracellular 
ice formation due to the speed of cooling. In the second method the cell mixture was 
cooled slowly allowing osmotic equilibration, which reduced the risk of ice forming 
within the cells, but increased the exposure time and potential for toxicity of CPA. 
Lastly, DMSO was the CPA used in my study, as it has been found to 
be most 
effective, producing rapid diffusion into cells (Walcerz & Karow 
1996). It is a by- 
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product of paper manufacturing and is a hydroscopic polar compound that is also used 
as a solvent for insecticides. On resuscitating the cells in this study, the cryovials were 
warmed in air rather than in a water bath, to allow warming without large osmotic 
shifts and crystal formation. 
5.1.4 In this chapter 
The aim of the studies in this chapter was to determine whether cryopreservation could 
be used to store bone marrow-derived MSCs before transplant and to determine 
whether this method of storage has any effect on proliferation rate and osteogenic 
potential of the MSCs. Cryopreservation was performed immediately after bone 
marrow aspiration and the results were compared with a control from each patient 
sample that was cultured from the time of harvest. After resuscitation the behaviour of 
the cell cultures in vitro was observed and compared against the control. Following 
this, serial proliferation rate after each of 4 passages was compared between cells that 
had been cryopreserved and the control. For MSCs to be useful for the tissue 
engineering of bone, the method of storage should not affect the differentiation ability 
of the cells into osteoblasts, thus this was also tested. 
5.1.5 Hypothesis 
Human MSCs can be cryopreserved and stored as a fresh bone marrow aspirate with 
no loss of cell proliferation or differentiation into osteoblasts. The three specific 
hypotheses tested in this chapter were: 
1. Bone marrow aspirate fractions can be stored by cryopreservation and 
successfully resuscitated to produce viable MSCs to grow in vitro. 
2. Cryopreservation does not affect the MSCs ability to differentiate 
into 
osteoblasts when stimulated in culture by OS, as compared to cells 
in standard 
culture. 
3. Cryopreservation does not affect the proliferation rate of MSCs after 
resuscitation. 
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5.2 MATERIALS and METHODS 
5.2.1 Materials 
Cell culture materials as Chapter 2 
Dimethyl sulphoxide (Sigma D2650) 
Freezing container Nalgene (Sigma C 1562) 
Cryovials (Nunc 343958) 
Isopropyl alcohol (BDH Chemicals) 
ALP, osteopontin, osteocalcin and DNA assays as Chapter 2 
Alamar blue assay as Chapter 3 
5.2.2 Bone marrow aspiration and cryopreservation 
Two experiments were conducted in this chapter, using different methods of 
cryopreservation, which varied the rate of slow cooling of the cell suspensions. For 
these experiments, bone marrow aspirates were taken from fifteen patients - ten 
aspirates were used for Experiment 1 and 5 for Experiment 2. In both cases, each 
patient's bone marrow aspirate was divided into two halves, from which the fraction of 
marrow containing MSCs was isolated by the process of Ficoll® gradient separation, 
using methods described in Chapter 2. Two cell pellets were thus generated from each 
aspirate. One pellet was cryopreserved, while the other was seeded in a culture flask as 
a control. 
5.2.3 Experiment 1 
5.2.3.1 Cryopreservation Method 
5.2.3.1.1 Storage 
From each of the 10 bone marrow aspirates, one of the cell pellets was resuspended 
in 
lml of freezing mixture (10% DMS0 in foetal calf serum) using a 23G needle. The 
cell suspensions were then transferred to cryovials and placed in a -70°C 
freezer for 24 
hours, following which the vials were transferred to liquid nitrogen for a 
further 7 
days. 
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5.2.3.1.2 Resuscitation 
The vials were removed from the liquid nitrogen and placed in the incubator at 37°C 
until the ice had almost thawed, at which point they were transferred to the laminar air- 
hood. An equal volume of lml of medium, warmed to 37°C, was initially added to 
each vial of cells and the suspensions were mixed through 23G needles. They were 
then left for 1 minute to allow temperature equilibration and this was done between 
each addition of medium. Following addition of the first ml of medium, the cell 
suspensions were transferred to a universal container, where 2ml and then 4m1 of 
warm medium were added until a volume of 8ml was reached. The cell suspensions 
were centrifuged at 2000rpm for 5 minutes, resulting in the reformation of cell pellets. 
These were resuspended in 2m1 of medium and transferred to culture flasks. 
5.2.3.2 Cell culture 
The primary cultures from each aspirate (the control) and the resuscitated 
cryopreserved MSCs were grown at 37°C and 5%CO2 in monolayer until confluent. 
Initially, to assess the cryopreservation method of the bone marrow isolated cells, cells 
that had been resuscitated were observed under light microscopy and photographs were 
recorded. 
To assess the effect of this method of cryopreservation, cells that had been 
cryopreserved and the control cells were cultured following the scheme detailed in 
figure 4.1 a and 4.1 b. The cells reached confluency at 5 days, at which point they were 
passaged, counted and seeded in well plates for biochemical and Alamar blue assays, 
to assess proliferation and osteoblastic differentiation (see figure 4.1). The remainder 
of the cells were then divided into 2 flasks, one continued to be cultured in standard 
medium and the other in OS. 
5.2.3.3 Assessment of differentiation of MSCs into osteoblasts 
5.2.3.3.1 ALP 
The effect of cryopreservation on the potential differentiation of 
MSCs down the 
osteoblastic lineage was assessed, by culturing the cryopreserved and control 
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Figure 4.1a: The culture scheme followed for Experiment 1, by the control population of 
MSCs 
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Figure 4.1b: The culture scheme followed for Experiment 1, by the cryopreserved 
population of MSCs 
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populations with OS as compare to standard medium and measuring the production of 
osteoblastic protein markers by each sample of cells. 
In Experiment 1,15 sets (5 patients, 3 samples for each) of 10,000 cells were cultured 
for each time point: 5 and 15 days following passage 2 (P2), and 5 days following P4, 
for both conditions: osteogenic or standard medium, for both populations: 
cryopreservation compared with the control (see figure 4.1). The ALP protein 
production divided by total DNA content for each sample was measured using assays 
described in Chapter 2. 
5.2.3.3.2 Osteocalcin 
The production of osteocalcin/DNA was measured on 10 sets (5 patients, 2 samples for 
each) of 10,000 cells cultured in either OS or standard medium for 15 days after P2. 
This was repeated for cells that had been cryopreserved, to assess the effect of 
cryopreservation on MSCs differentiation resulting from culture with OS (see figure 
4.1). The assay used to measure osteocalcin was described in Chapter 2 Method. 
5.2.4 Experiment 2 
5.2.4.1 Cryopreservation method 
5.2.4.1.1 Storage 
For the second experiment the method of cryopreservation was revised, with the cell 
suspension in DMSO freezing mixture being cooled at a rate of -1 °C/minute to -70°C. 
This was achieved by placing the cryovials in a Nalgene® freezing container 
containing isopropyl alcohol in the base, for 24 hours in the -70°C freezer before 
transfer to liquid nitrogen. 
5.2.4.1.2 Resuscitation 
After 7 days in liquid nitrogen cells were resuscitated using the same process for 
Experiment 1. 
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5.2.4.2 Cell culture 
The primary cell aspirate and cryopreserved populations were cultured as for 
Experiment 1. Both populations of cells were culture expanded up to P3, following 
which MSCs were grown in well plates for biochemical assays. The number of cells 
used in each sample in Experiment 1 was small and on analysis of the results it was 
felt that this could explain the lack of osteocalcin detected so in Experiment 2,200,000 
cells were seeded per well. 
5.2.4.3 Measures of differentiation of MSCs into osteoblasts 
5.2.4.3.1 ALP 
Ten samples (5 patients, 2 repeats for each) of 200,000 MSCs, from P3 were cultured 
for 7,14 and 21 days in either OS or standard medium (see figure 4.2). Following 
which ALP/DNA content was measured, as in Experiment 1 and compared between 
the cryopreserved and control populations for each condition. 
5.2.4.3.2 Osteopontin 
Osteopontin protein levels were measured after 14 days in OS compared with standard 
conditions, for both cryopreserved and control MSCs (see figure 4.2), using the 
method described in Chapter 2. A similar ten samples to those used in the ALP study 
were used (see 5.2.4.3.1). 
5.2.5 Assessment of cellular proliferation rate 
5.2.5.1 Alamar blue assay in Experiment 1 
To assess quantitatively the proliferation rate of MSCs, Alamar blue assays were 
performed on cryopreserved and control cells in standard culture, after each passage 
until the fourth. Thus, for each of the 10 patients aspirates, 6 wells with 10,000 cells 
(total 60 samples) in each were cultured, as shown in figure 4.1. As Alamar 
blue is 
non-toxic to cells in culture, the assay was performed serially after days 1,5 and 
15 
following each passage in Experiment 1 (for details of the Alamar blue assay see 
Chapter 2 Method). 
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Figure 4.2: The culture scheme followed for Experiment 2, by the control and 
cryopreserved population of MSCs. 
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5.2.5 Statistical tests 
The results from MSCs that had been cryopreserved were compared with cells that had 
been cultured directly following aspiration. Statistical test were used to assess the 
distribution of the results and Kolmogorov-Smimov and Shapiro-Wilk tests shows that 
the results did not follow a normal distribution. As a consequence, non-parametric 
statistical tests were used to analysis the data. These were performed to compare the 
effect of cryopreservation on osteoblastic protein production following the addition of 
OS to the culture and the proliferation rate of the cells as measured by Alamar blue. 
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5.3 RESULTS 
5.3.1 Assessment of Cryopreservation storage methods 
5.3.1.1 Light microscopy observations 
Both control and crvopreserved MSCs were observed to grow in culture, behaving in a 
similar manner. In primary culture the MSCs resembled spindle-shaped fibroblasts in 
morphology (see ligure 43), formed colonies and became confluent after a similar 
time in culture, 12 14 days, irrespective of cryopreservation. 
Figure 4.3: Light microscopy pictures of MSCs from one of the control samples. after 
14 days in culture, bar -- 200µm. 
1i 
5.3.2 Osteoblastic differentiation potential following cryopreservation 
5.3.2.1 Light inicroscopi, observations 
Following the addition of OS a change in morphology was noted 
in both the 
eryoTreserved and control cultures. with the cells becoming smaller and 
less spindle- 
like (see 1igture 4.4). 
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Figure 4.4: Light microscopy pict 
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5.3.3 Measurement of Osteogenic differentiation potential - 
Experiment I 
5.3.3.1 ALP protein production 
For both the crvopreserved and control populations, ALP production was measured 
quantitatively and the amount produced by MSCs cultured in OS was compared with 
standard medium. As the results did not follow a normal distribution, non-parametric 
tests - Mann Whitney U were applied, unless otherwise stated, this was the case ti)r all 
statistical comparisons in this chapter. 
The production ofALP/UNA was significantly greater for MSCs cultured with OS 
compared with the control standard medium. for both the crvopreserved and control 
Populations at each time point measured (P<0.005), (see figure 4.5). 
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The increase in ALP/DNA production for the cells cultured in OS in excess of in 
standard medium was calculated for each time point, by measuring the ALP/DNA for 
the MSCs grown in OS minus the ALP/DNA for the corresponding control. Hence, the 
effect of cryopreservation on the increased production of ALP by cells stimulated by 
OS could be assessed. There was not found to be a significant difference in the 
increase in ALP/DNA between MSCs that had been cryopreserved compared with the 
control (P>0.05), (see figure 4.6). 
Figure 4.5: A box plot showing the production of ALP/DNA for both cryopreserved 
and control cells, when MSCs were cultured in OS compared to standard medium 
(DM), *P<0.005 (0 outliers). 
10000 - 
a) 
E 
75.00 - 
D 
C 
O* 
n 
50.00 -* 
CL 
x as * z 
2500 -- 
000 - 
"UUiUUU NNNNVCCVNNNä 
CL aaanQaaQ. nd 
cri cri uý ui Ui vi 
'r 
mmcmmmm cv >m 
vvcvvcvvDV1V 
(6 Mý C6 (6 vi Ö0000O0p0 (n vi D0 
ä0 75 °°ö° 
z U0 O000V00 U 
culture conditions and time 
248 
Chapter 5 Results 
Figure 4.6: Box plot showing the increase in ALP/DNA for cells cultured with OS 
above standard conditions (OS - DM), comparing between MSCs that have been 
cryopreserved and the control populations, # P>0.05, (° outlier). 
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5.3.3.2 Osteocalcin protein production 
In this study 10,000 MSCs were cultured with and without OS for 15 days for both the 
cryopreserved and control cells. However. the readings obtained from the 
radioimmunoassay were below the reference range, so no statistical tests could be 
performed on the results. 
5.3.4 Measurement of Osteogenic differentiation potential - 
Experiment 2 
5.3.4.1 ALP protein production 
In Experiment 2a larger number of cells (200,000) were cultured for each sample, 
for 
the cryopreserved MSCs compared to the control, for different time periods, 7,14 and 
21 days, with and without OS. The ALP/DNA production increased when MSCs were 
cultured with OS compared with standard medium, for both the cryopreserved and 
control cells (P<0.005 for day 7 and 14 and P<0.05 for day 21 cryopreservation 
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group), (see figure 4.7). These results indicated that MSCs were producing more ALP 
when stimulated by OS, irrespective of whether they had been cryopreserved. 
Figure 4.8 shows the calculated increase in ALP/DNA production when then cells 
were cultured with OS, comparing the cryopreserved and control MSCs, after each 
time period. Similarly to the results for Experiment 1, the increase in ALP/DNA 
production when MSCs were cultured with OS was calculated. There was no 
significant difference in the increase in ALP/DNA with OS, between the cryopreserved 
and control MSCs (P>0.4), (see figure 4.8). Therefore, cryopreservation does not effect 
the increased production of ALP associated with culture in OS. 
Figure 4.7: A box plot showing the production of ALP/DNA when the MSCs were 
cultured in OS compared with standard culture (DM). The difference after each time 
interval measured was found to be significant, * P<0.005, AP<0.05, (° outliers) for both 
cryopreserved and control populations. 
1500.00 
1000.00 - 
J 
Z 
500.00 - 
J 
0.00 
C mwm 
mim 
l0 l0 W0T 
00 
* 
__ 
ýý 
N N 
T T T T 
V V im im 
Uý cd :i 6 O o 0 0 0 
Q p p O 
C () V 
C 
0 
U 
0 
U 
culture conditions and time 
*1 n 
N fV 
N 
cc 
va 
0 0. 
Ö0 
0V 
250 
Chapter 5 Results 
Figure 4.8: Box plot showing the increase in ALP/DNA for cells cultured with OS 
above standard conditions, comparing cryopreserved cells with the control population 
# P>0.4, (° outliers). 
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5.3.4.2 Osteopontin protein production 
Osteopontin protein synthesis was measured as a marker of cell function to compare 
the effect of cryopreservation on MSCs. There was no significant difference in the 
production of osteopontin/DNA following cryopreservation as compared with the 
control, after 14 days in either OS or standard culture conditions (P>0.5), (see figure 
4.9). 
Although the production of osteopontin was observed to increase when the MSCs were 
cultured in OS compared with standard conditions for 14 days, the difference was not 
found to be significant, for either the cryopreserved or control MSCs (P<0.05). 
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Figure 4.9: Box plot showing the production of osteopontin/DNA by MSCs 
comparing cryopreservation with the control; no significant difference between these 
two groups (# P>0.2), for either standard medium (DM) or OS, (° outlier). 
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5.3.5 Assessment of Proliferation rate - Experiment 1 
5.3.5.1 Alamar blue assay results 
The alamar blue absorbance increased over the 15 day time period for culture (see 
figure 4.10). Therefore, each sample of cells increased in proliferative activity over the 
culture period. 
Figure 4.10 shows the comparative absorbance of alamar blue between the 
cryopreserved and control MSCs over 15 days in standard culture conditions, 
following passages 1-4 (P 1-4). There was no significant difference in alamar blue 
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absorbance between the cryopreserved and control MSCs, after 15 days in culture 
following each passage tested (P>0.05). In addition to this, there was no significant 
difference after 5 days in culture following PI, 2 and 4 (P>0.05). 
After 1 day in culture following P 1, the absorbance of alamar blue was significantly 
greater for MSCs that had not been cryopreserved (P<0.05). However, following P2,3, 
and 4, the absorption was significantly greater, after I day in culture, for the MSCs that 
had been cryopreserved (P<0.05), (see figure 4.10). 
Figure 4.10: Alamar blue absorbance over 15 days in culture, following passages 1- 
4 in standard medium, comparing the effect of cryopreservation; no significant 
difference between cryopreserved MSCs and the control, # P>0.05. 
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5.4 DISCUSSION 
For MSCs to be used for tissue engineering applications, a reliable source of bone 
marrow-isolated cells is needed. Cryopreservation was tested in this chapter as a 
method of storing MSCs in liquid nitrogen for 7 days. If this method was to be used 
clinically for cell storage, especially if allogenic cells could be used clinically and a 
bank of MSCs created, the cells would need to be kept for longer than 7 days prior to 
use. However, it is the processes of freezing and resuscitating cells that put the cells at 
risk of damage. While cells are in liquid nitrogen storage they are stable and the only 
risk is to the DNA from background radiation, the effect of which occurs over a 
number of years. Therefore, similar results would be expected if the MSCs were stored 
by cryopreservation for months rather than days. 
5.4.1 Effect of cryopreservation on observations of cells in culture 
The first hypothesis in this chapter stated that, following isolation from bone marrow, 
MSCs could be stored by cryopreservation and successfully resuscitated. This was 
indicated to be the case, as every cryopreserved aspirate was resuscitated successfully 
and grown in cell culture. 
The cells in this study were observed to behave similarly in culture to those described 
in the literature (Friedenstein et al. 1970; Lazarus et al. 1995). Under light microscopy, 
each MSC sample was observed to have followed an identical pattern irrespective of 
cryopreservation, whereby MSCs in both sets of primary cultures formed colonies, as 
described in Chapter 2. It was this phenomenon, noted first by Friedenstein that caused 
him to name these cells as a separate cell type, `Colony Forming Units- Fibroblastic', 
(Friedenstein 1976) and indicates the stem cell nature of MSCs (see Chapter 1). In 
addition, both populations of cells grew at similar rates becoming confluent after an 
equal time period in culture following each passage. 
Although, as stated above, every cell sample was successfully resuscitated following 
cryopreservation, it was not possible to measure the percentage of cell survival, as this 
would require the number of viable MSCs to be counted and compared, 
before and 
after cryopreservation. While Ficoll separation reduced the volume of cells other than 
MSCs present in the marrow, it does not remove all the erythrocytes. 
As a result of 
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this, a relatively large numbers of erythrocytes obscured the MSCs when the marrow 
fraction was placed on a haemocytometer and consequently, MSC cell counts could 
not be reliably obtained. 
Therefore, in order to measure accurately the percentage of viable MSCs, before and 
after the cryopreservation process, a specific cell marker would need to be used to 
count functioning MSCs. Stro-1 is one such marker that could be used in combination 
with a cell sorting method (Simmons & Torok-Storb 1991). 
Alternatively, changes in cells viability following cryopreservation can be measured by 
observation of changes in cell function, such as protein production or proliferation 
rates. This measurement is more relevant to the potential clinical use ofMSCs, where 
the cells need to maintain their ability to differentiate into osteoblasts. MSCs must also 
maintain their capacity for self-renewal to replace cell loss due to cryopreservation, 
compensating for this when the cells are expanded in culture after resuscitation and 
seeded onto a scaffold for tissue engineering uses. Therefore, differentiation into 
osteoblasts and proliferation potential were also measured in this study. 
5.4.2 Conclusions from assessment of osteoblastic potential following 
cryopreservation 
5.4.2.1 Light microscopy 
Irrespective of cryopreservation, the morphology of the MSCs cultured with OS was 
observed to change and become consistent with the shape of osteoblasts (Aubin & Liu 
1996; Holtrop 1990). This change in cell shape and size was not delayed for the cells 
that had been cryopreserved when compared with the control. Therefore, these 
observations were evidence that the process of cryopreservation did not effect 
osteoblastic differentiation of MSCs. However, morphology alone is a relatively poor 
marker of cell type and other markers of osteoblasts were measured for both 
populations. 
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5.4.2.2 ALP 
ALP protein levels have been used previously in my thesis as a quantitative measure of 
osteoblastic differentiation (see Chapter 2). There was found to be a significant 
increase in ALP protein synthesis by MSCs cultured in OS compared with standard 
medium for all cryopreserved and control MSCs (P<0.005), which is consistent with 
the findings in Chapter 2. This was found for both Experiments 1 and 2, where slightly 
different cryopreservation methods had been used and the number of cells seeded and 
culture periods were varied. Therefore, cryopreservation does not have a significant 
affect on the production of ALP when MSCs are stimulated by OS. 
In Experiment 1, the effect of osteogenic culture conditions was also assessed after 
passage 2 and 4, and a significant increase in ALP was noted on addition of OS 
compared with standard culture, irrespective of passage number or cryopreservation. 
Hence, after both passages 2 and 4 MSCs maintain their osteogenic potential, as 
measured by ALP, regardless of this method of slow cooling cryopreservation. 
Furthermore, in Experiment 2, when a different cooling method was used and the 
temperature was reduced by 1 °C/minute prior to cryopreservation, the same 
relationship was found, whereby ALP levels increased significantly when the MSCs 
were cultured in OS over the 15-day culture period, for both the cryopreserved and the 
control MSCs. 
For both cryopreservation methods, the increase in ALP synthesis when MSCs were 
cultured in OS over the matched standard medium control was calulated. The increase 
in ALP indicates osteoblastic differentiation and was used to assess the effect of 
cryopreservation on the ability of MSCs to differentiate into osteoblasts. There was not 
found to be any significant difference in the increase in ALP when MSCs had been 
cryopreserved prior to culture (using either method from Experiments 1 or 2), 
indicating the same potential for osteoblastic differentiation. 
5.4.2.3 Osteopontin 
Osteopontin is a protein produced by osteoblasts during bone matrix 
deposition 
(Nakase et al. 1994), (see Chapters 1 and 2). Therefore, the synthesis of this protein 
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was measured to assess the effect of cryopreservation on the cellular function of 
MSCs. After 14 days, there was not found to be any significant difference in the 
expression of osteopontin between the MSCs that had been cryopreserved and the 
control population, cultured in either OS or standard conditions (P>0.5). 
However, there was not found to be a significant increase in the production of 
osteopontin when the MSCs were cultured with OS as compared with standard 
conditions, for either the cryopreserved or control MSCs. In comparison, it was 
reported in Chapter 2 that, after 14 days in OS culture, a significant increase in 
osteopontin production was seen (P<0.005). Conversely, in that study a larger cell 
seeding density of 250,000 rather than 200,000 cells was used. The larger cell number 
would have caused the cells to become confluent more rapidly, which may have 
allowed earlier deposition of extracellular matrix, resulting in observed greater 
osteopontin production. 
In Chapter 3, osteopontin production was measured after MSCs had been cultured for 
14 and 28 days on HA. By the 28-day point, the osteopontin measurements were 
significantly greater than at the earlier point (P<0.05). Therefore, further to the 
experiments performed in this chapter, a larger number of cells would need to be 
cultured over a longer time in order to allow OS to stimulate MSCs to differentiate 
sufficiently to produce significantly greater amounts of osteopontin. 
Nevertheless, for the culture conditions used in this chapter, it was observed that 
cryopreservation had no significant effect on the function of the cells measured by 
production of osteopontin, thus supporting the hypothesis that cryopreservation does 
not affect the MSCs ability to differentiate into osteoblasts in vitro. 
5.4.2.4 Osteocalcin 
Osteocalcin is an extracellular protein involved in binding calcium to the extracellular 
matrix during the mineralisation phase, and is therefore a marker of mature osteoblasts 
(see Chapters 1 and 2). In this study, 10,000 MSCs were cultured with and without OS 
for 15 days. 
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The small number of cells seeded and short culture period, compared with Chapter 2, 
where osteocalcin was found to be produced after culturing 250,000 MSCs in OS for 
28 days, may explain why the osteocalcin levels were below the reference range in this 
study. To investigate this further, the experiment would need to be repeated using a 
greater seeding number of cells and longer culture period. 
5.4.3 Conclusions from cellular proliferation rate assessment 
following cryopreservation 
5.4.3.1 Alamar blue 
The effect of cryopreservation on the proliferation rate of the MSCs was assessed 
using Alamar blue assays. Alamar blue is an indictor of cellular redox state, as 
metabolic activity of cells in culture causes the dye to change colour, the degree of 
which can be measured, equating to the proliferation rate of the cells (see Chapter 3 
Discussion). 
In this study, the absorbance of Alamar blue was measured for both the cryopreserved 
and control MSCs on 6 wells from each of 10 patients' samples, resulting in a total of 
60 samples for each 15 day period of culture, following passages 1 to 4. In all samples, 
Alamar blue absorbance increased over 15 days, indicating that MSCs from both 
populations continued to proliferate over the culture period. 
Although after day 1 following the first passage the Alamar readings were significantly 
greater for the MSCs that had not been cryopreserved (P<0.05), there was no 
significant difference in absorbance between the populations after day 5. It has been 
shown previously that cryopreservation had a negative effect on proliferation of 
chondrocytes until day 7 (Rendal-Vazquez et al. 2001). As it was not possible to count 
the number of resuscitated MSCs using a haemocytometer (see above), the Alamar 
blue assay could not be performed until after the first passage when comparative 
samples could be assembled. However, it seems that the initial period of relative 
inactivity of the cryopreserved MSCs was brief. 
In contrast, subsequent to each passage 2 and 4, it was observed that, after 
1 day in 
culture, the Alamar absorbance was significantly greater for MSCs that 
had been 
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cryopreserved. It has been shown that cryo-resuscitation can induce a stress response 
in fibroblasts that can trigger a compensatory release of growth factors (Liu et al. 
2000). Such a response by cells to release growth factors may explain an increase in 
proliferation within the first few days following cryo-resuscitation of MSCs, but for 
the difference to have persisted over 4 passages modification would need to be 
inherited. In bovine retinal pigment epithelial cells, cryopreservation has been found to 
alter DNA (Basu et al. 1983), whereby the genotype of the cell could be changed. 
However, an increase in Alamar absorbance was not observed after passage 1 and did 
not continue after day 1 following each passage 2 and 4, and therefore is less likely due 
to a change in the cells as a result of cryopreservation and more likely to have occurred 
as a result of the passage itself or an unseen variation in the method used to assemble 
the cells for the experiment. Although, to clarify these observed changes further 
research comparing gene expression following cryopreservation compared with a 
control is necessary. 
In my study, cryopreservation did not reduce the proliferation rate of MSCs after 5 
days in culture following passage 1,2 and 4, as measured 
by Alamar blue. 
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6.1 DISCUSSION 
6.1.1 Conclusions from this thesis 
In my thesis the isolation of MSCs from human bone marrow aspirates and their 
suitability for use in tissue engineering of bone was investigated. In order for these 
cells to be useful, their potential for osteoblastic differentiation needed to be 
demonstrated. It was suggested that HA would encourage such differentiation (Furlong 
& Osborn 1991; Yoshikawa et al. 2000), (see Chapter 3 Introduction) and thus MSCs 
were cultured on porous HA scaffold. Having confirmed that the cells indeed 
differentiated down the osteoblastic lineage, this capability was tested further in my 
novel bioreactor and storage methods for the cells were also investigated. 
In Chapter 2 it was shown that a population of cells could be isolated from human 
bone marrow aspirates and grown in culture. Stro-1 positively identified the marrow- 
isolated cells and its expression was observed to decrease as the cells were stimulated 
to differentiate into osteoblasts, indicating that it was a primitive marker. Although 
Stro-1 has been suggested as a reliable marker of MSCs (Gronthos et al. 1994; 
Simmons & Torok-Storb 1991), it should be acknowledged that there are difficulties in 
finding consistent markers for stem cells due to the cells changing phenotype, in 
response to their environment. 
It was also shown, in Chapter 2, that the isolated cells could be stimulated to 
differentiate into osteoblasts, chondrocytes and adipocytes, thus confirming their 
multipotency. However, as histological stains were used to identify the differentiated 
chondrocytes and adipocytes, this only allowed observational identification. 
Furthermore, the substance stained to identify chondrocytic cells was organised 
collagen extracellular matrix, which is not totally specific to collagen type II or to this 
cell type. However, as my thesis involved the tissue engineering of 
bone, the 
occurrence of osteoblastic differentiation was clarified further using additional 
phenotypic markers. 
It was then shown that marrow-isolated cells produced significantly more 
ALP and 
osteopontin when cultured with OS. These proteins are 
known to be produced by 
263 
Chapter 6 
osteoblasts, but production is not specific to this cell type. Osteocalcin is specifically 
produced by osteoblasts and this was only produced when the MSCs were cultured 
with OS, thus confirming osteoblastic differentiation. 
The small number of colonies that were cultured from each aspirate confirmed the low 
density of MSCs within the bone marrow. Large cell numbers are required for tissue 
engineering, so it was important to establish the capacity for MSCs to proliferate. 
Cell proliferation was assessed using several methods, in my studies. DNA levels 
within samples were measured using Hoechst assay and, as the amount of DNA within 
a cell is constant, this was used to assess cell number. Although the assay does not 
distinguish between DNA from alive and dead cells, debris from dead cells would be 
removed with cell washes. Alamar blue assays were also used as a measure of 
metabolic activity of cells in culture over time, thus giving an indication of 
proliferation over a culture period (Ahmed et al. 1994; Nakayama et al. 1997). A 
simple method of assessing cell proliferation is to count the number of cells and this 
was done to assess growth on HA scaffolds. However, small errors in counting when 
multiplied can have a large effect on the results so, although this is the most direct 
measurement of proliferation it was not applied to other parts of my study. 
In order to generate tissue-engineered bone for implantation into patients, cells that are 
committed to the osteoblastic lineage need to be grown on a substrate. In Chapter 3 the 
tissue engineering of bone was explored using marrow-isolated MSCs, as these cells 
can be differentiated into osteoblasts as demonstrated in Chapter 2. As HA is the major 
constituent of inorganic bone, an HA surface was investigated as a substrate on which 
to grow MSCs. It was found that MSCs grown on this surface produced significantly 
greater amounts of ALP and osteopontin; both indicators of cell differentiation down 
the osteoblastic lineage. Additionally, the cells produced osteocalcin, indicating that 
MSCs differentiated into osteoblasts. This differentiation occurred without the 
osteogenic stimulants that were needed in monolayer as shown 
in Chapter 2. 
Various factors may explain my findings of osteoblastic differentiation of MSCs on 
HA. HA promotes the formation of an apatite layer on its surface, as a result of HA 
dissolution. Thus, as the extracellular matrix produced by osteoblasts 
is mineralised to 
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produce an apatite, it is likely that the extracellular matrix proteins produced by the 
differentiating cells attach to HA. Secondly, when HA alone is implanted at extra- 
skeletal sites in vivo, bone has been noted to form (Ripamonti 1996; Yamasaki & Saki 
1992; Yuan et al. 1999), which suggests that HA may be osteoinductive when 
influenced by growth factors. Furthermore, HA with a rough surface has been shown 
to promote bone formation in vivo (Yuan et al. 1999). These factors may have 
stimulated the differentiation of MSCs into osteoblasts. The effect of HA is seen in 
patients as bone binds directly onto HA coated prostheses (Furlong & Osborn 1991; 
Okumura et al. 1997). 
A 3-d structure is needed to construct a suitable graft for tissue engineering and as HA 
was shown to stimulate osteoblastic differentiation, a porous HA scaffold was 
investigated. Under SEM, MSCs were shown to cover the surfaces of the HA scaffold, 
attaching and proliferating on the surface. Evidence for MSCs binding to the HA was 
observed by the large numbers of cell processes attaching the MSCs to HA, seen under 
SEM and TEM in Chapter 3. The production of osteoblastic proteins, such as 
osteopontin, osteocalcin and ALP, by the MSCs cultured on HA scaffolds increased 
over the 15-day culture period indicating differentiation into osteoblasts. The micro- 
pores on the scaffolds' surface measured approximately 10µm, which is similar in size 
to canuliculi-lacunar structure within cortical bone (Qin et al. 1999). This may imitate 
the physiological environment and act as a further trigger for the attachment and 
differentiation of MSCs, although further work is needed to confirm this. 
Investigations of cells cultured in vitro have traditionally used a 2-d environment. In 
these conditions the cells attach themselves and orientate in one direction on the 
culture surface. However, this is artificial when compared with the growth of cells in 
vivo. For example in bone, osteocytes are attached to other cells by long processes and 
are surrounded by extracellular matrix. The replacement of diseased tissue requires a 
biological structure similar to that of the original. Therefore one of the goals of tissue 
engineering is the formation of 3-d cell constructs. 
Therefore, to tissue-engineer a bone graft for clinical use, the cells need to penetrate 
through the scaffold growing in an orientated manner on every surface, thereby 
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forming a 3-d construct like cells within the Haversian system of cortical bone. 
Furthermore, as a large constituent of bone is extracellular matrix, the cells need to 
produce this. In the design of my novel bioreactor the flow of fluid through living bone 
was simulated through the HA scaffold. This was found to increase cell penetration, 
measured by cell counts, differentiation tested by osteoblastic protein levels and 
extracellular matrix production, assessed by pro-collagen assays and TEM. The use of 
my bioreactor resulted in constructs that resembled bone tissue, where bone cells 
penetrated through the porous scaffold attaching to all surfaces and produced 
extracellular matrix. 
HA is brittle and does not possess the same mechanical strength as bone and therefore, 
cannot be used for load-bearing support. However, the strength of HA grafts has been 
shown to increase once bone starts to grow into it (Ohgushi et al. 1989a). Therefore the 
strength of the tissue-engineered construct may be greater than HA alone, as a result of 
extracellular matrix formation. 
The same methods of assessing cell proliferation and osteoblastic differentiation were 
used to determine whether cryopreservation affected the proliferation or differentiation 
capacity of MSCs. Although, the limitations of these assays, as discussed above, would 
also apply to these results, nonetheless it was shown that this means of storing freshly 
isolated MSCs can be used for cells prior to use in the tissue engineering of bone 
without affecting the abilities of MSCs. 
In conclusion, MSCs can be successfully isolated 
from human bone marrow aspirates, 
which can be easily harvested from patients, and cultured 
for use in the tissue 
engineering of bone. HA has been determined as a suitable surface on which to culture 
MSCs as it stimulates differentiation into osteoblasts. 
My novel bioreactor enhances 
the tissue engineering of an osteogenic construct that could 
be implanted into patients 
to heal bone defects. Furthermore, as it was shown that cryopreservation 
does not 
affect MSCs potential for tissue engineering, this can 
be used to store cells prior to 
implantation. Although this research proves the concept, further testing 
in an animal 
model is necessary before clinical trials could 
be started. 
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6.1.2 Clinical relevance of the studies 
From the in vitro experiments in my thesis, it can be concluded that MSCs can be used 
to construct grafts for potential use in tissue engineering bone defects. As detailed in 
Chapter 1, bone defects that are greater than a critical size will not heal. Such defects 
can be caused by fractures, excision of bone tumours and revision of joint 
replacements. These clinical situations are currently treated with either autologous or 
allogenic bone graft, in addition to synthetic substances, but these treatments are 
associated with various difficulties (see Chapter 1). Therefore, if my osteoinductive 
HA-MSC constructs were implanted into bone defect in vivo, bony healing would be 
expected. A further clinical use of my tissue-engineered bone would be in joint 
fusions, for example spinal fusions, where current practice uses a mixture of 
autologous and allogenic bone graft. 
For bone marrow isolated MSCs to be used in patients in the way described above, a 
consistently reliable method of storage is needed for the cells, as the time between 
harvest and transplant of autologous cells may vary. Therefore, bone marrow could be 
harvested at the time of the primary operation, for example the debridement of 
osteomyelitic bone or compound fracture. The MSCs would be isolated and stored, 
before they were needed for clinical implantation at the second stage operation. 
Cryopreservation has been identified as useful for the storage of biological material, as 
it is not associated with the risks of maintaining cells in culture, including infection; it 
also reduces the time and cost involved. In Chapter 5 it was confirmed that 
cryopreservation of MSCs freshly isolated from bone marrow did not alter the function 
of the cells. Thereby, for autologous MSCs to be used in clinical cases, once the time 
frame for implantation of the construct is determined, cells could be resuscitated and 
cultured on an appropriate scaffold. This method of storing the freshly isolated MSCs 
results in one culture process, reducing the risks associated with it. Continued storage 
by cryopreservation of half the harvested MSCs would also provide the security of a 
further sample if the primary culture becomes contaminated, removing the need for 
obtaining a second marrow aspirate. Patients could also have 
bone marrow isolated 
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MSCs cryopreserved for use in later life, for example possibly for the treatment of 
osteoporosis. 
Furthermore, if allogenic MSCs were to be used for tissue engineering, a storage 
method to provide a reservoir of cells would be necessary. Therefore, a bank of 
cryopreserved MSCs could be created, from which cells could be taken and implanted 
to treat connective tissue defects. However, the implantation of allogenic cells into a 
patient carries the risk of host immune hypersensitivity reaction. To reduce the 
incidence of this immune reaction, the cells could be Human Leucocyte Antigen 
(HLA) matched, as applied to organ donation. However, it has been shown that a Dog 
Leucocyte Antigen (DLA) mismatch goes not affect the healing of a segmental bone 
defect in canines, with MSCs still improving the rate of bone healing (Livingston et al. 
2001). If this is also the case for humans, it increases the potential clinical use of 
MSCs for the treatment of bone defects. Therefore, the immune reaction generated by 
allogenic human MSC needed to be investigated further. 
6.1.3 Further work 
For MSCs to be reintroduced into humans for tissue engineering, concerns may be 
raised about the theoretical transmission of prions from the foetal calf serum (FCS) 
used in culture medium. It has been shown that FCS is necessary for the initial 
adhesion of rat MSCs in primary culture, but following passage 1 this is no longer 
necessary for cell growth (Lennon et al. 1995). Therefore, to reduce the possibility of 
prion transmission from the serum into the cells, culture of MSCs without the use of 
FSC needs to be investigated. It maybe possible to use small amount of autologous 
serum initially, separated from the patient's blood, thus avoiding the need for FCS. 
As the HA surface used in this thesis was shown to stimulate the differentiation of 
MSCs into osteoblasts, HA with a similar macro and micro-porous surface could be 
used to coat prostheses. Further, autologous MSCs could 
be cultured on the surface of 
prostheses and following implantation the resulting 
bony ingrowth studied. 
Use of the novel bioreactor also has massive 
potential for tissue engineering as it 
promotes 3-d growth of cells through a scaffold. 
Firstly, the effect of varying the flow 
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rate of medium through the system on the proliferation and differentiation of MSCs 
could be examined. The growth of MSCs on different scaffolds could be tested, for 
example, allograft or titanium could be investigated for increased osteogenesis. 
Furthermore, the penetration of cells through viscous substrates such as collagen or 
fibrin could be investigated will the aim of creating a glue-like substance that could be 
used in fracture healing. As the increased supply of nutrients was able to support a 
greater cell proliferation, further research would also include using a lower initial cell 
seeding density, thereby reducing the length of time in cell culture prior to growing 
MSCs on a scaffold and the overall time necessary to tissue engineer bone constructs. 
Additional bioreactor chambers set up in parallel within the system could be used to 
culture larger amounts of cells-scaffold constructs. 
Further to being used for culturing osteoblasts from MSCs for the production of tissue- 
engineered bone, the principles of this bioreactor could be applied to other tissues. By 
varying the flow rate and scaffold on which the MSCs are cultured, different types of 
connective tissue could be engineered. For example, MSCs on an alginate substrate 
perfused with a lower tension of oxygen for the tissue engineering of cartilage or the 
differentiation of MSCs into fibroblasts when cultured on sheets of collagen for the 
tissue engineering of skin, could be investigated. 
Lastly, cryopreservation has been shown to be an effective method of storing 
Dermograft®, which is a preparation of fibroblasts on a degradable scaffold that has 
been used clinically to increase the healing rates of skin ulcers (Mansbridge et al. 
1998). Therefore, following the investigation of the impact of cryopreservation on the 
storage ofMSCs, it is suggested that MSCs within a scaffold could be stored using the 
same method of cryopreservation, for example the MSC-HA combination as studied in 
my thesis. These tissue-engineered constructs could be stored by cryopreservation 
prior to implantation into patients commercially. However, this also requires further 
research. 
6.1.4 Limitations of the methods used in this thesis 
Although the cells isolated from bone marrow demonstrated properties of 
MSCs, it is 
unlikely that a truly homogenous population of cells were 
isolated. 
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Cell culture experimentation has specific limitations associated with it, which include 
the selection of cells that survive in these conditions. In the case of chondrocytes, this 
can lead to de-differentiation of cells, although in my experiments the cells continued 
to function demonstrated by protein production. Furthermore, when cells are grown on 
flat surfaces in cell culture, the cells become orientated in one direction, resulting in 
loss of 3-d structure. However, the use of an HA scaffold in Chapters 3&4 allowed 
the cells to grow in a 3-d environment resulting in the formation of extracellular 
matrix. 
All the studies in my thesis were conducted in vitro therefore these results may not 
directly reflect cell behaviour that would occur in vivo. However, in the controlled 
environment of cell culture, the experiments of my thesis form the preliminary work 
for the use of MSCs for tissue engineering of bone. This forms the basis from which 
animal studies can be conducted before testing in clinical trials. 
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